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 I 
Abstract 
The Golgi apparatus is the main crossroad of the intracellular trafficking network in 
all eukaryotic cells and plays a crucial role in the distribution of cellular material. To 
ensure the proper sorting and delivery of cargo proteins to their destination while 
maintaining Golgi homeostasis the coordination of all transport events to and from 
this organelle is required. Although a cascade of activation events has already been 
reported for Golgi Ypt/Rab proteins that function in the exocytic pathway, their 
connection to incoming vesicles from endosomal compartments or to the different 
Arf mediated vesicle formation machineries has still to be established. In addition, 
the role of lipids and the interplay between lipid and protein regulators at the Golgi 
are largely missing. In the present study, we used several approaches to unravel the 
crosstalk between known regulators of Golgi trafficking and to identify new proteins 
involved in this process. As starting point, we considered the results from four 
different screens before focusing on the role of Arf exchange factors. We report two 
new physical interactors of the late Golgi Arf-GEF Sec7p: the lipid kinase Pik1p and 
the cyclic nucleotide phosphodiesterase Cpd1p. In addition, our studies on the 
function of Sec7p revealed additional feature of this protein and it’s relationship to 
the other yeast Golgi Arf-GEFs. 
 
Arf proteins and their regulators play an important role in the formation of vesicles 
at the exit from the Golgi apparatus. There are three Golgi-localized Arf-GEFs in 
S.cerevisiae, Sec7p and the redundant Gea1p/Gea2p. While it has been established 
that Sec7p function does not overlap with the Gea’s, the specific role of these 
proteins remains unclear. We show that Sec7p colocalizes poorly with the Gea’s, 
indicating that these proteins activate Arf on different Golgi sub-compartments. In 
addition, our data suggest that Sec7p mainly promotes the formation of post-Golgi 
transport vesicles supporting forward transport from the late Golgi while the Gea’s 
primarily regulate COPI-mediated retrograde traffic. This observation is consistent 
with published data from mammalian cells and suggests that the spatial and 
temporal regulation of Arf is conserved from yeast to mammals. 
 
Both Arf regulation and phosphatidylinositol 4-phosphate (PI4P) metabolism are 
important factors for Golgi function. Here, we show that the yeast PI4-kinase, Pik1p 
binds specifically to Sec7p but not Gea1p or Gea2p. Taken together, the physical 
interaction, the colocalization and similar transport phenotypes of the respective 
mutants suggests a functional link between Pik1p and Sec7p but not the Gea’s. In 
addition, Pik1p binds to the catalytic domain of Sec7p and could directly influence 
the activity of the GEF. We propose that this interaction coordinates Arf activation 
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with PI4P production to generate a highly specific dual recognition system for the 
recruitment of specific effectors to the late Golgi. 
 
Besides its catalytic domain, Sec7p shares several conserved regions with other 
members of the BIG/GBF Arf-GEF subfamilies, including the N-terminal DCB 
(Dimerization/Cyclophilin Binding) domain. We show that a single point mutation in 
the DCB domain of Sec7p efficiently inhibits Arf activation without affecting 
membrane recruitment of the GEF and could interfere with a possible dimerization 
of the protein. We identified Cpd1p as an allele specific dosage suppressor of the 
Sec7p DCB domain mutation. Cpd1p and Sec7p physically interact and both 
proteins localize independently to the late Golgi. Increased Golgi level of Cpd1p 
compensates for the loss of interaction due to the mutation in the DCB domain of 
Sec7p. The catalytic activity of Cpd1p is important for the rescue, indicating an 
intriguing connection between the Arf activation cycle and ADP-ribose derivates. We 
also find that Cpd1p interacts with several other proteins involved in Golgi- and 
post-Golgi transport events. Hence, Cpd1p is a new regulator of vesicular traffic at 
the Golgi that could act as a scaffolding factor for Sec7p and other transport 
proteins. 
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 1 
1/ Introduction 
In all eukaryotes, compartmentalization of cellular function made vesicular traffic an 
essential process connecting the different organelles with each other and supporting 
the material flow between them. This interconnection gives rise to a very intricate 
network of transport pathways, which requires a very tight spatial and temporal 
regulation to ensure specificity of cargo delivery and maintain a proper balance of 
intracellular material. The Golgi apparatus is the central sorting station inside cells, 
however the machinery for vesicle formation and cargo sorting at the Golgi exit 
remains poorly understood. Despite the identification of several proteins associated 
with this transport step, their exact functions are only partially characterized. 
Furthermore, the regulation mechanism responsible for the coordination of material 
entering and exiting the Trans-Golgi Network (TGN) is a mystery. The current work 
was directed toward understanding the crosstalk between known transport proteins 
at the TGN and the identification of new players involved in this process.  
 
1.1/ General overview of protein transport 
The unraveling of molecular mechanisms that underly vesicular transport started in 
the late 1970’s with the isolation of temperature sensitive SEC mutants in yeast [1, 
2] and the reconstitution of protein transport in a cell free system [3, 4]. Those early 
experiments confirmed the vesicular transport hypothesis and generated the tools to 
investigate its molecular basis. The field elicited even more interest some years later 
when the conservation of the vesicular transport machinery between yeast and 
mammals was shown [5]. Since that time, the mechanisms of the different steps of 
vesicluar transport, coat recruitment, cargo sorting, vesicle budding, tethering and 
fusion have been intensively studied. The considerable amount of data generated 
gives us a yet incomplete picture of the life-cycle of transport vesicles as well as an 
insight into the complex interplay of the different transport pathways and the basic 
mechanisms of cargo sorting.  
 
1.1.1/ Transport pathways 
The more complex structure of higher eukaryotic cells compared to S.cerevisiae is 
reflected in their transport network, which is bound to be even more intricate than 
in budding yeast. However, the very high conservation of transport mechanisms 
makes S.cerevisiae a good model organism to dissect the basic principles of 
membrane transport and study this process on a molecular level. 
 
The main transport pathways identified in the yeast S.cerevisiae are illustrated in 
Figure 1. The biosynthetic pathway, delivering newly formed proteins from the ER to 
their cellular destination, relies on proteins encoded by SEC (secretory) [1, 2] and 
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VPS (vacuolar protein sorting) [6] genes. SEC genes are essential and have been 
divided into several groups. Early acting SEC genes are required for anterograde and 
retrograde transport between the ER and the Golgi apparatus and the formation of 
secretory vesicle at the Golgi [7]. They affect the whole biosynthetic pathway, 
disrupting transport of cargoes to the vacuole as well as to the plasma membrane. 
Late acting SEC genes are involved in protein delivery from the Golgi to the plasma 
membrane and do not disturb protein sorting to the vacuole [8]. Mutations in late 
SEC genes result in complete arrest of secretion by blocking fusion of exocytic 
vesicles with the plasma membrane. These mutant cells accumulate two kinds of 
secretory vesicles that differ both in cargo and density [9]. Basing on this 
observation, the existence of two parallel pathways from the Golgi to the plasma 
membrane that need the same machinery once they reach their destination has 
been proposed [9]. The two kinds of secretory vesicles are not affected to the same 
extend by mutations impairing the endocytic pathway, and cargoes from one path 
can be redirected into the other one [10, 11]. The implication of these observations is 
still debated and has lead to several hypotheses, including a model where one 
branch of the secretory pathway transits via an endosomal compartment before 
reaching the surface [10]. The redundance of the system could partly explain the 
difficulties encountered so far in isolating proteins involved in secretory vesicle 
formation at the Golgi. 
 
Proteins encoded by VPS genes are needed for proper delivery of cargo to the vacuole 
and act between the Golgi and this compartment. The different routes to the vacuole 
are named after the cargoes they transport. The CPY (carboxypeptidase Y) pathway 
transits via late endosomal compartments before reaching the vacuole [12], while 
the ALP (alkaline phosphatase) pathway, also known as AP-3 pathway, describes a 
more direct route bypassing late endosomes [13-15]. The trafficking routes between 
Golgi and endosomes mediated by clathrin-coated vesicles are referred to by the coat 
adaptors required for their assembly. Cargoes transported from the Golgi toward 
early endosomes belong to the AP-1 pathway, while the GGA pathway, which 
partially overlaps with the CPY pathway, carries proteins directly from the Golgi to 
late endosomes [16-19]. 
 
Endocytosis and protein retrieval from later compartments to earlier ones further 
complicates the network of transport pathways. Internalized material from the cell 
surface encounters biosynthetic cargoes at the endosomal levels [12]. From there, 
cargoes can either proceed toward the vacuole or be retrieved to the Golgi 
apparatus. The route from the plasma membrane to the vacuole transits via two 
different compartments [20, 21]. Specific proteins are retrieved to the Golgi either 
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from the early endosomes via the recycling pathway [22] or from a later endosomal 
compartment by the retromer complex [23].  
 
 
 
 
Figure 1: Overview of the different transport pathways in S.cerevisiae 
The different steps of the secretory and endocytic pathways (ER-to-PM and PM-to-vacuole) are 
relatively well characterized, while the different routes connecting the Golgi to endosomal 
compartments are still debated. The existence of a direct route from the endosomal 
compartments to the cell surface has been proposed but lacks experimental evidence. (SV = 
secretory vesicle, MVB = multivesicular body, CPY = carboxypeptidase Y, ALP = alkaline 
phosphatase). In the literature, the nomenclature of the different yeast endocytic 
compartments is misleading. In this study I will refer to early and late endosomes, meaning 
the following: 
Early Endosome (EE) = Post-Golgi Endosome (PGE) = Tlg1p positive compartment. 
Late Endosomes (LE) = PreVacuolar Compartment (PVC) = Pep12p positive compartment.  
MVBs = transport intermediates between late endosomes and vacuoles (not represented).  
 
 
1.1.2/ Transport vesicles 
Small transport vesicles carry material along the different pathways described above 
by budding from a donor and fusing with an acceptor compartment. The abundance 
of transport pathways clearly reveals the complexity underlying cargo sorting and 
targeting, processes in which coat proteins play a central role together with small 
GTPases, tethering factors and proteins involved in the docking and fusion process.  
 
Coat proteins, which are in general highly conserved throughout evolution both in 
structure and function [24, 25], regulate specific transport pathways. Thus, COPII 
vesicles mediate anterograde transport between the ER and the Golgi compartment, 
while the COPI coat is involved in retrograde transport within the Golgi and from the 
Golgi back to the ER [26, 27]. Clathrin, another highly conserved coat complex, is 
involved in formation of endosomal-targeted vesicles from the TGN [28, 29]. It also 
plays an important role in endocytosis [28, 30-32]. The retromer complex has been 
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proposed to function as a coat for vesicles trafficking between late endosomes and 
the Golgi [23]. So far, no coat component associated with secretory vesicles has been 
identified except for the exomer [33]. However, this coat seems yeast specific and is 
only involved in the delivery of a subset of cargoes to the plasma membrane [33]. 
 
Formation of coated vesicles is initiated by the activation of small GTPases of the Arf 
family that recruit soluble coat components from the cytosol to the donor 
membrane. Cargo sorting and concentration in the nascent bud proceeds together 
with coat assembly and membrane deformation. Mature vesicles are pinched off 
from their donor compartments and released into the cytosol. Until recently, vesicles 
were believed to uncoat before tethering to their acceptor compartment, however this 
view is challenged by the report of a direct interaction between COP coat 
components and their tethering complexes at the Golgi [34, 35]. Recognition of a 
vesicle with its target membrane is first mediated by tethering factors working in 
combination with small Rab GTPases. Assembly of a trans-SNARE complex triggers 
the subsequent docking step by bringing the two membranes close to each other 
and allowing for fusion (reviewed in [36]). 
 
Small GTPases of Ypt/Rab protein family act as key regulators in all vesicular 
transport events in eukaryotic cells. These proteins, like all GTPases, cycle between 
an inactive GDP-bound and an active GTP-bound form in which they interact with a 
host of effectors. The cycling between the two forms is regulated by guanine 
nucleotide exchange factor (GTP to GDP) and GTPase activating proteins (GDP to 
GTP). These proteins are found in both soluble and membrane-bound forms 
depending on their nucleotide-binding state, activated Rabs being tightly associated 
with membranes. Ypt/Rab proteins regulate docking by recruitment and assembly 
of different tethering factors, thereby contributing to specificity of vesicle 
recognition. In addition, several studies suggest the involvement of these GTPases in 
the temporal regulation of membrane traffic by demonstrating the existence of two 
Rab cascades in yeast [37, 38]. In addition, some studies link Rab function to Rho 
signaling [39], and genetic interactions between Rab and Arf GTPases suggest a 
connection between vesicle budding and fusion [40] (reviewed in [41]). 
 
Tethering is the process where transport carriers are first brought in contact with 
their target membrane. This interaction can occur over a considerable distance and 
is mediated by two different kinds of factors: long coil-coiled proteins and large 
hetero-oligomeric protein complexes. Proteins belonging to each class have been 
shown to be involved at the same transport steps. Multi-subunit complexes are 
found on many different membranes. The exocyst, which tethers secretory vesicles 
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with the plasma membrane, is a hallmark for sites of polarized secretion. The GARP 
(Golgi-associated retrograde protein), TRAPP (transport protein particle) and COG 
(conserved oligomeric Golgi) are three large complexes associated with the Golgi 
apparatus and the HOPS (homotypic fusion and vacuole protein sorting) complex 
works at the endosomal level (reviewed in [42]). Members of the long coiled-coil 
family of tethering factors have been identified only at the Golgi (referred to as 
golgins) and endosomes where they work in pairs with Rab GTPases. The central 
role of these coiled-coil proteins in transport was first demonstrated in vitro where 
p115/Uso1p is the only cytosolic protein required for tethering of purified COPII 
vesicles with washed acceptor membranes [43]. The apparent overlapping function 
of different tethering factors at single transport steps underlines the importance of 
accurate vesicle recognition by acceptor membranes and hints toward a two step 
tethering process instead of a single event (reviewed in [42, 44]). 
 
The last step of vesicle life before fusion is the docking stage triggered by the 
assembly of trans-SNARE complexes. The SNARE hypothesis formulated by 
Rothman in 1994 proposes that each vesicle and receptor membrane contains 
complementary SNAREs that bind to each other and promote fusion of the two 
membranes [45]. This model is supported by a growing load of evidence. Monomeric 
SNAREs found on vesicles bind to trimeric SNARE complexes on acceptor membrane 
resulting in the formation of a tight helical bundle. This bundle brings the two 
membranes in close proximity and the energy released during this process could 
drive membrane fusion. After fusion, the SNARE complex binds to SNAP, which 
recruits NSF. This factor dissociates the SNARE complex by hydrolyzing ATP and 
releases the four SNAREs for a new round of fusion. The intracellular distribution of 
SNAREs suggests a role for these proteins in determining the specificity of fusion 
reactions, since SNARE pairs are associated with different transport steps. However, 
both the lack of specificity of SNARE pairing in vitro and the involvement of some 
SNAREs in several transport steps indicates that they cannot be the only 
determinant of fusion accuracy and are likely to cooperate with other factors to 
achieve cargo delivery to the right compartment (reviewed in [46]). 
 
1.1.3/ Lipids 
Lipids are the backbone of organelle membranes and transport vesicles and a 
growing amount of data indicates that lipids do not just form an inert matrix but 
actively participate in transport processes. Lipid-lipid and protein-lipid interactions 
are important for vesicle formation, organelle identity and are key intermediates in 
signaling transduction pathways.  
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Recent work considerably changed our conception of membrane architecture. The 
“fluid mosaic model”, proposed by Singer and Nicholson in 1972 is still used in most 
textbooks and represents membranes as a continuous lipid bilayer with few proteins 
spread across the surface. Among other evidence (reviewed in [47]), the detailed 
analysis of synaptic vesicles [48] demonstrates the overwhelming space proteins 
occupy on the surface of membranes and indicates that the accessibility of surface 
lipids by soluble proteins is an issue to take in consideration. 
 
Lipid composition of membranes changes from one organelle to the next, as does the 
lipid distribution across the bilayer, resulting in more or less asymmetric 
membranes. The important flow of material between different membranes would 
rapidly lead to homogenization except for the action of a host of proteins working to 
create and maintain the characteristic composition of each compartment. 
 
Asymmetry between two membrane leaflets is reflected by the distribution of 
different lipids across the bilayer. ER membranes where most lipids are synthesized 
are symmetric, while in the majority of eukaryotic cells the plasma membrane is 
asymmetric. Therefore, membrane asymmetry must be established along the 
secretory pathway. Lipid translocation across membranes, an intrinsically slow 
process, is catalyzed by specialized trans-membrane proteins, like flippases 
(aminophospholipid translocases). Different members of the flippase family are 
involved in specific transport steps to and from the yeast Golgi apparatus and take 
part in coated vesicle formation. Several models have been proposed to explain the 
role of these proteins and most of them emphasize a mechanistic aspect: 
translocation of specific phospholipids across membranes can influence curvature. 
Thus, flippases could help the vesicle budding machinery by creating either a 
positive curvature where vesicles assemble or reverse the negative curvature due to 
vesicle release creating a suitable template for a new round of vesicle budding 
(reviewed in [49]). Besides flippases, several other processes are known to influence 
membrane curvature and thus promote vesicular transport (reviewed in [50] and see 
update in [51]).  
 
Unlike other phospholipids, phosphatylinositol (PI) can be further phosphorylated 
on three different position of the inositol ring leading to a variety of derivatives 
named phosphoinositides (see Figure 2). Even if these lipids represent only a minor 
proportion of the total phospholipids in cells, their specific subcellular distribution 
makes them attractive candidates as organelle markers. Phosphoinositides are 
found on the cytosolic leaflet of membranes and their characteristic distribution is 
maintained by the combined action of PI-kinases and PI-phosphatases (reviewed in 
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[52]). The intracellular distribution of phosphoinositides and their regulatory 
proteins in yeast is illustrated in Figure 2.  
 
The physiological role of phosphoinositides is mediated by their polar head group 
facing the cytosol, which can recruit specific effectors to the membrane as well as 
regulate membrane proteins though interaction with their cytosolic domain. Several 
protein domains, like the plextrin homology (PH) domain, interact preferentially with 
a given phosphoinositide and account for the specificity of effector recruitment 
(reviewed in [53]). These lipid-binding modules are found in proteins mediating a 
broad range of cellular functions including signal transduction, cytoskeleton 
organization and nearly all aspects of vesicular trafficking. The role of 
phosphoinositides as organelle landmarks is also tightly linked to the action of small 
GTPases like Ras, Rab or Arf, which recruit specific effectors in their active 
membrane-bound conformation. The collaboration between GTPases and 
phosphoinositides provide interesting means to couple spatial and temporal 
regulation. Examples of cooperation include simultaneous binding of effectors as 
well as activation of positive or negative feedback loops between regulators of the 
different partners (reviewed in [54, 55]). 
 
 
 
Figure 2: Phosphoinositide distribution in S.cerevisiae 
Only PI3P, PI4P, PI(4,5)P2 and PI(3,5)P2 have been detected in yeast, the other PI derivatives 
are shown in gray. The table lists the kinases and phosphatases catalyzing the different steps 
of the phosphoinositide cycle. The subcellular localization of the different phosphoinositides 
and their kinases is illustrated in the lower panel, using the same color code as above. Only 
the major site of action of each kinase is represented. Phosphoinositide phosphatases are less 
well characterized than the kinases and their putative site of action correlates with their 
function. 
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1.2/ The Golgi apparatus 
Even if the Golgi apparatus is the major sorting station in cells (see Figure 1), 
sorting is not the only function of this intriguing organelle. The Golgi is also an 
important site for protein and lipid modification where glycosylation of biosynthetic 
molecules takes place [56]. Moreover, several signal transduction pathways as well 
as cytoskeleton organizers use the Golgi as a platform for their signaling activities 
(reviewed in [57-59]).  
 
In order to perform these different functions, the Golgi apparatus is organized as a 
succession of sub-compartments or cisternae recognizable by their biochemical 
content [56, 60]. As observed for the first time in the mid 1950s [61], in most 
eukaryotic cells, Golgi cisternas are organized as a series of flattened stacks. The 
Golgi structure in the yeast S.cerevisiae is particular since it is composed of 
scattered mobile cisternae. However, even in this case, sub-compartmentalization is 
maintained and markers for early and late Golgi are found on distinct structures 
[62]. Despite the apparent morphological disparity between yeast and higher 
eukaryotes, it is interesting to note that, under special circumstances, stacks 
strongly resembling mammalian Golgi structures can be induced in S.cerevisiae [7]. 
 
Newly synthesized proteins coming from the ER enter the Golgi on the cis- side and 
progress through the different compartments before leaving the organelle from the 
trans-Golgi network (TGN). How this progression is achieved without affecting the 
overall structure of the Golgi is still a matter of debate. The most common models 
are presented in Figure 3. In the vesicular transport model, small vesicles carry 
material between stable cisternae in both the anterograde and retrograde direction. 
The maturation model, on the contrary, considers single Golgi stacks as dynamic 
entities changing with time, and limits the role of vesicular transport to the recycling 
of resident proteins to earlier compartments. Arguments supporting each model 
have been reviewed numerous times [63-67] and additional models trying to 
reconcile both positions have been presented [64, 66]. The inter-cisternal 
connections model has been proposed recently and is based on the observation that 
interconnection between different stacks through tubules can be induced under 
specific conditions [68]. The validity of these different models is presumably 
organism [63] and even cell-type dependent. In animal cells with structured Golgi 
stacks, most of the transport might result from vesicular carriers, while maturation 
is likely to be slow. In simpler organisms lacking discernable stacks, like budding 
yeast, maturation of single cisternae seems a good strategy. Indeed, two recent 
studies provide evidence that Golgi cisternae do mature over time in S.cerevisiae [69, 
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70]. Finally, creation of tubules might be an efficient way to transiently handle a 
large quantity of material [67]. 
 
 
 
 
Figure 3: Intra-Golgi transport models 
A. In the vesicular transport model, Golgi compartments are stable structures and exchange 
between cisternae is carried out by vesicular transport. B. The cisternal maturation model 
postulates a continuous maturation of single cisternae balanced by the retrieval of Golgi 
resident proteins to younger cisternae by COPI vesicles. C. In the inter-cisternal connections 
model, the different cisternae are connected with each other by tubules through which 
material can diffuse from one compartment to the next.  
 
 
Golgi partitioning during cell division is another controversial issue that shows how 
little is known about the regulation of this organelle. Golgi inheritance is organism 
specific and the different strategies seem linked to the requirement for a functional 
secretory pathway during cytokinesis [71]. The most striking reorganization of the 
Golgi during cell division is seen in many animal cells where the organelle 
disassembles and Golgi proteins seem to accumulate in the ER. After completion of 
the cell division, a new Golgi is formed [72]. On the other side of the scale, 
S.cerevisiae, where the Golgi is present in discrete structures, partitions late Golgi 
elements to the growing bud, while early Golgi elements are linked to the inheritance 
of the ER [73, 74]. Alternative mechanisms include de novo formation of the Golgi in 
daughter cells (Pichia pastoris) [75] or binary fission of a large Golgi structure (algae) 
[76]. The debate on Golgi inheritance centers on the capacity of this organelle to 
reform on it’s own (de novo formation) or the necessity of a template to do so [77, 
78]. The interesting question underlying this debate is which proteins are involved 
in the generation of the new stacks and how this process is regulated. Answers to 
these questions would greatly help to understand how Golgi homeostasis is achieved 
and subsequently maintained. This process is intimately linked to vesicular 
transport and the function of small GTPases of the Arf family (reviewed in [79]). 
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1.3/ The role of Arf in vesicle formation at the Golgi 
ADP-ribosylation factors (ARFs) received their name from their ability to catalyze 
ADP-ribosylation of G proteins by cholera toxin [80]. They are small GTPases playing 
a central role in vesicle formation. Like Ypt/Rab proteins, they cycle between an 
active and an inactive conformation, a process that is catalyzed by guanine-
nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs). Activated 
Arf is tightly associated with membranes and recruits a variety of effectors involved 
in all aspects of vesicle formation (reviewed in [81, 82]). 
 
Inactive Arf is mainly found in the cytosol and can only weakly interact with lipids 
through its myristoylated tail [83]. A tight association of Arf and with membranes 
occurs only after nucleotide exchange, which leads to a conformational change 
resulting in insertion of the amphipathic helix into the membrane [83]. The 
mechanism behind membrane recruitment of GDP-bound Arf is poorly understood 
but it is required for activation through the GEFs [84]. The role of membrane 
receptors for Arf was first assigned to the GEFs, however, some studies suggest that 
both factors are recruited independently and interact with each other only after 
membrane attachment [85-89]. However, this issue remains unclear [87, 90]. 
ArfGEF proteins form a vast family, whose members all contain a characteristic 
~200aa long domain, called “Sec7 domain” [91, 92]. The Sec7 domain is necessary 
and sufficient to catalyze nucleotide exchange on Arfs [40, 93, 94]. As Arf proteins 
themselves, Arf-GEFs are peripheral membrane proteins that cycle through the 
cytosol and little is known about their recruitment [87, 89, 91]. 
 
Once activated, Golgi-localized Arf proteins interact with a host of effectors to 
promote formation of different coated vesicles. Coatomer, the building unit of COPI 
vesicles, was the first Arf effector identified [95, 96]. Further work showed that 
activated Arf and coatomer are sufficient to form COPI vesicles from synthetic 
membranes containing acidic phospholipids [97], although additional factors are 
required in more physiological conditions [98]. Activated Arf also recruits two classes 
of clathrin adaptors to the Golgi: AP-1 and GGAs [99, 100]. The AP-1 complex 
promotes the assembly of clathrin coated vesicles at the TGN and its localization 
depends both on Arf and phosphatidylinositol 4-phosphate (PI4P), the Golgi 
phosphoinositide pool (reviewed in [101]). GGAs are monomeric clathrin adaptors 
which can bind ubiquitylated cargoes and participate in their sorting from the Golgi 
to endosomes (reviewed in [102, 103]). Arf has also been reported to influence traffic 
by interacting with lipid modifying enzymes such as phospholipase D (PLD) and 
phosphatidylinositol 4-kinase (PI4K) [104, 105]. Activation of PLD in vitro is a 
fundamental property of all Arfs and belongs to the criteria for naming Arf family 
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members [106]. However, the physiological relevance of PLD activation for vesicle 
formation is not clear (reviewed in [107]). In vitro experiments have also led to the 
conclusion that Arf can recruit PI4K to the Golgi and stimulate its activity [105], but 
in vivo data are missing. The last category of Arf effectors in mammalian cells is 
affecting the actin cytoskeleton and thereby the structure of the Golgi apparatus 
(reviewed in [58, 82]). 
 
Arf-GAPs catalyze hydrolysis of the bound GTP and release Arf from membranes 
[108]. Since the release of the COPI coat from vesicles is tightly coupled to Arf 
inactivation, the role of Arf-GAPs was long thought to be restricted to vesicle 
uncoating following budding of the membranes [108]. However, Arf-GAPs also play a 
direct role in cargo sorting and COPI vesicle formation [90]. This observation 
combined with the tight link between GAP activity and membrane curvature [109, 
110] as well as the dynamics of coat components cycling to and from the membrane 
[111], has led to a new model for the role of Arf-GAPs [90, 109, 111]. Hence, 
hydrolysis of GTP-bound Arf is no longer considered as a punctual event following 
vesicle budding but a continuous process, triggering several rounds of cargo 
recruitment. In addition, the link between GAP activity and increased membrane 
curvature could act as a timing device regulating coat stability (reviewed in [67]). 
Although this model for Arf-GAP function was derived from studies on COPI vesicles 
formation, the notion that Arf hydrolysis plays a role in coat assembly is supported 
by studies on AP-1 and formation of clathrin coated vesicles [112]. 
 
The central role of Arf in Golgi homeostasis is highlighted by the dramatic alteration 
of this organelle upon brefeldin A (BFA) treatment. BFA is a bacterial toxin that acts 
as an uncompetitive inhibitor of Arf activation by stabilizing an inactive complex 
between GDP-bound Arf with its GEF [113]. The addition of BFA to mammalian cells 
results in a very rapid redistribution of Golgi markers and leads to organelle 
disassembly, cis- and medial-Golgi stacks collapsing back in the ER while later 
compartments mixing with endosomes [114, 115]. This dissociation of the Golgi 
compartments resembles the Golgi fragmentation observed during mammalian cell 
division. Since the different compartments fully regenerate after wash-out of the 
drug, BFA has proven a powerful tool to dissect the fundamental role of Arf in Golgi 
biogenesis (reviewed in [79]). In addition to stabilizing a GEF-Arf-GDP complex, BFA 
treatment of mammalian cells results in the ADP-ribosylation of CtBP/BARS, a 
protein required for membrane fission. Failure to detach vesicles by inhibiting 
CtBP/BARS leads to excessive tubulation of Golgi membranes, which, combined 
with the inhibition of Arf function in cells exposed to BFA, promotes the break down 
of the organelle (reviewed in [116]). The action of BFA on transport is not restricted 
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to mammalian cells as this drug effectively blocks trafficking in the yeast early 
secretory pathway and strongly affects the morphology of endosomal compartments 
[117, 118]. 
 
Arf function is also linked to protein kinase A (PKA) activity in mammalian cells. In 
the absence of cyclic AMP (cAMP), PKA is found in an inactive complex with its 
regulatory subunits, while in the presence of cAMP, the kinase is released and 
phosphorylates a wide range of substrate thereby modulating their activity. The 
regulatory subunits of PKA determine its subcellular localization by binding to A-
kinase anchoring proteins (AKAPs). In traffic, PKA is important for the biogenesis 
and maintenance of Golgi structure and transport through the Golgi [119-123]. In 
addition, activated PKA increases Arf recruitment to membranes in vitro [119-123]. 
The effect of PKA at the Golgi is, at least partially, mediated by its interaction with 
the Arf-GEFs, BIG1 and BIG2. Both contain AKAP sequences and bind to a 
regulatory subunit of PKA [124, 125]. These GEFs are also phosphorylated by PKA 
and this modification decreases their GEF activity in vitro [126]. In vivo, PKA 
phosphorylation of the GEFs result in decreased membrane attachment and under 
certain conditions promotes relocation of BIG1 to the nucleus [125-127]. 
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1.4/ Traffic regulators at the yeast Golgi  
The study of vesicular transport to and from the Golgi apparatus is crucial to 
understand how the dynamic equilibrium of this complicated organelle is 
maintained and how different cargoes can be segregated from each other and 
accurately targeted to their proper cellular destination. To address the overall 
regulation of the Golgi apparatus we use the small budding yeast S.cerevisiae. The 
high conservation of both Golgi function and transport processes through evolution 
makes yeast an ideal model organism to unravel the basic principles of membrane 
transport. This chapter will deal with the current knowledge on key regulators of 
vesicular traffic at the yeast Golgi and their direct mammalian homologues. The 
main focus represents small GTPases, which are powerful molecular switches able 
to act both as spatial and temporal regulators, and the Golgi specific 
phosphoinositide, PI4P. 
 
1.4.1/ Members of the Arf protein family at the Golgi 
There are three Arf proteins in yeast, Arf1p and Arf2p are redundant and play an 
important role in traffic from the Golgi [128, 129] and in maintenance of organelle 
integrity in the secretory and the endocytic pathway [130]. Arf3p has been shown to 
be involved in endocytosis, actin polymerization and polarized secretion at the 
plasma membrane, as it’s closest mammalian homologue ARF6 [131-133]. 
Interestingly, a study in mammalian cell suggests that all Class I and II ARFs (ie all 
ARFs except ARF6) function as pairs and different pairs influence specific transport 
steps [134].  
 
1.4.1.1/ Arf effectors in yeast 
As in other organisms, the yeast Arfs are believed to control the formation of COPI 
coated vesicles, which mediate Golgi-to-ER and intra-Golgi retrograde transport [26] 
and to promote the assembly of clathrin-coated vesicles (CCVs) that support 
transport from the Golgi to the endosomes [29, 135]. Arf is also required for the 
assembly of the yeast specific exomer coat complex [33] (see Figure 4). Yeast cells 
have two Gga’s and one adaptor (AP) complex binding clathrin at the Golgi [136, 
137]. Genetic data show that deletion of either AP-1 or Gga’s is less detrimental than 
mutation in the clathrin heavy chain, while the deletion of both AP-1 and Gga’s has 
a synthetic effect, suggesting a common function [17]. However they only partially 
overlap since depletion of either AP-1 or Gga’s does not affect transport of different 
cargoes to the same extend [16, 138, 139]. Moreover, Gga’s are able to support 
clathrin-mediated Golgi-to-endosome transport independently of AP-1 [18, 19, 140, 
141]. The model that best supports the available data proposes that AP-1 promotes 
formation of vesicles directed to early endosomes while Gga’s are involved in 
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clathrin-mediated transport to the late endosomal compartment, with partial 
rerouting of cargoes under specific conditions [16-18]. Clathrin and AP-1 have also 
been implicated in the formation of heavy density secretory vesicles [142]. 
 
 
 
 
Figure 4: Golgi exit routes controlled by Arf proteins 
Arf supports transport from the Golgi by promoting the assembly of COPI, clathrin and 
exomer coated vesicles. Two kinds of Golgi-derived clathrin coated vesicles (CCVs), can be 
formed through the interaction of Arf with either one of the two clathrin adaptors present at 
this compartment (AP-1 or Gga’s). No involvement of Arf in the yeast AP-3 pathway has been 
reported. 
 
 
As illustrated in Figure 4, Arf is thought to control many pathways out of the yeast 
Golgi, however, direct in vivo evidences are scarce. Activated Arf localizes to the 
Golgi and arf mutants interact genetically with both COPI and clathrin mutants 
[130, 135, 143, 144]. As COPI mutants, arf mutants are defective in Golgi-to-ER 
retrieval. However, ARF mutations have a broader effect on Golgi and endosomal 
structure than copI mutants, which is consistent with additional roles of Arf beside 
the formation of those vesicles [130, 145]. A physical interaction between COPI and 
Arf has so far only been shown in vitro [146]. In addition, while both Gga’s and AP-1 
bind to clathrin in vivo [17, 19], only Gga’s were shown to bind activated Arf. 
However, this interaction seems to play only a minor role in their recruitment to the 
yeast Golgi, while in mammalian cells ARF is essential for proper GGAs localization 
[100, 136, 147, 148]. No direct interaction between yeast AP-1 and Arf has been 
reported, but BFA treatment results in dissociation of AP-1 from membranes [137].  
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In addition to the effectors discussed above, Arf1p also recruits Rud3p, a long 
coiled-coil protein of the golgin family, to the cis-Golgi [149]. There is currently no 
direct evidence supporting a role for Arf in lipid metabolism in vivo and yeast PLD is 
not activated by Arf neither in vivo nor in vitro [150]. To my knowledge, no direct link 
between Arf and the cytoskeleton has been reported in yeast.  
 
1.4.1.2/ Arf exchange factors (GEFs) in yeast 
The yeast genome encodes five genes containing the Sec7 domain signature of Arf 
guanine nucleotide exchange factor, among which four exhibit in vitro GEF activity 
[40, 92]. Three of them, Sec7p, Gea1p and Gea2p have identified roles at the Golgi 
[2, 151-153]. The fourth, Syt1p, is a high copy suppressor of a Ypt31/32p double 
mutant, hinting at a post-Golgi function [40]. In addition, deletion of SYT1 impairs 
the growth of an mss4 mutant, the only yeast phosphatidylinositol-5-kinase (PI5K) 
involved in actin cytoskeleton organization at the plasma membrane [154]. Both 
Syt1p and the last ORF containing a Sec7 domain, YBL060w, have an additional PH 
domain at their C-terminus [92]. 
 
Sec7p is the homologue of mammalian BIG1 and BIG2, while Gea1p and Gea2p 
correspond to GBF1. All these proteins are over 180 kDa and contain a central Sec7 
domain that is sufficient for GEF activity. However, in the case of Sec7p, this 
domain represents less than 10 % of the protein and neither the N- nor C-terminal 
parts of the protein have assigned functions. Five additional conserved domains 
were identified by sequence analysis of the different homologues of the BIG and GBF 
subfamilies, which are not present in other GEFs (see Figure 5) [155]. Although the 
function of these domains remains uncharacterized their conservation suggest a 
common architecture between those GEFs and hints toward shared mechanisms of 
action. 
 
In mammalian cells, BIG1 and GBF1 localize to different Golgi compartment: BIG1 
colocalizes with late Golgi markers and clathrin, while GBF1 is found together with 
COPI on the cis-Golgi and ERGIC (ER to Golgi intermediate compartment) [156]. 
BIG2, which is partly found in a complex with BIG1, is localized to the TGN and 
recycling endosomes together with AP-1 and interact with a component of the 
exocyst complex [157-159]. In addition, interference with GBF1 function results in 
dissociation of COPI from the Golgi but does not affect clathrin [160], while a 
dominant-negative BIG2 mutant specifically interferes with membrane recruitment 
of AP-1 and GGAs [161]. Moreover, overexpression of BIG2 protects AP-1 from 
redistribution after BFA treatment [162]. Hence, GBF1 is believed to regulate 
retrograde transport by forming COPI vesicle on early Golgi compartments while 
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BIGs are thought to promote forward transport from the TGN and RE through CCVs. 
This model is attractive and coherent with the available data but still leaves many 
unanswered questions especially concerning intra-Golgi transport. The importance 
of proper Arf activation for cell function is highlighted by the involvement of 
mammalian GEFs in key cellular functions and their connection to diseases. GBF1 
is a target of polio- and coxsackie-viruses [163-165], while BIG2 binds to and 
regulates exocytosis of TNF and GABAA receptors, which are involved in immune 
response and neurotransmitter uptake, respectively [166, 167]. In addition, a severe 
human hereditary disease called autosomal recessive periventricular heterotopia 
with microcephaly (or ARPHM) has been linked to mutations in the DCB domain of 
BIG2 [168].  
 
 
 
 
Figure 5: Conserved domains of the BIG/GBF subfamilies of Arf GEFs 
Sequence alignments of 42 ArfGEFs belonging to the BIG or GBF families, identified 5 
conserved domains in addition to the catalytic Sec7 domain [155]. No function is assigned to 
them yet but a steadily growing number of interactions are reported for each of these 
conserved regions. In addition to the features listed in the table, BIG2 interacts with Exo70p 
through an N-terminal region encompassing both the DCB and HUS domain [159], and with 
the β subunit of the GABAA receptor through its extreme C-terminus, downstream of the 
HDS3 domain [166]. The N-terminus of GBF1, containing the HUS and DCB domains, also 
interacts with the Coxsackievirus protein 3A [164]. Reference in the figure: 1[169], 2[170], 
3[171], 4[124], 5[168], 6[172], 7[173], 8[87]. 
 
 
In yeast, the distinct role of the three Golgi Arf GEFs is less clear. Double deletion of 
gea1/2 is lethal and cannot be rescued by overexpression of Sec7p nor can Gea1/2p 
overexpression overcome the defect of sec7 mutants [93]. Hence, Gea1/2p share an 
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essential function that does not overlap with Sec7p, indicating that at least two 
different GEF activities at the Golgi are required for viability.  
 
Sec7p is an essential protein, reported to affect ER-to-Golgi, intra-Golgi and post-
Golgi transport [153, 173-175]. The abnormal glycosylation pattern and the 
transport delay of cargoes from both the secretory and vacuolar sorting pathways in 
sec7 mutants suggest a defect in Golgi function [175, 176]. Morphological data 
support this conclusion since sec7 mutants accumulate both ER membranes and 
aberrant Golgi structures, called Berkeley bodies, which are characteristic for 
mutants affecting TGN exit [2, 173, 176]. In addition, immunofluorescence 
experiments show a good colocalization between Sec7p and Kex2p, a late Golgi 
marker [153]. Lack of Sec7p activity affects transport through the endosomal 
pathway but not the internalization step of endocytosis [118]. In addition, Sec7p 
seems required for fusion in cell free assay reproducing ER-to-Golgi transport [177] 
and physically interacts with Arf1p and COPI through its Sec7 domain and with 
COPII via the C-terminus in vitro [173]. Interestingly, nutrient availability influences 
the severity of sec7-1ts mutant phenotypes: in media containing standard glucose 
concentration (2%) the growth defect at non-permissive temperature is not reversible 
and the strain accumulates Berkeley bodies, but in low glucose media (0.1%) the 
growth defect is reversible and the mutant accumulates stacks of membranes 
resembling mammalian Golgi cisternae. This glucose dependency is not seen with 
other sec mutants [7]. 
 
Most studies suggest a role of Gea1p and Gea2p in retrograde transport from the 
Golgi to the ER but they have also been reported to directly affect anterograde traffic 
between these two organelles [87, 151, 152]. There is a tight link between Gea1/2p 
and COPI coat components: first, the transport defects of gea double mutants and 
COPI mutants are similar; second, both GEAs and SEC21, a COPI coat subunit, are 
high copy suppressors of each other [93, 151]. Strong defects in anterograde 
transport, independent of COPI mediated retrograde traffic, has been reported for 
some gea mutants but the structure of the endosomal system seems unaffected 
when visualized with the dye FM4-64 [152, 178]. Both Gea1p and Gea2p bind to 
Gmh1p, a Golgi-localized trans-membrane protein that cycles through the ER [87]. 
This interaction seems to participate in the association of the Gea’s with the Golgi 
but is not required for their recruitment [87]. At the ultrastrucural level, gea 
mutants accumulate ER membranes and tubular structures probably originating 
from the Golgi, but no Berkeley bodies [151, 152, 178]. Gea1/2p segregate with 
Golgi markers by fractionation [152, 172].  
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Interestingly, Gea2p interacts in vivo with Drs2p, one of the five members of a P4-
ATPase protein family with putative phospholipid translocase or flippase activity 
[172]. Several studies involve Drs2p and the other members of the flippase family in 
the establishment and maintenance of the plasma membrane asymmetry [179-182]. 
Loss of function of Drs2p results in accumulation of Berkeley bodies and transport 
defects through and from the Golgi, which strongly resembles the phenotypes of 
clathrin mutants [182-184]. Drs2p function is also tightly linked to the formation of 
at least one class of secretory vesicles together with clathrin, Arf1p and AP-1 but not 
the Gga’s [142]. Although Drs2p is required for lipid translocation in isolated 
secretory vesicles and purified TGN membranes, the relevance of this activity for 
transport from the Golgi is not clear [180-182]. Drs2p is a transmembrane protein 
that localizes to the late Golgi, gets incorporated into secretory vesicles and recycles 
via the plasma membrane [179, 181-185]. Despite this cycling, Drs2p is not believed 
to be active at the plasma membrane where two other flippases account for the 
translocation activity [179, 185]. Drs2p binds to the Sec7 domain of Gea2p and also 
interacts with Gea1p by yeast-two-hybrid [172]. However, the physiological role of 
the interaction between Drs2p and these ArfGEFs remains unclear, since Drs2p is 
not required for localization of Gea2p and disruption of the Gea2p interaction 
domain of Drs2p results only in mild transport defects and accumulation of ER 
membranes [172, 185]. 
 
Although the Gea’s have been primarily implicated in Golgi function in association 
with Arf1/2p, they have also been connected to actin cytoskeleton organization and 
Arf3p function. In yeast, actin cable polymerization is independent of the Arp2/3 
complex but relies on the action of formins, which are stimulated by profilin in this 
process [186]. Overexpression of the GEA’s can bypass the requirement for profilin 
[133]. This rescue is formin-dependent and partially mediated by Arf3p, however, 
GEF activity of the Gea’s toward Arf3p still has to be shown [133]. 
 
In summary, general Golgi function and morphology is strongly impaired in all GEF 
mutants, resulting in aberrant glycosylation and delayed delivery of cargo to the cell 
surface and the vacuole, however there are marked differences between sec7 and 
gea mutants. Some of the data presented above might indicate a role for Sec7p in 
later Golgi functions than the Gea’s, which would be consistent with the studies in 
mammalian cells. However, not all evidence support this interpretation and 
comparison between the different studies is very complex due to the variety of 
experimental procedures, transport assays and organelle markers used. 
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1.4.1.3/ Arf activator proteins (GAPs) in yeast 
There are four yeast proteins with in vitro GAP activity toward Arf and partially 
redundant functions in vivo [187-190]. Gcs1p is the most abundant Arf-GAP and 
has been implicated together with Glo3p in Golgi-to-ER retrieval and with Age2p in 
post-Golgi transport [188-190]. Gcs1p is so far the only GAP with a dual activity 
toward Arf and Arf-like (Arl) proteins and seems to participate in Arl dependent 
pathways (see § 1.4.1.4) [144, 191]. Besides its role in transport from the Golgi, 
Gcs1p is reported to affect early endosome-to-Golgi retrieval, actin cytoskeleton 
organization and mitochondria morphology [192-195]. Although both Gcs1p and 
Glo3p share a role in retrieval to the ER, only the latter binds to COPI in vivo and is 
required for COPI vesicle formation in vitro [190, 196-199]. Therefore Glo3p is 
considered to be the major GAP involved for Golgi-to-ER retrograde transport. Age1p 
and Age2p, the two last Arf-GAPs are expressed at low levels in exponentially 
growing cells [190]. Age2p is important for TGN exit in absence of Gcs1p while 
Age1p is not yet assigned to a specific pathway [189, 190]. Gcs1p, Age2p and Age1p 
also affect endocytosis [189, 190, 200]. Hence, except Glo3p, which has an 
established role in COPI mediated retrograde transport from the Golgi, the function 
of the other Arf-GAPs remains obscure and the apparent overlap between them 
might reflect the multiple functions of Arf at the Golgi and its strong influence on 
endosome integrity. 
 
1.4.1.4/ Arf-like (Arl) proteins at the yeast Golgi 
Arf-like proteins are very similar to Arfs but do not catalyze the ADP-ribosylation 
activity of cholera toxin in vitro [106]. There are two Arl proteins in yeast, both 
playing a role at the Golgi [201].  
 
Unlike Arf proteins, which have a myristoylated tail and no identified membrane 
receptor, Arl3p is N-terminally acetylated and its localization to the Golgi requires 
interaction with the transmembrane protein Sys1p [202, 203]. Activated Arl3p 
recruits Arl1p to the Golgi, which in turn recruits Imh1p, the only yeast GRIP 
domain containing protein [204, 205]. The function of this interaction cascade 
remains unclear. On one hand, overexpression of this pathway rescues ∆ypt6 
mutants, and the VFT/GARP complex is an effector of both Arl1p and Ypt6p, 
implicating Arl’s in tethering of endosome-derived vesicles with the Golgi ([203, 204] 
and see §1.4.2.4). On the other hand, secretion of a specific GPI-anchored protein, 
Gas1p, relies on the integrity of the Arl cascade, involving it in anterograde 
transport from the Golgi to the plasma membrane [191]. One of these process is 
probably the consequence of the other, however, further work is needed to sort out 
this issue. 
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Interestingly, although no Arl-GEF has been identified, Arl1p directly interacts with 
Mon2p, a large protein, which shares homology with the Arf-GEF family but lacks 
the catalytic Sec7 domain [206, 207]. Mon2p binds equally well to all nucleotide 
forms of Arl1p and is not required for localization of Arl1p or recruitment of the 
Arl1p effector, Imh1p [207, 208]. Hence, it is unlikely that Mon2p acts as a true Arl-
GEF. Interestingly, Mon2p binds to Neo1p, an essential P-type ATPase of the Drs2p 
family, believed to act mainly in the endosomal system [209], an interaction 
reminiscent of the one between Gea2p and Drs2p. Genetic interactions support a 
functional relationship between Arl1p and Neo1p, since deletion or inactivation of 
Arl1p can rescue the growth defect of a temperature sensitive neo1 mutant [209]. 
Mon2p also recruits Dop1p to the Golgi, an essential protein, whose function is not 
established [207]. The only Arl-GAP reported so far is Gcs1p, which in vitro has 
activity towards both Arl1p and Arf1/2p [144]. Gcs1p influences the recruitment of 
Imh1p to the Golgi, the secretion of Gas1p and cycling of Snc1p trough the early 
endosomes, a pathway controlled by Ypt6p, suggesting a role for this GAP in an Arl-
dependent pathway [144, 191, 194]. However, these are only indirect evidences and 
could be due to secondary effects on Golgi and endosomal morphology resulting 
from increased Arf activity. The identification of the in vivo target(s) of Gsc1p GAP 
activity as well as characterization of additional interacting partners are required to 
gain a better insight in the role of this protein as well as the other members of the 
GAP family. 
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1.4.2/ Ypt/Rab GTPases at the yeast Golgi 
Eleven proteins of the Ypt/Rab family have been identified in yeast, and nine of 
them are assigned to specific transport steps as illustrated in Figure 6. Four Ypt’s 
play a direct role at the Golgi apparatus: Ypt1p, Ypt31/32p and Ypt6p. Both genetic 
and physical interactions indicate a strong crosstalk between these GTPases and 
hint toward collaboration among proteins controlling the different entry and exit 
routes at the Golgi.  
 
 
 
 
Figure 6: Distribution of Ypt/Rab GTPases in S.cerevisiae 
Nine of the eleven yeast Ypts are assigned to specific transport steps. The four Ypts involved 
in Golgi functions are described in the text. Sec4p promotes the polarized transport and 
fusion of secretory vesicles with the plasma membrane by interacting with its GEF Sec2p and 
the exocyst complex respectively, Ypt51/52/53p are involved in endocytosis and vacuolar 
protein transport. Ypt7p mediates docking of all incoming vesicle to the vacuole. The two last 
yeast Rab proteins, Ypt10p and Ypt11p, are poorly characterized but have been implicated in 
endocytosis and ER inheritance, respectively. 
 
 
1.4.2.1/ Ypt1p – ER-to-Golgi and intra-Golgi transport 
Ypt1p, the functional homologue of Rab1, is an essential GTPase that localizes to 
the Golgi [210] and is involved in vesicle docking to this organelle. The most 
conclusive data for the function of Ypt1p comes from physical interactors of this 
GTPase. First, it’s GEF, TRAPPI, is a Golgi localized multi-subunit tethering complex 
involved in docking of ER-derived COPII vesicles [34, 211-213]. Second, Uso1p, a 
long coiled-coil protein functions together with Ypt1p in tethering COPII vesicles to 
the Golgi [214, 215]. Moreover, while yeast genetics suggest Uso1p as a Ypt1p 
effector, p115, the mammalian homologue of Uso1p, binds to Rab1 in a GTP-
dependent manner [216]. Third, the COG tethering complex, which is an effector of 
Ypt1p, can bind COPI and is believed to mediate intra-Golgi transport [35, 217]. 
Taken together, these data are consistent with a role for Ypt1p in the docking of 
vesicles at the cis-Golgi. In addition, a study using an in vitro ER budding assay also 
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involves Ypt1p, Uso1p and some subunits of the COG complex in protein sorting 
during COPII vesicle formation at the ER [218].  
 
Attribution of different GAPs to specific Ypts has proven difficult, since most of these 
proteins display very little substrate specificity in vitro [219-224]. Moreover, the 
possibility that several GAPs could inactivate a single GTPase in vivo should be kept 
open, since this could prevent inappropriate activation of a given GTPase. Hence, 
different GAPs show substrate specificity toward Ypt1p in vitro [220, 224], but so far 
only Gyp1p, a Golgi located protein, seems physiologically relevant [225]. 
Interestingly, a study using the GTP-locked form as the only source of Ypt1p, shows 
that GTP hydrolysis is dispensable secretion and do not affect growth [226]. 
However, strains carrying the GTP-locked Ypt1p are still sensitive to the expression 
of a dominant negative mutant sequestering the GEF, suggesting that the activated 
form is not sufficient for function and interaction with the GEF is required [226]. 
 
1.4.2.2/ Ypt31p and Ypt32p – Golgi exit 
Ypt31p and Ypt32p, the yeast homologues of Rab11, share more than 81% 
homology with each other and are highly redundant. Expression of at least one of 
the two GTPases is required to sustain viability. Studies using conditional double 
mutants reported accumulation of Berkeley bodies, inhibition of protein delivery to 
the plasma membrane as well as slow transport of vacuolar proteins [227, 228]. 
These data are consistent with a role for Ypt31/32p in late Golgi function and are 
supported by studies localizing Ypt31p and Ypt32p mainly to the Golgi apparatus 
both in yeast and mammalian cells [229-232]. The involvement of Ypt31/32p in 
Golgi-to-plasma membrane transport is supported by their role in recruitment of 
Sec2p to secretory vesicles [38]. Moreover, overexpression of Ypt32p affects Golgi 
integrity and disturbs cycling through this organelle [232, 233]. The GEF for Ypt31p 
and Ypt32p has been identified to be the TRAPPII complex. This complex differs from 
the Ypt1p GEF by three additional subunits and might link Golgi entry and exit 
routes [37, 213, 234, 235]. As for Ypt1p, several GAPs have in vitro activity toward 
Ypt31/32p, but so far only Gyp2p could be confirmed in vivo [229]. 
 
Besides Sec2p, the only other effector for Ypt31/32p identified to date is the F-box 
protein Rcy1p [232], which is involved together with Skp1p in recycling from the 
endosomes to the plasma membrane through the Golgi apparatus [236, 237]. 
Usually, F-box proteins determine the substrate specificity of SCF-(Skp1p-cullin-F-
box protein) complexes, which are ubiquitin-ligases regulating a variety of cellular 
functions [238]. Like other F-box proteins Rcy1p binds to Skp1p, but does not seem 
to form a classic SCF-complex since no cullins do not bind to the pair and do not 
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influence recycling [237]. ∆rcy1 accumulates the same kind of abnormal membrane 
structures as Ypt31/32p double mutants, but is viable and no secretion or 
vacuolar-sorting defects were identified [236]. Consistent with their role in 
Ypt31/32p cycling, both mutation of TRAPPII subunits and overexpression of Gyp2p 
interfere with recycling [239, 240]. Interestingly, deletion of GYP1 can rescue the 
recycling defect of a ∆rcy1 strain [239], suggesting that additional factors might be 
involved. Despite all the data outlined above the role of Ypt31p and Ypt32p in 
recycling remains unclear. The GTPases are required for proper localization of 
Rcy1p, which can directly bind to Snc1p [232], one of the cargos of the recycling 
pathway [22]. Rcy1p can also bind the flippase Drs2p [241], which has been 
involved in formation of clathrin-coated vesicle at the TGN [49]. However, so far, the 
physiological role of these interactions is not understood.  
 
1.4.2.3/ The “Ypt/Rab cascade” 
All Ypts involved in exocytosis are linked together by a chain of activation reactions 
known as “Rab cascade”. To begin with, the TRAPP complex can be found in two 
different configurations known as TRAPPI (7 subunits) and TRAPPII (10 subunits). 
As explained above, TRAPPI activates Ypt1p, while TRAPPII is the GEF for 
Ypt31/32p. The two TRAPPII specific subunits Trs120p and Trs130p do not only 
determine the specificity of the complex towards Ypt31/32p but also interfere with 
the activation of Ypt1p [37]. Hence, the two forms of the TRAPP complex are not 
independent from each other and can control the sequential activation of the 
GTPases. Once activated, Ypt32p recruits Sec2p [38], the GEF for Sec4p [242], to 
secretory vesicles and in turn, GTP-bound Sec4p can interact with the exocyst 
complex promoting docking [243] and eventually fusion of secretory vesicles with the 
plasma membrane. This cascade is consistent with the genetic interactions observed 
between different mutant-forms of the Ypts [244].  
 
Genetic interactions between Arf-GEFs and Ypt/Rab proteins also suggest a 
coupling of Arf and Ypt/Rab regulated events along the secretory pathway and 
reveal a fundamental difference between two sec7 mutant alleles: sec7-1ts mutants 
are specifically rescued by overexpression of Ypt1p, while sec7-4ts mutants are 
rescued by Ypt31/32p [40].  
 
1.4.2.4/ Ypt6p – Recycling pathway 
Ypt6p, the Rab6 homologue, is the last Rab protein localized to the yeast Golgi 
apparatus [230, 245]. This GTPase is involved in endosome-to-Golgi recycling [246, 
247] and is required for viability only at higher temperatures [248]. Interestingly, the 
retrieval route from the endosomal system controlled by Ypt6p is independent from 
 24 
the retromer complex and recycles cargoes from an earlier endosomal compartment 
[22, 249] (see Figure1). The GEF for Ypt6p consists of a complex between Ric1p and 
Rgp1p, which are responsible for it’s localization to the Golgi [245]. As for the other 
Rabs, several GAPs showed in vitro activity toward Ypt6p, but although Gyp6p 
seems to be highly specific in those assays [219], none of them has been confirmed 
in vivo. 
 
Two effectors of Ypt6 have been identified, Sgm1p and the VFT/GARP complex [250, 
251]. Sgm1p binds activated Ypt6p through its coiled-coil domain and is equivalent 
to the mammalian golgin TMF/ARA160 [250, 251]. TMF can bind to the different 
Rab6 isoforms and influences Golgi morphology in mammalian cells [252]. Hence, 
Sgm1p is likely to be a tethering factor working together with Ypt6p in a manner 
similar to Uso1p and Ypt1p. The VFT/GARP tethering complex requires Ypt6p 
activation to be recruited to the Golgi [251, 253], where it is required for retrograde 
transport from endosomes [254]. This complex also binds the SNARE Tlg1p through 
a different subunit than Ypt6p [253, 255]. Since the SNARE Tlg1p is cycling between 
the TGN and endosomes, the VFT/GARP complex could promote SNARE complex 
formation at the TGN. 
 
Both Ypt6p and Ypt1p are involved in vesicle docking at the Golgi and seem to work 
in a similar fashion with specific tethering factors. The analogy between these two 
Rab proteins is supported by the observation that under particular circumstances 
Ypt6p can substitute for Ypt1p [256]. Ypt6p is not included in the exocytic Rab 
cascade, but is likely to interact with it since maintenance of Golgi homeostasis 
requires coordination of all the pathways entering or leaving this organelle. Since 
the secretory pathway is essential while recycling from endosomes is only required 
at elevated temperatures, the impact of Ypt6p on secretion should be minor 
compared to the influence of Ypt1p and Ypt31/32p on recycling. Indeed, hydrolysis 
of Ypt1p is required for recycling [257] and Ypt31/32p have a strong impact on this 
process through their interaction with Rcy1p [232]. 
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1.4.3/ The Golgi phosphoinositide pool: PI4P  
The PI4P pool at the yeast Golgi is important both for secretion and organelle 
maintenance and might play a role in signal transduction. However, little is known 
about its regulation or the identity and function of its effectors. 
 
1.4.3.1 / Regulation of PI4P levels 
The yeast genome encodes three phosphatidylinositol 4-kinases (PI4K): Pik1p, Stt4p 
and Lsb6p (see Figure 2). The majority of PI4P is produced by the two kinases Pik1p 
and Stt4p, which are required for the generation of different essential pools of PI4P 
[258]. Pik1p is responsible for the Golgi pool [258, 259], while Stt4p generates the 
plasma membrane pool, which can be converted to PI(4,5)P2 by Mss4p and activates 
the PKC pathway [260]. The third yeast PI4K, Lsb6p, is non-essential, locates to the 
plasma membrane and is involved in endosome motility [261-263].  
 
Pik1p is found at the Golgi as well as in the nucleus [258, 259, 264] and is 
important for normal secretion and maintenance of Golgi integrity [258, 259]. 
Whether Pik1p plays an active role in the nucleus is still unclear, although both the 
Golgi and the nuclear pool are reported to be essential [265]. How Pik1p localization 
is regulated is a mystery. The only known interactor of Pik1 is a myristoylated Ca2+ 
sensor called Frq1p [266]. Because of its lipid tail, Frq1p has been suggested to act 
as a membrane anchor for Pik1p, but experimental evidence is lacking [267]. 
Interestingly, in vitro, activated Arf can recruit the mammalian homologue of Pik1p, 
PI4Kβ, to membranes and seems to stimulate its activity [105]. However, this has 
not been confirmed in vivo. In addition, PI4Kβ interacts with activated Rab11, the 
Ypt31/32p homologue, and interference with this binding, results in mislocalization 
of Rab11 to the cytosol [268]. In yeast, no similar interaction between Arfs, Ypts and 
PI4-kinases has been reported. 
 
Besides Pik1p two additional enzymes, Sac1p and Sec14p, regulate PI4P levels at 
the Golgi. Sac1p is the PI-phosphatase responsible for the turnover of PI4P [269, 
270]. It is an integral ER membrane protein that can cycle through the Golgi 
apparatus [271]. Sec14p is a phosphatidylinositol/phosphatidylcholine transfer 
protein (PITP) [272], which catalyze transfer of PI and PC across membrane bilayer. 
The fundamental principle of this process is not clear yet, but Sec14p and has a 
strong effect on vesicle formation at the TGN that relies on its catalytic activity [2, 
272, 273]. 
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1.4.3.2 / PI4P role at the Golgi 
The importance of PI4P in secretion and Golgi morphology is derived from studies 
affecting its different regulatory proteins. Since loss of function of Pik1p or Sec14p 
leads to a decrease in PI4P levels [258, 273] while PI4P accumulates in ∆sac1 cells 
[269], opposite effects of those mutations on Golgi traffic are expected. Indeed, both 
pik1 and sec14 mutants display a similar block in secretion and delay in vacuolar 
transport and both accumulate Berkeley bodies [2, 8, 258, 259]. The role of Pik1p in 
secretion from the Golgi is further supported by negative genetic interactions with 
mutants defective in Golgi exit or late acting SEC genes [229, 259]. Mutation in 
SEC14 can be partially rescued by overexpression of Pik1p [273]. Sac1p is a non-
essential gene and seems to affect PI4P pools generated by Pik1p as well as Stt4p 
[269, 274]. Therefore, studies of sac1 mutants resulted in less striking phenotypes 
than Pik1p or Sec14p. However, deletion of sac1 phenocopies the chitin transport 
defect of Pik1p overexpression [269] and can bypass the requirement of the 
otherwise essential Sec14p [275]. 
 
Despite the increasing number of lipid binding domains identified, only few PI4P 
effectors are known. In yeast, only the two closely related PH domains of Osh1p and 
Osh2p and the “PH-like” domain of Kes1p/Osh4p have been shown to specifically 
bind the PI4P pool generated by Pik1p at the Golgi [276-278]. These three proteins 
belong to the same family of oxysterol binding proteins (OSBPs), which consists of 
seven members. None of these genes is essential and only the combined deletion of 
the whole protein family affects viability [279]. OSBP function is poorly understood 
but seems linked to sterol homeostasis, which in turn affects both endocytosis and 
cell polarity maintenance [280-282]. Interestingly, although no cellular function has 
been identified for Kes1p, loss of function of this enzyme can rescue sec14 mutants 
[283]. Hence, kes1 mutants have the same sec14 bypass phenotype as sac1 
mutants. However, the Osh proteins cannot account for the pleiotropic effects, due 
to alteration in PI4P levels. Therefore, more PI4P effectors are likely to be identified 
in yeast, even if the proteins regulating PI4P levels have additional functions in 
transport besides lipid metabolism. 
 
In mammalian cells, beside OSBPs some additional PI4P effectors have been 
identified and partially characterized: FAPP1 and FAPP2 who seem involved in 
vesicle fission at the TGN [284]; AP-1, a clathrin adaptor complex involved in vesicle 
formation [285] and EpsinR, an AP-1 interacting protein probably affecting 
membrane curvature [286, 287]. 
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The PH domains of FAPP1 and OSBP have been used for localization studies in yeast 
and resulted in two major findings. First, the two domains are properly targeted to 
the Golgi, meaning that the recognition mechanisms for those PH domains is 
conserved and second, their localization required not only PI4P but also Arf GTPases 
[277]. 
 
1.4.3.3/ The dual function of Sec14p 
Even if the data presented above suggest that Sec14p influences transport through 
its effect on PI4P production, the dual activity of this enzyme should not be 
underestimated. Indeed, while both Pik1p and Sac1p are specifically involved in 
PI4P production and turnover, Sec14p has an impact on PC as well as PI. Besides 
loss of function of SAC1 and KES1, mutations in five other genes abolish the 
requirement for Sec14p function, i.e. bypass Sec14p. Strikingly, all five mutations 
disrupt synthesis of PC [288, 289]. Moreover, Sec14p is a known inhibitor of the 
CDP-choline PC synthesis pathway [290] and extended studies of the lipid content of 
sac1 mutants revealed that, beside their high PI4P content, they also affect rates of 
PC synthesis and turnover [291]. Interestingly, PC formation through the CPD-
choline pathway consumes one mole of DAG per mole PC generated. Those 
observations, combined with the requirement for phospholipase D (PLD) for efficient 
Sec14p bypass [292], suggest that decreased PC or increased PA or DAG levels could 
be the key factor behind the rescue (see Figure 7). PLD is the only enzyme able to 
convert PC to PA in S.cerevisiae [293] [294]. This idea is also supported by the 
observation that high PI4P levels are not sufficient to fully rescue sec14 mutations 
[273, 278, 291]. How those different lipids influence vesicle formation is not clear 
but they seem to be connected to the Arf cycle. In vitro, both DAG and PA can 
stimulate the activity of two Arf GAPs, Gcs1p and Age2p, while PC acts as an 
inhibitor [295, 296]. Whether this regulation of GAP activity is direct or a 
consequence of the lipid sensing properties of those proteins in an artificial system, 
analogous to the in vitro triggering of vesicle budding by acidic phospholipids [98], 
remains to be established. 
 
Loss of KES1 is a special case of sec14 bypass for two reasons. First, overexpression 
of Kes1p suppresses any other sec14 bypass mutations [283], indicating that Kes1p 
acts downstream of all other suppressors. Second, Kes1p recruitment to the Golgi is 
essential for its function and depends on its ability to bind PI4P [278]. The ability of 
sac1 mutants to bypass sec14 results, at least partially, from the mislocalization of 
Kes1p [278] since the PI4P pool accumulating in sac1 is generated by Stt4p and not 
the Golgi-localized PI4P-kinase Pik1p [274, 297]. Moreover, since deletion of KES1 
partially rescues a pik1 mutant [278], Kes1p seems to be a general negative 
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regulator of Golgi function. How Kes1p affects Golgi function is not clear, but, 
genetic data also point towards an interference with the Arf cycle [278]. 
 
In summary, the role of Sec14p at the Golgi is not yet clarified and the essential 
function of this protein is linked to both PI and PC metabolism. Indeed, sec14 
constructs where either PC or PI transfer function are selectively blocked, are viable 
[298, 299]. Taken together, the available data point toward a general role for Sec14p 
in controlling the lipid content of Golgi membranes, thus providing an appropriate 
lipid environment to support secretion from this organelle.  
 
 
 
 
Figure 7: Sec14p-related pathways for Golgi secretory functions 
The yeast PI/PC transfer protein, Sec14p is an important regulator of late Golgi functions, 
although the mechanical aspects of this process are still unclear. The different targets of 
Sec14p activity and their effects on vesicle formation at the TGN are schematically illustrated: 
increase in PI, DAG and PA levels is thought to promote vesicle formation while PC and Kes1p 
negatively regulate this process.  
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2/ Rational 
The Golgi apparatus is the main crossroad of all traffic events in eukaryotic cells. This 
central position confers a crucial role to this organelle in maintaining proper cellular 
organization and provides an ideal template for the integration of regulatory signals. The 
unique properties of the Golgi are reflected both by its unusual architecture and the 
dynamics of its remodeling. An extending amount of work performed on the Golgi since 
it’s discovery has lead to the identification of many factors involved in its function, from 
traffic regulators to resident glycosylation enzymes. Although the molecular 
characterization of these proteins has unraveled a number of mechanisms underlying 
vesicular transport and protein modification, the fundamental processes maintaining 
Golgi homeostasis and regulating protein sorting at this organelle are still enigmatic. 
 
To maintain proper material balance of the Golgi apparatus and its different 
subcompartments the coordination of all entry and exit routes from this organelle as 
well as the appropriate distribution of resident proteins is required. All these processes 
imply an extensive crosstalk between the machineries carrying out the different steps. 
Small GTPases of both the Arf and Ypt/Rab proteins family are key regulators of 
transport through out the cell. Several members of these families carry out essential 
function at the Golgi. These proteins are ideal candidates for a role in the spatial and 
temporal regulation of Golgi homeostasis and the organization of the different activities 
at this organelle.  
 
Finally, the specific lipid composition of the Golgi apparatus is important not only for its 
structural integrity but participates actively in trafficking events at this organelle. 
Phosphatidylinositol 4-phosphate (PI4P) plays a central role in the formation of vesicles 
and proteins involved in its metabolisms are key components of the Golgi regulatory 
machinery. However, PI4P is not the only lipid involved in Golgi transport and a fine 
balance between the different lipid species has to be maintained. In addition, both the 
lipid and protein composition of the membrane depend on each other and has therefore 
to be co-regulated. 
 
Although many regulators of Golgi function have been identified, there is very little 
information on how they communicate with each other. Therefore, the present work was 
directed toward understanding the crosstalk between known Golgi trafficking regulators 
and identifying new components participating in this process. As starting point for this 
work, we focused on four proteins influencing exit from the TGN: the small GTPases 
Ypt31/32p, the Arf-GEF Sec7p and the Golgi PI4-kinase Pik1p. We combined genetic 
and biochemical approaches to identify the molecular mechanisms underlying the 
coordinated action of those proteins. 
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3/Results 
As starting point we used two different approaches to identify new genetic or 
physical interactors of known Golgi traffic regulators.  
 a/ High copy suppressor screen of the Golgi Arf-GEF mutant sec7-1ts. 
 b/ Ypt/Rab effector column using either Ypt31p or Ypt32p. 
 
We also considered the results of two other screens done previously in the lab (c) or 
in collaboration with the group of Kai Simons (d) :  
 c/ Yeast two-hybrid screen using Pik1p as bait  
 d/ Visual screen using a GFP-reporter expressed in the yeast ko collection. 
 
3.1/ Cpd1p is a new regulator of Golgi function through its 
interaction with the Arf-GEF Sec7p 
Two different temperature-sensitive alleles of the Arf-GEF SEC7 have been reported. 
Both mutants strongly affect Golgi morphology and impair ER-to-Golgi transport. 
However, the sec7-4ts allele, which carries a point mutation inside the Sec7 domain, 
displays a complete block in CPY transport already five minutes after shifting to 
non-permissive temperature, while the sec7-1ts allele responds slightly slower to 
heat shock, which allows the visualization of an additional Golgi-to-vacuole 
transport defect [173]. The mutation of sec7-1ts has not been mapped but was 
reported to be outside of the Sec7 domain [173]. The regions of Sec7p outside its 
catalytic domain represent more than 90% of the protein and are likely to contain 
regulatory elements controlling the timely activation of Arf. These regions could also 
participate in yet unidentified functions of Sec7p besides the Arf-GEF activity. 
Therefore, to investigate the regulatory role of Sec7p at the Golgi, the sec7-1ts 
mutant allele was preferred over sec7-4ts. 
 
3.1.1/ Characterization of the sec7-1ts mutant and high-copy suppressor 
screen 
Since most of the previous studies on Sec7p focused on the sec7-4ts mutant and 
provide only little information about sec7-1ts, the growth and traffic phenotypes of 
this mutant had to be established. Growth of the mutant is completely abolished at 
36˚C and 37˚C and already impaired at 34˚C both on YPD and synthetic media (data 
not shown). In accord with previous studies [2, 173], this strain was found to be 
defective in secretion, Golgi morphology, vacuolar protein sorting (see below), and 
actin cytoskeleton organization (data not shown). 
 
Sequencing of the sec7-1ts ORF revealed a single point mutation in the N-terminal 
part of the gene resulting in the substitution of a serine residue by leucine (S404L). 
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This mutation is situated between two α-helixes of the conserved DCB domain of the 
BIG/GBF protein family. The position of the mutation as well as the lack of 
similarity of the residues adjacent to the serine with any known kinase recognition 
motif, suggest that the mutation destabilizes the N-terminal part of the protein at 
higher temperature.  
 
Since the N-terminal part of BIG1, including the DBC and most of HUS domain, are 
necessary and sufficient for Golgi localization [300], the localization of wild type and 
mutant Sec7p protein, endogenously tagged with GFP, was compared by live 
microscopy. As shown in Figure 8A, membrane recruitment of Sec7-1p-GFP at non-
permissive temperature does not seem to be impaired. The difference in organelle 
appearance might reflect the Golgi morphology defect of sec7ts mutant strains rather 
than localization to a different compartment. However, since this punctated pattern 
 
 
 
 
Figure 8: Phenotypes of the sec7-1ts mutant 
A. Localization of wild type and mutant Sec7p. Sec7p-GFP (yGY84) and Sec7-1p-GFP (yGY87) 
tagged at the genomic locus, were visualized by life microscopy. B. Internalization of FM4-64 
in wild type (NY10) or sec7-1ts (NY760) cells. Cells, preincubated at respective temperature for 
15 minutes, were labeled and chased for 10 or 60 minutes under the same conditions. 
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is typical for endosomes, it prompted me to visualize the endocytic pathway in sec7-
1ts mutants using the lipophilic styryl dye FM4-64. This marker associates with 
membrane and is efficiently internalized by endocytosis [301]. Inside the cells, FM4-
64 is either delivered to the vacuolar membrane or recycled back to the surface, 
where the fluorescence fades due to release from membranes [236, 301]. Figure 8B 
shows that although the internalization of the dye by sec7-1ts mutants is slowed 
down even at permissive temperature, it can still be delivered to the vacuole even at 
non-permissive temperature. Most importantly, despite accumulation of abnormal 
membranes in the mutant at 37˚C, none of the intermediate compartments labeled 
by the dye resembles the Sec7-1p-GFP containing structures in Figure 8A. 
 
Since P. Novick reported a glucose dependency of the Golgi morphology defect of the 
sec7-1ts mutant that is specific for this sec mutant [7], I wondered whether this 
effect is allele specific. Therefore, samples from the two different sec7 mutants were 
prepared for electron microscopy, in collaboration with T. Mueller-Reichert, using 
the cryo-fixation procedure. The accumulation of stacked structure resembling 
mammalian Golgi cisternae was easily visualized in both sec7 mutants grown in 
0.1% glucose, while the strains grown with standard glucose levels (2%) contained 
numerous Berkeley bodies (see Figure 9). Hence, this effect seems to be a general 
feature of sec7 mutants suggesting a connection between Sec7p function and 
response to nutrient availability. 
 
To learn more about the function of Sec7p and in particular it’s N-terminus, I 
analyzed the colonies isolated previously by Ch. Walch-Solimena during a high copy 
suppressor screen of sec7-1ts. Plasmids were recovered from the 33 colonies 
expressing an insert able to suppress the growth defect of sec7-1ts at 37˚C and 
subsequent analysis resulted in the identification of four ORFs: SEC7, ARF1, SRO9 
and CPD1. The isolation of SEC7 itself as well as ARF1 as high copy suppressors 
validates the screen. Interestingly, the N-terminal half of the SEC7 gene, containing 
only the DCB, HUS and ~3/4 of the Sec7 domain, is able to rescue the growth defect 
of sec7-1ts mutants.  This suggests either that this part of the protein is sufficient to 
perform the essential function of Sec7p or point toward a possible oligomerization of 
the protein. 
 
SRO9 encodes a protein primarily known to associate with ribosomes which might 
play a role in translation accuracy [302]. However, several studies link Sro9p to 
trafficking and actin cytoskeleton organization. First, SRO9 is a known allele specific 
high copy suppressor of sec7-1ts, further confirming the screening results [248]. 
Second, overexpression of SRO9 also rescues the growth defects of ∆ypt6ts and 
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∆rho3, two GTPases involved in endosome-to-Golgi transport and actin organization, 
respectively [248, 303]. Finally, a synthetic interaction between ∆sro9 and ∆tpm1 
reinforce the connection to the cytoskeleton, since TPM1 encodes tropomyosin, a 
protein binding to and stabilizing actin cables [303]. Sro9p has also been involved in 
regulation of Hap1p in response to oxygen levels [304, 305] and is a substrate for 
the PAS kinase, Psk2p, which regulates sugar flux and translation [306]. 
 
 
 
 
Figure 9: The morphology of sec7 mutants is less affected in low glucose media 
sec7-1ts (NY760) and sec7-4ts (AFM69-1A) cells grown in YPD (2% glucose), where incubated 
1h at 25˚C in high (2%) or low (0.1%) glucose containing media before shifting to 37˚C for 1h. 
Samples were prepared for electron microscopy with the cyro-fixation procedure. Both 
mutants incubated in low glucose media accumulate stacked structures instead of Berkeley 
bodies, indicating that the phenotype observed by P. Novick is not allele specific. Note the 
reproducibility of the phenotype despite the difference in experiment procedure: 1h 
preincubation in low glucose media before heat shock (here) instead of 2h incubation in low 
glucose at 37˚C [7]. Bar = 500 nm 
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The last candidate from the screen is CPD1, which encodes a cyclic nucleotide 
phosphodiesterase, an enzyme that hydrolyses a by-product of the tRNA synthesis 
(see Figure 10) [307, 308]. One molecule of Appr>p is produced with each tRNA 
splicing reaction, which has been estimated to ~500’000 events per generation in 
S.cerevisiae and, in absence of metabolic turnover, intracellular levels of this 
metabolite could reach up to 10-40 µM [309]. Cpd1p is the only yeast protein 
mediating this specific diesterase activity [308, 310], although it cannot be excluded 
that Cpd1p also processes additional substrates in vivo [309]. No cellular function 
for Appr>p nor its processed form are known, but the splicing pathway leading to its 
generation is conserved throughout evolution [311, 312]. 
 
 
 
 
Figure 10: Processing of Appr>p by Cpd1p and Poa1p 
Appr>p is a by-product of the tRNA splicing pathway. The production of Appr>p is conserved 
throughout evolution, although vertebrates process most of their tRNA through an alternative 
splicing pathway. Neither Appr>p nor Appr-1’’p belong to any identified metabolic pathway 
and no function has been reported for any of them despite their abundance. 
Appr>p = ADP-ribose-1’’,2’’-cyclic phosphate, Appr-1’’p = ADP-ribose-1’’ phosphate. 
 
 
3.1.2/ CPD1 is a true high copy suppressor of sec7-1ts 
Overexpression of CPD1 from a 2µ plasmid efficiently rescues the growth defect of 
sec7-1ts at 36˚C and enhances growth at 37˚C (Figure 11A). In addition, this rescue 
is allele specific since CPD1 does not improve the growth of a sec7-4ts mutant under 
the same conditions.  
 
Next, the impact of CPD1 overexpression on specific trafficking defects of sec7-1ts 
mutants was investigated. First, the general secretion competence of the mutant 
cells was estimated using a pulse-chase experiment. Yeast cells secrete only a 
limited number of proteins into the surrounding media that can easily be resolved 
by SDS-PAGE after TCA precipitation [26, 313]. As seen in Figure 11B, 
overexpression of CPD1 nicely restores the secretion pattern of sec7-1ts mutant cells 
but does not seem to affect wild-type cells.  
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In order to get a more quantitative estimation of the exocytosis defects, the secretion 
of the periplasmic enzyme invertase was monitored. Invertase expression is induced 
by shifting yeast cells to low glucose media, and the relative amount of secreted 
protein is determined by comparing the enzymatic activity of the secreted pool to the 
total cell lysate [1]. Measurements of invertase secretion in sec7ts mutants proved to 
be difficult, since the induction capacity and the strength of the secretion block was 
quite variable between experiments, a problem never encountered with any other 
strain tested. This variability might be connected to the glucose dependency of sec7 
mutant phenotypes. However, the improvement of invertase secretion in sec7-1ts 
cells overexpressing CPD1 is reproducible and the values indicate approximately a 
doubling in the secretion efficiency compared to the mutant carrying the vector 
alone (see example in Figure 11C). 
 
Finally, the delivery of the CPY to the vacuole was followed by pulse chase kinetics. 
CPY is a vacuolar hydrolase, found in a precursor form in the ER (p1) modified in 
the Golgi (p2) and cleaved to the mature form in the vacuole (m) [314]. Hence, by 
monitoring its maturation, the transport of this enzyme from the ER to the vacuole 
can be followed. As shown in Figure 11D, transport of CPY is efficiently blocked at 
an early stage in sec7-1ts mutants and overexpression of CPD1 partially rescues this 
phenotype. The accumulation of the p1 form of CPY in sec7-1ts mutants, indicates 
the retention of the enzyme in the ER or cis-Golgi [117]. Interestingly, 
overexpression of CPD1 seems to increase the rate of CPY delivery to the vacuole in 
wild-type cells (see below). 
 
3.1.3/ Cpd1p colocalizes with Sec7p  
Since Cpd1p is an allele specific high copy suppressor of the sec7-1ts mutation, I 
next wanted to investigate the localization of this protein with respect to Sec7p. 
Therefore, two C-terminal GFP tagged constructs of CPD1 were generated: either 
behind the endogenous promoter or the constitutive high expression ADH promoter 
(see Figure 12A). Both constructs are expressed on CEN plasmids, to avoid variation 
in expression levels typical for 2µ plasmids. Both plasmids were tested for their 
ability to rescue sec7-1ts mutants (Figure 12B) and their respective expression level 
was verified by western blotting (Figure 12C). The growth rescue by overexpressed 
Cpd1p-GFP indicates that the fusion protein is functional, but high protein levels 
are required, since mere doubling of the intracellular concentration is not sufficient 
to improve growth of sec7-1ts mutants.  
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The same constructs were used for colocalization studies with Sec7p-DsRed. Figure 
12D shows very good overlap between the two fluorescent signals independently of 
the expression levels of Cpd1p-GFP. To obtain strong Sec7p labeling, a strain 
expressing Sec7-DsRed behind the strong TPI1 promoter was used [315]. The same 
result was obtained with a genomically dsRed tagged version of Sec7p (data not 
shown), indicating that the localization of Cpd1p-GFP is not a result of Sec7p-DsRed 
overexpression. 
 
The localization of Cpd1p-GFP in wild type or sec7-1ts mutants was also investigated 
and is shown in Figure 12E. Interestingly, the staining pattern in sec7-1ts cells 
overexpressing Cpd1p-GFP is indistinguishable from wild-type cells even at non-
permissive temperature. In contrast, the labeling in cells expressing lower levels of 
the fusion protein resembles the sec7-1p-GFP staining seen in Figure 8A. Hence, 
Cpd1p-GFP association with membranes does not seem disrupted by sec7-1ts 
mutation and its overexpression seems to rescue the Golgi morphology defect of 
these mutants [69, 70, 315]. Deletion of ARF1 has also no effect on Cpd1p-GFP 
localization (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Cpd1p-GFP localization to the Golgi (see following page) 
A. Schematic representation of the different Cpd1p-GFP constructs. B. Overexpression of 
Cpd1p-GFP is required for the rescue. Wild type (NY10) and sec7-1ts (NY760) cells were 
transformed with the CPD1-GFP constructs (pYG32 and pYG34) or the corresponding empty 
plasmids (pRS416ADH-GFPc) and ten-fold dilution series were spotted on selective media. p* 
indicates the 2µ plasmid originally isolated in the screen. C. Expression levels of the 
constructs used in B, detected with α-GFP antibodies. D. Cpd1p-GFP colocalizes with Sec7-
DsRed. Cpd1p-GFP constructs were expressed in a strain containing Sec7-DsRed behind the 
TPI promoter (CSY394) and observed by confocal microscopy. E. Localization of Cpd1p-GFP in 
wild type and sec7-1ts mutant cells. The same strains as in B. were visualized by life 
microscopy. 
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According to the localization studies, Cpd1p-GFP is apparently associated with 
membranes despite the lack of predicted trans-membrane or lipid-binding domains 
in the protein sequence. Therefore, the distribution of Cpd1p-GFP between soluble 
and membrane-bound fractions was investigated by differential centrifugation. As 
illustrated in Figure 13, only a minor fraction (~9%) of the protein is recovered in the 
microsomal fraction (P100) containing transport vesicles and Gogi/endosomal 
membranes [316]. In addition, this distribution is identical in wild type and mutant 
cells. Hence, Cpd1p-GFP is only to a small extend associated with membranes, and 
this association does not depend on a functional N-terminal part of Sec7p. 
 
 
 
 
Figure 13: Cpd1p-GFP only partially associated with membranes 
Samples from wild type (NY10) and sec7-1ts (NY760) cells, expressing Cpd1p-GFP behind the 
ADH promoter (pYG34), were prepared by subcellular fractionation and analyzed with α-GFP 
and α-ADH antibodies. The ratio of membrane bound versus soluble Cpd1p-GFP was 
calculated by taking into account the correction from the α-ADH blot (see material and 
methods): S100 ≈ 90%, P100 ≥ 9%, P13 ≤ 1%.  
 
 
3.1.4/ Catalytically active CPD1 strongly influences the morphology defects of 
sec7-1ts mutants 
At non-permissive temperature, sec7 mutants accumulate a wide range of abnormal 
membrane structures [2, 173, 176]. Since overexpression of CPD1 considerably 
improves the growth and transport phenotypes of sec7-1ts mutants, it is likely to 
result in a partial rescue of the morphology defect of these strains. This hypothesis 
is supported by the live imaging of Cpd1p-GFP. Therefore, samples were prepared 
for electron microscopy using a chemical fixation procedure to study the morphology 
at an ultra-structural level. Indeed, overexpression of CPD1 resulted in a complete 
rescue of the morphology defects of sec7-1ts strain (see Figure14B, lower left panel). 
 
Cpd1p has already an established function in the catalysis of a by-product of tRNA 
synthesis. Therefore, to determine the role of this enzymatic activity in sec7-1ts 
rescue, one of the core histidine residues was replaced by alanine (H39A), a 
mutation reported to completely abolish the catalytic activity [310]. Overexpression 
of the mutant cpd1 did not suppress the growth defect of sec7-1ts (Figure 14A) and 
had no effect on its morphology (Figure 14B). 
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Figure 14: Catalytically active Cpd1p rescues the morphology defect of sec7-1ts 
A. The catalytic activity of Cpd1p is important for the rescue. Wild type (NY10) and sec7-1ts 
(NY760) strains were transformed with 2µCPD1 (pYG30), 2µCPD1H39A (pYG45) or empty vector 
(pYG28) and ten-fold dilution series were spotted on selective media. B. Overexpression of 
catalytically active Cpd1p rescues the morphology defects of sec7-1ts mutants. The same 
strains as in A. were prepared for electron microscopy using a chemical fixation procedure. 
Bar = 280 nm 
 
 
The requirement for a catalytic active Cpd1p for the rescue of sec7-1ts mutation 
could indicate that the substrate or the product of the reaction are involved in the 
process. As an indirect way to assess the importance of Appr>p and its hydrolysis 
product in the rescue, I tried to interfere with their levels in the sec7-1ts mutant by 
deleting either CPD1 or POA1 (see Figure10). According to the literature, deletion of 
CPD1 should result in a massive increase of Appr>p and effectively block Appr-1’’p 
synthesis [310]. On the contrary, deletion of POA1 should lead to increased Appr-
1’’p levels since Poa1p was reported to convert ~90% of the cellular pool of this 
metabolite to ADP-ribose [309]. However, neither deletion affected the growth of 
sec7-1ts mutants (data not shown). 
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3.1.5/ CPD1 can influence traffic on its own and is related to Arf function 
Mutations affecting Golgi function or transport through the endocytic pathway often 
result in missorting of the vacuolar hydrolase CPY to the cell surface were it can be 
detected using colony blotting [317]. This phenotype is also observed in sec7 
mutants grown at semi-permissive temperature and, while studying the rescue of 
sec7-1ts transport defects, a strong increase in CPY secretion, resulting from CPD1 to 
overexpression, was observed (Figure 15A). This effect was surprising considering 
the improvement of the other trafficking phenotypes of sec7-1ts, especially since the 
same defect is observed in sec7-4ts cells, which otherwise remained insensitive to 
CPD1 overexpression. Therefore, the impact of CPD1 on CPY secretion was 
investigated in wild-type cell where overexpression of this gene resulted in a partial 
missorting of the vacuolar enzyme at higher temperature (Figure 15B). This 
observation was not due to cell lysis, since no increase of the cytosolic protein 
Adh1p could be detected (data not shown). To quantify the transport defect, CPY 
secretion was monitored using a pulse chase method followed by immuno-
precipitation of CPY from cell and media fractions. The upper panel of Figure 15C, 
shows the result of such an experiment and indicates that, after 30 minute chase, 
the totality of intracellular CPY is processed to the mature vacuolar form and only 
the Golgi-modified (p2) form is secreted. The quantification of this effect, displayed 
in the lower panel of Figure 15C, was obtained by comparing the band intensities in 
three independent experiments. The basal level of CPY secretion observed is 
consistent with previous studies reporting the detection of a small amount of CPY in 
the media of wild-type cells [318]. A clear increase in CPY secretion can be detected 
from cells overexpressing CPD1 after incubation at 37˚C, confirming the result of the 
colony-blotting assay. Hence overexpression of CPD1 results in vacuolar protein 
sorting defect at a Golgi or post-Golgi level especially when cells are exposed to a 
higher temperature. 
 
Previous studies reported that deletion of CPD1 does not result in any growth defect 
on rich or synthetic media at temperatures ranging between 16 and 37˚C ([310] and 
data not shown). In addition, ∆cpd1 has no invertase or α-factor secretion defect, 
does not missort CPY and does not affect the cycling of GFP-Snc1p at 25˚C (data not 
shown). The localization of Sec7-DsRed or Arf1p-GFP does not depend on the 
presence of Cpd1p (Figure 15D + data not shown).  
 
However, ∆cpd1 is hypersensitive to brefeldin A, a toxin that specifically interferes 
with the Arf activation cycle (Figure 15E). We could not detect any effect of CPD1 
overexpression on BFA sensitivity of wild-type strain (data not shown). Since Cpd1p 
function is tightly linked to Arf activation, the connection between the two proteins 
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was investigated. Overexpression of CPD1 does not rescue the cold-sensitive growth 
or the invertase secretion defects of a ∆arf1 strain nor does it rescue the 
temperature sensitivity of an arf1-18∆arf2ts mutant (data not shown). Taken 
together, these data point to a direct effect of Cpd1p on Sec7p function rather than 
Arf itself, which is consistent with the allele specificity of the rescue, since sec7-4ts 
mutants that affect Arf activation more directly are not suppressed by CPD1 
overexpression. 
 
 
 
 
Figure 15: Cpd1p can affect transport on its own 
A-C. Overexpression of Cpd1p results in CPY secretion. Wild type (NY10), sec7-1ts (NY760), 
sec7-4ts (AFM69-1A) and ∆vps1 (yGY13) strains were transformed with 2µCPD1 (pYG30) or 
empty vector (pYG28). These strains were spotted on selective media and the secretion of CPY 
was monitored by colony immuno-blotting (A+B). A semi-permissive temperature of 34˚C had 
to be used for the sec7 mutants to allow for reasonable growth (A), however, in wild type cells 
the phenotype clearly increases with temperature (B). Secretion of CPY in wild type cells 
overexpressing CPD1 was also monitored by pulse-chase experiments (C). Cells were labeled 
with S35-methionine and chased for 30 minutes. CPY was immunoprecipitated from the media 
and pellet fractions and analyzed by autoradiography. The values reported in the graphic 
represent the means of three independent experiments. D. Sec7-dsRed does not require 
Cpd1p for localization. Strains expressing Sec7-DsRed behind the TPI promoter in wild type 
(CSY394) or ∆cpd1 background (yGY77) were observed by confocal microscopy. E. Deletion of 
CPD1 results in increased BFA sensitivity. A ten-fold dilution series of wild type (NY10) or 
∆cpd1 (yGY39) strains were spotted on MPD + 3x10-3 % SDS plates supplemented with either 
DMSO or 77µg/ml BFA. 
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Since deletion of CPD1 has no effect cell growth under standard laboratory 
conditions and did not lead to any transport phenotype that could be detected with 
classic transport assays, we decided to turn to a more global approach to determine 
its function. Therefore, I carried out a synthetic genetic array (SGA) analysis to 
identify genes that are required for viability in the absence of CPD1. This kind of 
analysis has often been useful to determine component acting in the same or a 
parallel pathway of the gene of interest [319]. The screen was performed by crossing 
a ∆cpd1 strain with all the ~4800 viable single deletion strains of the Euroscarf 
knockout collection and double mutants, exhibiting differences in growth compared 
to single mutants, were scored as previously described [319]. The full dataset from 
the screen is presented in Appendix A. However, besides ∆pho85 and ∆pho86, none 
of the double mutants had a strong growth defect although several strains had a 
weak synthetic phenotype. Both Pho85p and Pho86p are involved in a signaling 
pathway regulating the cellular responses to phosphate levels and deletion of either 
of them results in the constitutive expression of Pho5p, a secreted acid phosphatase 
[320-322]. The link between Cpd1p and the PHO pathway could easily be quite 
remote since the turnover of Appr>p is liberating equimolar amounts of inorganic 
phosphate [309, 310]. Hence the enzymatic activity of Cpd1p might account for a 
significant portion of the intracellular phosphate pool and therefore contribute to the 
maintenance of proper phosphate levels. 
 
Eight of the candidates from the screen (Synthetic defect: ∆pho85, ∆pho86, ∆erp5, 
∆hsv2 / Synthetic rescue: ∆fun56, ∆laa1, ∆npp1, ∆vps15) were selected for further 
characterization and the corresponding ORFs were deleted in a sec7-1ts strain. The 
double mutants were tested for growth at different temperatures in the presence or 
absence of 2µ CPD1, to detect a possible genetic interaction with sec7-1ts and to 
determine their role in the rescue of this mutant by CPD1 overexpression. Except 
∆vps15, deletion of none of the candidates significantly affected growth of sec7-1ts 
mutants and in all cases, including ∆vps15, overexpression of CPD1 improved the 
growth of the double mutants. Vps15p is a protein kinase required for the 
recruitment and activation of the sole yeast PI3-kinase, Vps34p on membranes [323, 
324]. PI3P is particularly enriched in the endosomal system and required for cargo 
delivery to the vacuole [324, 325]. Since deletion of VPS15 results in reduced fitness 
of yeast strains (unpublished observation) and PI3P is an important regulator of 
Golgi to vacuole transport [55], the synthetic lethality of ∆vps15 with sec7-1ts could 
reflect the combination of both Golgi and endosomes functions impairment rather 
than a direct interaction. In addition, confirmation of the positive genetic interaction 
between ∆cpd1 and ∆vps15 by tetrad dissection revealed that the growth defect of 
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the double mutant was only slightly less pronounced than the one of ∆vps15 alone 
although reproducible (data not shown). 
 
3.1.6/ Cpd1p binds to Sec7p in vitro and in vivo 
Since high copy suppression is sometimes an indication of physical interaction 
between the two partners [326], a potential binding between Sec7p and Cpd1p was 
investigated in vitro. GST-fusion proteins of wild-type and mutant Cpd1p were 
purified from bacteria, immobilized on Glutathione Sepharose beads and incubated 
with yeast cytosol from strains containing different SEC7 alleles endogenously 
tagged with GFP. The results of these pull-down assays are displayed in Figure 16A-
B. While wild type Cpd1p and Sec7p readily interact with each other, the mutation 
in Sec7-1p effectively abolishes this binding. Although the mutation of the catalytic 
domain of Cpd1p affects the binding efficiency toward Sec7p, the two proteins retain 
the ability to interact. Hence, overexpression of Cpd1p in sec7-1ts mutants seems to 
compensate for the loss of interaction between the two proteins and the catalytic 
activity of Cpd1p is not absolutely required for this interaction. 
 
 
 
 
Figure 16: Cpd1p physically interacts with Sec7p but not the Sec7-1p mutant protein 
A+B. Cpd1p interacts with Sec7p but not Sec7-1p in vitro. GST-Cpd1p (pYG154), GST-
Cpd1H39Ap (pYG163) and GST alone (pGEX-6P-1) were expressed in bacteria. Purified proteins 
immobilized on Glutathione Sepharose beads were incubated with yeast cytosol prepared 
from endogenously tagged Sec7p-GFP (yGY84) (A) or Sec7-1p-GFP (yGY87) (B) strains. 
Proteins specifically binding to the columns were recovered and analyzed using an α-GFP 
antibody. The enrichment was calculated by comparison to the background in the GST alone 
preparation. C. Cpd1p interacts with Sec7p in vivo. Cpd1p-GFP was immuno-precipitated 
with α-GFP antibodies from wild type (NY10) strains expressing Cpd1p-GFP behind 
endogenous (pYG32) or ADH (pYG34) promoter or the corresponding empty plasmid 
(pRS416ADH-GFPc). The presence of Sec7p in the precipitation was detected with α-Sec7 
(0641). 
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To confirm the Cpd1p-Sec7p interaction in vivo, Cpd1p-GFP was 
immunoprecipitated using α-GFP antibody and the presence of endogenous Sec7p 
detected with α-Sec7 antibody raised against the N-terminal part of the protein (see 
material and methods for the purification and characterization of the α-Sec7 
antibody). To compare the effect of different expression levels of Cpd1p on the 
interaction, the two Cpd1p-GFP constructs described in Figure 12A were used for 
this experiment. The result of these immunoprecipitations, shown in Figure 16C, 
demonstrates that Cpd1p and Sec7p do indeed interact in vivo, but this interaction 
is very weak and does not depend on the expression levels of Cpd1p-GFP.  
 
3.1.7/ Cpd1p interacts with many proteins involved in traffic at the Golgi 
Increased Cpd1p levels at the Golgi can compensate for its loss of interaction with 
Sec7-1p and promotes forward transport in wild-type cells, while the lack of this 
protein does not substantially affect protein transport along the secretory pathway 
or viability of sec7-1ts mutants. In addition, since increased Cpd1p expression does 
not considerably enhance binding to Sec7p, high levels of this protein at the Golgi 
could trigger the recruitment or activation of additional components involved in 
Sec7p function. Therefore, to investigate the role of Cpd1p at the Golgi and the 
mechanism of the sec7-1ts mutant rescue in more detail, I tried to identify additional 
interactors of this protein besides Sec7p. Thus, the pull-down procedure used in 
Figure 16A-B was repeated with wild type yeast cytosol and the proteins obtained 
separated on a gradient SDS-PAGE gel, shown in Figure 17. The gel was analyzed by 
A. Shevchenko and H. Thomas using nanoelectrospray tandem mass spectrometry. 
The most relevant results of this analysis are displayed in Table I, while the full list 
is available in Appendix B and C.  
 
Among the most interesting candidates, identified with this method, are components 
of the Arf driven vesicle formation machinery, members of the exocyst complex and 
proteins involved in the early endosome-to-Golgi retrieval pathway (see discussion). 
However, the most striking result is the strong binding of Arf1/2p to the catalytically 
inactive form of Cpd1p. In contrast to all other candidates, which are present in 
relatively low amounts, the enrichment of Arf in the GST-Cpd1H39Ap sample is nearly 
stoichiometric. In addition, the majority of Arf1/2p detected in this sample migrates 
at a much higher molecular weight than usual (around 40 instead of ~21kDa). This 
shift in molecular weight cannot be attributed to the experimental procedure used, 
since Arf1/2p detected in the wild type Cpd1p sample, although at a much lower 
level, migrates at the expected size. Arf myristoylation cannot account for this shift, 
since Arfmyr runs slightly faster than non-myristoylated Arf (T. Baust personal 
 46 
communication), and no corresponding protein modification, like ubiquitin, was 
identified during the mass spectromertry analysis. 
 
 
 
 
 
 
Figure 17: Cpd1p and Cpd1H39Ap interact with many trafficking-related proteins 
To identify potential interactors of Cpd1p, GST-Cpd1p (pYG154) and GST-Cpd1H39Ap 
(pYG163) were expressed in bacteria. Purified proteins immobilized on Glutathione Sepharose 
beads were incubated with yeast cytosol prepared from wild type strains (NY10) and 
separated on a 4-16% gradient SDS gel. The gel was analyzed by nanoelectrospray tandem 
mass spectrometry. The most interesting candidates are displayed in the figure and their 
function described in table I. The poor visibility of the bands in the higher portion of the gel 
correlates with the low abundance of the detected proteins. The full lists of Cpd1p and 
Cpd1H39Ap interactors and their respective abundance in the purifications are shown in 
Appendix B and C. 
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Table I: Cpd1p interactors 
Columns 
Protein 
Cpd1p Cpd1H39Ap 
Function 
Sec7p  ++  Arf-GEF 
Arf1/2p  ++  +++1 ADP-ribosylation factor, Golgi GTPase 
Chc1p  +  + Clathrin heavy chain 
Vps13p  ++  ++ Protein involved in vacuolar sorting 
Sec21p  +  + Coatomer (COPI) coat component 
Sec10p  +  Component of the exocyst complex  
Sec15p  ++  + Component of the exocyst complex  
Exo70p  +  Component of the exocyst complex  
Ypt6p  ++  Rab GTPase, recycling pathway 
Rcy1p  +  + F-box protein interacting with Skp1p 
Skp1p  ++  Component of the SCF complex 
Ykt6p  ++  v-SNARE 
Sec18p    +  NSF, vesicle fusion 
Uso1p  ++  Golgin, docking of ER-derived vesicles 
Sar1p  ++  ++ GTPase, COPII vesicle formation 
Fas1p  +  + Fatty acid synthesis 
Fas2p  +  + Fatty acid synthesis 
Ypk1p  ++  + Protein kinase involved in cell wall integrity and endocytosis 
Vma1p   ++  + Component of the vacuolar membrane ATPase  
Vma2p  ++  ++ Component of the vacuolar membrane ATPase  
Vma8p    ++  Component of the vacuolar membrane ATPase  
Act1p  +  Actin 
Lsb3p  +  + Actin cytoskeleton organization 
Tub1p  ++  ++ Tubulin alpha-1 chain 
Tub2p  ++  ++ Tubulin beta chain 
Tub3p  ++  Tubulin alpha-3 chain 
Gcn1p  ++  + Activator of Gcn2p in response to amino-acid starvation 
 Legend:  1 nearly stoechiometric amount compared to the bait 
  ++ significant enrichement, + poor enrichement 
 
 
3.1.8/ sec7-1ts interacts with the endosome-to-Golgi retrieval pathway 
Several interacting partners of Cpd1p are involved in one of the two endosome-to-
Golgi retrieval pathways. The small GTPase Ypt6p as well as the Skp1p-Rcy1p 
complex are specifically required for the proper recycling of internalized cargoes 
from the early endosome to the Golgi [22, 236, 237, 245, 249]. In addition, the 
synthetic defect between sec7-1ts and ∆vps15 suggests a link between Sec7p 
function and endosomal transport. To test whether the sec7-1ts mutation specifically 
interferes with the recycling pathway, YPT6 and VPS35, a component of the retromer 
complex, were deleted in the sec7-1ts background. As illustrated in Figure 18A, the 
combination of ∆ypt6 with the sec7-1ts mutation affected growth at a temperature 
where both single mutants grow well (Figure 18A and data not shown). Hence, 
disruption of the recycling pathway but not the retromer resulted in synthetic 
growth defect when combined with Sec7-1p.  
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The exocytic SNARE Snc1p is continuously cycling from the plasma membrane to 
the Golgi via endosmal intermediates and is a known cargo of the recycling pathway 
[22]. The cycling of this protein can be followed both by microscopy and western 
blotting by using a GFP-Snc1p construct [22]. To compare the impact of different 
SEC7 mutations on recycling, GFP-Snc1p was introduced in the different sec7 
mutant alleles and followed by microscopy. However, since any delay in forward 
transport will affect the steady-state localization of GFP-Snc1p, the experimental 
conditions for the assay had first to be established and therefore, an internalization 
defective version, called GFP-Snc1ppem was used [22]. The comparison of the two 
lower panels in Figure 18B, illustrate this problem: in wild type cells, the mutant 
construct only labels the plasma membrane, showing that newly synthesized GFP-
Snc1pemp is quickly secreted, while in sec7 mutants some internal fluorescence 
already accumulates at 34˚C. However, at 32˚C, GFP-Snc1pemp seems properly 
localized in both sec7 mutants and this temperature was therefore selected to 
perform the assay. The upper panels of Figure 18B show the distribution of GFP-
Snc1p at 32˚C. This construct, which in wild type cells is predominantly localized to 
the plasma membrane labeling only few internal dots, clearly accumulates inside 
sec7-1ts but not the sec7-4ts cells.  
 
The localization of GFP-Snc1p can also be determined biochemically since this 
protein is hyperphosphorylated at the plasma membrane and accumulates 
internally in an underphosphorylated form in recycling mutants [237]. As illustrated 
in Figure 18C, about 50% of the GFP-Snc1p is found on the plasma membrane in 
wild type cells, while the amount of external GFP-Snc1p sec7-1ts mutants is already 
slightly decreased at 25˚C and reduced to the levels of a ∆ypt6 mutant at 32˚C. 
Hence, Figure 18C confirms the microscopy data and indicates that the GFP-Snc1p 
recycling defect of sec7-1ts mutants is allele specific.  
 
In addition, SRO9, another allele specific high copy suppressor of sec7-1ts, also 
rescues the temperature sensitive growth defect of ∆ypt6 ([248] + data not shown), 
thereby suggesting a specific link between this sec7 allele and the recycling 
pathway. Overexpression of CPD1 had no effect on growth of ∆ypt6 and neither 
∆sro9 nor ∆cpd1 had a GFP-Snc1p recycling defect (data not shown). 
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Figure 18: The sec7-1ts mutant specifically affects the recycling pathway 
A. sec7-1ts mutants interact genetically with ∆ypt6. Strains, carrying the sec7-1ts mutation in 
wild type (NY760), ∆ypt6 (yGY272) or ∆vps35 (yGY270) background, were spotted on YPD 
plates in a ten-fold dilution series. B+C. sec7-1ts mutants affect the recycling of GFP-Snc1p. 
Wild type (NY10), sec7-1ts (NY760), sec7-4ts (AFM69-1A) and ∆ypt6 (yGY43) strains were 
transformed with pGFP-Snc1p (pJMG118) or pGFP-Snc1pemp (pJMG122) and observed by live 
microscopy at different temperatures (B). The phosphorylation status of GFP-Snc1p under the 
same conditions was analyzed by western blotting of whole cell extracts with α-GFP 
antibodies and the relative amount of phosphorylated versus unphosphorylated protein 
calculated with Image Gauge (C). 
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3.2/ The Arf-GEF Sec7p interacts with the Golgi PI4-kinase Pik1p 
 
3.2.1/ Pik1p interacts with the Sec7 domain of yeast Arf-GEFs  
A yeast two-hybrid screen using full-length Pik1p, the Golgi PI4-kinase, as bait, was 
performed by M.Schoene and identified Gea2p as a potential interacting candidate. 
The Gea2p fragment isolated during the screen contained the highly conserved N-
terminal part of the Sec7 domain. Therefore, Pik1p interaction with the 
corresponding regions of Gea1p, Gea2p and Sec7p were analyzed with the same 
two-hybrid system in collaboration with a G. Weselek. We found that Sec7 domain 
fragments, corresponding to aa 819 to 942 of Sec7p (Sec7 domain of Sec7p = aa 824 
to 1010), interact with Pik1p. The interaction domain of Pik1p was further mapped 
by M. Beck to aa 301 to 769, containing the conserved PI4-kinase β similarity region 
as illustrated in Figure 19A. This domain has no identified function and was 
previously reported to be conserved between the PI4-kinases IIIβ, but not IIIα, 
subfamilies [327]. New sequence alignments of the PI4-kinase IIIβ homologues, done 
by B. Habermann, are shown in Figure19B and define the border of this similarity 
region to aa 436 and 528 of the Pik1p sequence. Interestingly as shown in Figure 
20, alignments of this domain to the corresponding region of the PI4-kinase IIIα 
subfamily indicates that the conservation of this domain might not be restricted to 
the IIIβ subfamily and will therefore be referred to as PI4-kinase similarity region. 
Any further truncation of the Pik1p interacting region did not give positive signals in 
the yeast two-hybrid system. 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Pik1p interacting domain (see following page) 
A. Schematic view of Pik1p protein domains and the ArfGEF interaction region. B. Sequence 
alignment of PI-4-kinase IIIβ homologues. Highlighted domains: green = Lipid Kinase Unique 
(LKU), aa 23-132; blue = PI-4-kinase similarity region, aa 436-528; red = catalytic domain, aa 
765-1066. Positions of the domains are given in the S.cerevisiae Pik1p coordinates. Accession 
numbers: HsPIK4b (NP_002642.1), XlPI4Kb (AAH73706.1), DrPI4Kb (MP_00103149.1), 
SpurPI4Kb (XP_782151.1), AmPI4Kb (XP_391922.1), ScPik1 (NP-014132.1), CaPik1 
(XP_714748.1), SpPik1 (CAA93903.1). 
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Figure 20: Conservation of the PI-4-kinase similarity region 
Alignments of the PI-4-kinase similarity region in PI-4-kinase III α and β families. Yellow = 
residues conserved between the two families, blue = residues conserved among the PI-4-
kinase III β family, green = residues conserved among the PI-4-kinase III α family. Accession 
numbers: HsPIK4b (NP_002642.1), XlPI4Kb (AAH73706.1), DrPI4Kb (MP_00103149.1), 
SpurPI4Kb (XP_782151.1), AmPI4Kb (XP_391922.1), ScPik1 (NP-014132.1), CaPik1 
(XP_714748.1), SpPik1 (CAA93903.1), HsPiKa (NP_477352.1), XlPiKa (AAH77604.1), DrPiKa 
(NP_001030144.1), ScStt4 (NP_013408.1), CaStt4 (XP_710429.1), SpStt4 (CAB54814.1). 
 
 
3.2.2/ Sec7p colocalizes poorly with the Gea’s 
Gea1p, Gea2p and Sec7p are three Golgi localized Arf-GEFs and despite previous 
studies showing that Gea1p and Gea2p functionally overlap with each other but not 
with Sec7p, very few studies directly compared these proteins. In addition, the 
available localization data for each of the three proteins are not sufficient to properly 
judge their spatial overlap in vivo. Therefore, the individual GEFs where tagged with 
either CFP or YFP and colocalization studies using each pair were carried out by live 
microscopy. To avoid any artifacts due to overexpression, the GEFs were C-
terminally tagged at their genomic locus. Single and double tagged strains were 
tested for growth at different temperatures and for single tagged Gea’s the 
redundant GEA was deleted to prevent rescue. All colonies grew indistinguishably 
from wild type strains up to 37˚C (data not shown). The intensity of the fluorescence 
signals decreased in the order Sec7p>Gea2p>Gea1p and is consistent with the 
relative abundance of the GEFs detected by western blot. 
 
The colocalization studies were performed with a wide-field fluorescent microscope 
equipped with a CCD camera and a highly sensitive filter set, allowing detection of 
the weak fluorescent signals resulting from the low expression levels of 
endogeneously tagged GEFs and the fast bleaching of the fluorophores. The results 
of this analysis are reported in Figure 21 together with an example illustrating the 
quantification procedure. More than 300 cells were counted for each GEF pair and 
despite a quite large standard deviation, the results clearly indicate that while 
Gea1p and Gea2p do overlap to quite some extend, they colocalize poorly with 
Sec7p. In addition, despite their redundancy, Gea1p and Gea2p can be found on 
different compartments indicating that they could have partially independent roles 
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under wild-type conditions. During the initial establishment of the microscopy 
procedure, we also noticed that the compartments labeled with Gea1p and Gea2p 
are slightly more mobile than the Sec7p positive structures, supporting their 
different nature. Finally, Sec7p overlaps to the same extend with Gea1p and Gea2p 
speaking against a model where the three proteins act consecutively. 
 
During the quantification, an unexpected feature of the subcellular distribution of 
the GEFs was noted: there are more Gea2p containing structures than Sec7p or 
Gea1p ones (see Figure 21C). This difference is slight and could hardly be noticed 
using a single fluorescent marker, however it becomes clear when the cells are 
double labeled. This difference is also visible in the colocalization values obtained for 
Gea2p: 62 % of the Gea1p labeled compartments also contain Gea2p but only 49 % 
of the Gea2p positive structures are associated with Gea1p. Interestingly, while the 
same amount of Sec7p-structures is found to associate with Gea1p and Gea2p, the 
decrease in the overlap observed with Gea2p labeled compartments (11%), indicates 
that this protein labels a separate pool of structures that do not participate in the 
colocalization events. This model is schematically illustrated in Figure 21D. 
 
 
 
 
Figure 21: Sec7p colocalizes poorly with the Gea’s 
The pair wise colocalization between the Arf-GEFs was done by live microscopy using a 
combination of CFP/YFP tags introduced at the genomic locus: Sec7p-YFP + Gea1p-CFP 
(yGY162), Sec7p-YFP + Gea2p-CFP (yGY163) and Gea1p-CFP + Gea2p-YFP (yGY152). A. 
Example of colocalization between Sec7p-YFP and Gea1p-CFP. Arrows = isolated structures, 
arrowhead = double labeled compartment. B. Combined results of the colocalization studies 
showing the total number of cells counted and the colocalization percentage of each pair. C. 
Average number of labeled structures per cell. D. Schematic model of the colocalization 
results. 
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3.2.3/ Sec7p is the physiological interaction partner of Pik1p 
The yeast two-hybrid data suggest that Pik1p can interact with the three Arf-GEF. 
To test the physiological relevance of these interactions, bacterially purified GST-
Pik1p was bound to Glutathione Sepharose beads and incubated with yeast cytosol 
containing either one of the GEFs C-terminally tagged with GFP at their genomic 
locus. Since full-length Pik1p is not expressed in E.coli, the fragment corresponding 
to the positive yeast two-hybrid interaction (aa 301-769) was used and the PI4-
kinase similarity regions of both Pik1p and Stt4p were tested in parallel. The 
outcome of this experiment is shown in Figure 22A and indicates a clear preference 
of the Pik1 aa301-769 fragment for Sec7p. Neither of the PI4-kinase similarity 
domains interacted with the GEFs, consistent with previous yeast-two hybrid data. 
Whether this indicates that residues outside this region are required for binding or 
that expression of this domain alone results in non-functional constructs is unclear. 
Attempts to create a dominant negative Pik1p construct by overexpressing the 
interaction domain (aa 301-769) in yeast did not yield any results, maybe due to a 
lack of localization of this construct since a GFP-tagged version is completely 
cytoplasmic (data not shown). 
 
To test whether Pik1p interacts preferentially with Sec7p in vivo, immuno-
precipitation experiments where performed with endogenously tagged GEF-GFP 
strains, and the presence of Pik1p in the precipitate was detected with α-Pik1 
antibody. Since the relatively low levels of endogenous Pik1p were insufficient to 
detect an interaction, Pik1p levels where increased by expressing the wild type 
protein from a 2µ plasmid. The overexpression of Pik1p had no discernable effect on 
growth or the localization of the GEFs, as determined by live microscopy (data not 
shown). The results displayed in Figure 22B confirm that Sec7p is the main 
physiological partner of Pik1p in vivo. Stronger exposure of the same blots showed 
no enrichment of Pik1p in the Gea lanes compared to the negative control, 
indicating that the absence of interaction is not due to the lower amount of bait 
precipitated from these samples (data not shown).  
 
3.2.4/ Sec7p colocalizes with Pik1p and its product PI4P 
Since Sec7p and Pik1p physically interact, their relative cellular localization was 
investigated. Therefore, strains containing Sec7-dsRed tagged at the genomic locus 
were transformed with a GFP-PIK1 construct expressed behind its endogenous 
promoter on a CEN plasmid. Since high levels PIK1 expression from a 2µ plasmid do 
not affect Sec7p localization, the addition of a single copy of this gene is unlikely to 
have important side effects. The functionality of the Pik1p construct has been 
demonstrated previously [265] and the dsRed tag on the essential Sec7p protein did 
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not affect the growth of these strains. In addition, use of the endogenously tagged 
Sec7p-dsRed did not result in the appearance of enlarged structures as is 
sometimes observed in strains overexpressing a similar construct behind the strong 
TPI promoter ([265, 315, 328] and see Figure 12D and 15D). As illustrated in Figure 
22D, the two proteins nicely colocalize with each other. 
 
Since Pik1p is responsible for the production of PI4P at the Golgi [258, 259], a GFP 
tagged PH domain construct, known to specifically recognize this pool of 
phosphoinositide [277], was used to determine the activity of Pik1p at the Sec7p 
labeled compartments. The colocalization between this PH domain and endogenous 
Sec7-dsRed is shown in Figure 22F and confirms that PI4P production is taking 
place on the same membranes. Colocalization studies between the PH-domain and 
either Gea1p or Gea2p resulted in a very poor overlap, which is consistent with the 
colocalization studies between the different Arf-GEFs (data not shown). 
 
3.2.5/ The GEFs and Pik1p do not absolutely require each other for 
localization or PI4P production 
Taken together, the above data indicate that Sec7p is present in the cells at the 
same compartments as Pik1p and its product PI4P. Therefore, one possible function 
of the Pik1p-Sec7p interaction could be that they recruit or activate each each other. 
To test this hypothesis, a pik1ts mutant, defective in PI4P production, was crossed 
into the strains expressing single GFP-tagged GEFs from their chromosomal loci. 
After tetrad dissection, the strains were observed by microscopy, but no reduction in 
membrane association of the Arf-GEFs was observed neither at 25 nor 37˚C (Figure 
22C and data not shown). However, all three pik1-101ts mutants containing C-
terminally tagged Arf-GEFs, had a strong morphological defect resulting in very 
elongated cells, indicating that this tagging is not entirely neutral. In addition, these 
strains were able to acquire suppressors within a week, effectively reducing our 
possibilities to investigate any further. These observations were completely 
reproducible when YFP tags where used instead of GFP (data not shown). 
 
In the complementary experiment, the GFP-PIK1 or PH-domain-GFP constructs were 
introduced into different gef mutants and imaged by confocal microscopy. For these 
experiments, the sec7-4ts mutant was in general preferred over sec7-1ts, since the 
shift to non-permissive temperature results in a more direct block in Arf activation. 
For the GEA’s, the use of a double mutant was compulsory to circumvent the 
functional redundancy. The gea1-6ts∆gea2 mutant, which has two point mutations 
in the C-terminal part of the protein, was preferred over the gea1-4ts∆gea2 mutant, 
which, like sec7-4ts, has mutations inside the Sec7 domain but is a poor 
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temperature-sensitive allele [152]. The results of these experiments are shown in 
Figure 22E and 22G, respectively, and demonstrate that although Pik1p is slightly 
more cytosolic in sec7 than gea mutants or wild-type cells, its ability to interact with 
membranes is not abolished. The interpretation of the PH-domain localization 
results is complicated by the dual recognition system of this reporter, which 
responds to the presence of both PI4P and activated Arf [277]. The residual 
membrane binding of the PH-domain in pik1-101ts mutant is likely to result from Arf 
activity as shown previously [277]. Although the pik1-101ts allele used for the 
present studies is different from the one studied previously, both mutants strongly 
affect the catalytic activity of the enzyme [258, 259] and are unlikely to behave 
differently in this assay. Both sec7 and gea mutants have a slightly higher cytosolic 
staining than wild-type cells possibly due to decreased Arf activity. The localization 
defect of the PH domain is clearly stronger in the sec7 mutant emphasizing a closer 
relationship between this GEF and Pik1p function. However, even in this case 
residual membrane binding still occurs indicating that intracellular PI4P production 
is not entirely disrupted in this mutant. Taken together, these data suggest that 
Pik1p or the GEFs are not acting as membrane receptors for each other. Mutations 
of these proteins seem to have an effect on each others localization, however, their 
impact on Golgi integrity has to be taken into consideration as well and might 
account for the observed phenotypes.  
 
 
 
 
Figure 22: Sec7p-Pik1p interaction (see following page) 
A. Pik1p interacts preferentially with Sec7p in vitro. The Pik1p yeast two-hybrid interaction 
domain (Pik1 aa301-769, pYG132), the PI4K similarity region of Pik1p (aa 436-528, pYG147), 
the PI4K similarity region of Stt4p (aa 1535-1625, pYG148) and GST (pGEX-6P-1) were 
expressed in bacteria. Purified proteins immobilized on Glutathione Sepharose beads were 
incubated with yeast cytosol prepared from endogenously tagged Sec7p-GFP (yGY84), Gea1p-
GFP (yGY136), Gea2p-GFP (yGY127) or Cdc16p-GFP (yWZ361). Proteins specifically binding 
to the columns were recovered and analyzed using an α-GFP antibody. The second band in 
the Sec7-GFP sample might be a degradation product due to the intrinsic instability bof the 
protein. B. Pik1p interacts with Sec7p in vivo. Endogenously tagged Sec7p-GFP (yGY84), 
Gea1p-GFP (yGY136), Gea2p-GFP (yGY127) strains containing 2µPIK1 (CSP8), were immuno-
precipitated with α-GFP antibodies and the presence of Pik1p detected with α-Pik1 antibody. 
An untagged strain (NY10) also containing 2µPIK1 (CSP8) was used as control. C. Pik1p 
function is not required for membrane localization of the Arf-GEFs. Sec7p-GFP (yGY84), 
Gea1p-GFP (yGY136), Gea2p-GFP (yGY127) were backcrossed to pik1-101ts (CSY93), dissected 
and observed by live microscopy. D+F. Sec7p colocalizes with Pik1p and its product PI4P. 
Endogenously tagged SEC7-DsRed (CSY901) was transformed with GFP-Pik1p behind the 
endogenous promoter (pp1500-GP)(D) or the reporter construct PHOSBP-GFP (pTL332) was 
integrated into the strain (yGY267) (F). The localization was investigated by confocal 
microscopy. E+G. Pik1p and PHOSBF-GFP are still able to localize to membranes in gef 
mutants. Wild type (NY10), sec7-1ts (NY760), sec7-4ts (AFM69-1A) and gea1-6ts∆gea2 (yGY166) 
were transformed with GFP-Pik1p behind endogenous promoter (pp1500-GP) and observed by 
confocal microscopy (E). The reporter construct PHOSBP-GFP (pTL332) was integrated in wild 
type (yGY257), sec7-4ts (yGY259) gea1-6ts∆gea2 (yGY261) and pik1-101ts (yGY260) strains and 
observed by live microscopy. 
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3.2.6/ Abnormal membrane structures accumulating in either gea or sec7 
mutants are found in pik1-101ts  
Mutation in GEAs, PIK1 and SEC7 result in abnormal membrane accumulation [2, 
151, 152, 173, 176, 178, 258, 259], however the structures observed in previous 
studies are extremely difficult to compare due to the differences in sample 
preparations and imaging technique used. Therefore, in collaboration with T. 
Mueller-Reichert, samples from pik1-101ts, gea1-6ts∆gea2 and sec7-4ts were prepared 
for electron microscopy using the cryo-fixation procedure. The result of this analysis 
is shown in Figure 23. As expected, both sec7-4ts and pik1-101ts mainly accumulated 
Berkeley bodies (panel C+E-F), while gea1-6ts∆gea2 double mutants were devoid of 
them. These latter mutants preferentially accumulated various large and intricate 
membrane aggregates (panel A-B). Interestingly, some of those larger structures 
were observed in the pik1-101ts sample although much less frequently (panel D). As 
previously reported, a certain degree of ER swelling was also observed in all gef 
mutants, but not pik1-101ts. 
 
The origin and nature of the different membranes observed are hard to determine 
without immunolabeling. However, the large multi-layered ring-like structures in the 
gea1-6ts∆gea2 samples (asterisks in panel A-B) are generally found in close 
proximity to the ER and sometimes seem even connected with it, suggesting that 
they could arise from a compartment belonging to the early secretory pathway. In 
contrast, Berkeley bodies were never obviously associated with the ER nor any other 
membranes and previous reports of these structures suggest a late Golgi origin. The 
large multi-lamellar structures seen in pik1-101ts and gea1-6ts∆gea2 are unlikely to 
be real MVBs (arrows in panel A-B+D). Even if their shape sometimes reminds of 
those late endosomal intermediates, the structures observed here are more 
heterogeneous and comparison between different section suggests the presence of a 
fenestrated structure rather than internalized vesicles. The small involuted 
structures in the sec7-4ts strain never reach a size comparable to the ones in pik1-
101ts or gea1-6ts∆gea2 and no extensive tubulation of the internal structures were 
observed in this case. 
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3.2.7/ Sec7p and Pik1p influence different transport steps than Gea1/2p 
If Sec7p and Pik1p interact and function at least partially together at the same 
compartment, inactivation of either protein could result in similar phenotypes. 
Therefore, different methods were used to compare the impact of the gea, sec7 and 
pik mutants with each other in a cellular context.  
 
Arf activity is strongly linked to COPI and clathrin coat recruitment although direct 
in vivo evidence for these processes is still incomplete (see § 1.4.1.1). In addition, in 
mammalian cells, GBF1 and BIGs are thought to promote the formation of different 
classes of vesicles [156, 160-162]. No such correlation between different GEFs and 
coat proteins has been shown yet in S.cerevisiae and the production of PI4P has not 
been linked to the formation of a particular kind of vesicles. Therefore, I studied the 
distribution of COPI and clathrin in gef and pik1 mutants and the subcellular 
localization of clathrin compared to Sec7p/Pik1p containing compartments. Strains 
containing the COPI subunit Sec21p or the clathrin heavy chain Chc1p, tagged with 
3XGFP or mRFP at their chromosomal locus, respectively [73, 137], were either 
transformed with the endogenously expressing GFP-Pik1p construct or back-crossed 
to our mutant strains. As shown in Figure 24A, Pik1p and Chc1p nicely localize to 
the same compartments, but Chc1p-mRFP seems to surround the Pik1p staining. 
This slight difference in localization might reflect the different function of the two 
proteins: while Pik1p should directly associate with Golgi membranes, the majority 
of the clathrin is expected to be concentrated on small vesicles leaving this 
organelle. The lower panel of Figure 24B shows an increased cytosolic staining for 
COPI in gea1-6ts∆gea2 mutants compared to sec7-4ts or wild type cells. On the 
contrary, as seen in the upper panel, membrane association of clathrin seems 
normal in gea1-6ts∆gea2 while it is clearly more cytosolic in sec7-4ts mutants. The 
localization of Sec21p in sec7-4ts mutants is clearly aberrant, however, since the 
membrane recruitment of the protein does not seem affected, this might reflect a 
loss in organelle integrity. The localization of clathrin in pik1-101ts cells strongly 
resembles the one of sec7-4ts mutants and it is tempting to speculate that they work 
together in the formation of clathrin-coated vesicles. However, since diploids 
heterozygous for pik1-101ts and Sec21-3xGFP are not able to segregate properly 
during sporulation, the effect of this mutant on COPI recruitment remains an 
intriguing issue that we were not able to resolve with the tools available. Taken 
together, these data indicate that there might be a correlation between the different 
GEFs and specific coat proteins in yeast, as shown in mammalian cells. In addition, 
Sec7p and Pik1p both seem strongly involved in clathrin function. However, our 
current data cannot exclude an additional role in COPI vesicle formation. 
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Figure 24: Pik1p and Sec7p interact preferentially with clathrin rather than COPI coats 
A. Pik1p colocalizes with clathrin heavy chain. A strain containing endogenously tagged 
CHC1-mRFP (3100-20D) was transformed with GFP-Pik1p behind the endogenous promoter 
(pp1500-GP) and observed by confocal microscopy. B. Differential recruitment of COPI and 
clathrin coats. Endogenously tagged Chc1p-RFP (3100-20D) crossed in pik1-101ts (yGY239), 
sec7-4ts (yGY250) and gea1-6ts∆gea2 (yGY240) and endogenously tagged Sec21-3XGFP 
(BGY211) crossed into sec7-4ts (yGY247) and gea1-6ts∆gea2 (yGY248), were observed by live 
microscopy. 
 
 
To study transport integrity of the early secretory pathway, a GFP-Rer1p reporter 
protein was used. GFP-Rer1p cycles between the ER and the cis-Golgi, and localizes 
to the Golgi at steady state [329]. In COPII mutants disrupting forward transport 
from the ER to the Golgi, this protein accumulates in the ER, while disruption of 
retrograde transport through COPI vesicles results in missorting to the vacuole 
[329]. The results of this experiment are displayed in Figure 25. As reported 
previously for other gea1/2 double mutants [178], gea1-6ts∆gea2 cells at non 
permissive temperature, clearly accumulate GFP-Rer1p in the ER. Neither of the 
sec7 mutant alleles nor pik1-101ts displays a similar accumulation. In these strains, 
the marker localizes to small structures spread throughout the cell. The lack of ER 
or vacuolar staining suggests that the cycling of the protein is not directly disturbed 
but that loss of Golgi integrity is the cause of the abnormal staining pattern. These 
results indicate a more direct role for Gea1/2p than Sec7p or Pik1p, in GFP-Rer1p 
cycling.  
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Figure 25: Cycling of a cis-Golgi marker is more affected in gea mutants 
GFP-Rer1p accumulates in the ER in gea but not sec7 or pik1 mutants. The GFP-Rer1p 
reporter construct (pSKY5-RER1-0) was transformed in wild type (NY10), sec7-1ts (NY760), 
sec7-4ts (AFM69-1A), gea1-6ts∆gea2 (yGY166), pik1-101ts (CSY712), sec21-1ts (NY424) and 
sec23-1ts (NY737) strains and observed by live microscopy. 
 
 
In addition, since Gea1/2p, Sec7p and Pik1p have all been independently linked to 
the organization of the actin cytoskeleton ([133, 259] and current study), the actin 
structures of each mutant was investigated by immuno-fluorescence. As seen in 
Figure 26A, none of the mutants has apparent actin cables and polarization is 
affected in all of them, although to a lesser extend in pik1-101ts cells. Abnormal 
polymerized actin structures, called actin bars, are particularly abundant in gea1-
6ts∆gea2 mutants but can also be found in pik1-101ts and sec7-4ts cells. Since 
overexpression of either of the GEA’s can bypass the profilin requirement in actin 
cable nucleation [133], I tested whether overexpression of SEC7 or PIK1 could have 
the same effect. As illustrated in Figure 26B, this is not the case. Similarly, 
overexpression of the actin related gene SRO9 rescues the growth defect of sec7-1ts 
but none of the other mutants tested (data not shown). Despite a common defect in 
actin cytoskeleton, the different mutants tested in this study have slightly different 
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phenotypes and thus do not seem to share a common function in organizing actin 
structures. In addition, a defect in cytoskeleton arrangements could result from an 
indirect effect caused by loss of Golgi function. 
 
E. Ercan, a master student in our lab, also compared the uptake of the endocytic 
dye FM4-64 by pik1-101ts, gea1-6ts∆gea2 and sec7-4ts mutants. Her results agree 
with the published data [152, 259] and show a delay in delivery of the dye in both 
pik1-101ts and sec7-4ts mutants, but not in gea1-6ts∆gea2 mutants (data not shown). 
 
 
 
 
Figure 26: The actin cytoskeleton defect is different in gea than in pik1 and sec7  
 mutants 
A. Gea mutants have more actin “bars” than pik1 or sec7 mutants. Wild type (NY1211), pik1-
101ts (CSY712), sec7-4ts (AFM69-1A) and gea1-6ts∆gea2 (yGY166) cells were prepared for 
immuno-fluorescence, stained with α-actin antibodies and observed by fluorescence 
microscopy. B. Overexpression of SEC7 or PIK1 does not rescue a profilin mutant. The 
temperature sensitive profilin mutant, pfy1-111ts (yGY148) was transformed with 2µGEA2 
(pYG107), 2µSEC7 (pYG108), 2µPIK1 (CSP8) or empty plasmid (pYG28) and ten-fold dilution 
series were spotted on selective media. 
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3.3/ Ypt31/32p effector columns 
Ypt31p and Ypt32p are two redundant GTPases of the Ypt/Rab family, thought to 
play a role in TGN exit. However, only very few effectors of these proteins are known 
and their respective function remains obscure. To identify more interaction partners 
of Ypt31/32p, a method proven efficient for the characterization of Rab5 and Ypt6p 
effectors [251, 330], was applied. The concept of this method relies on the capacity 
of GTPases to bind to different sets of proteins in their active and inactive forms. 
Ypt31p and Ypt32p were produced as recombinant fusion proteins in bacteria, 
immobilized on a matrix and loaded with either GDP or a non-hydrolyzable form of 
GTP (GTP-γ-S) before incubation with yeast cytosol. Proteins binding specifically to 
each column were recovered and analyzed by mass spectrometry. Figure 27A shows 
the typical outcome of such an experiment. Since Sec2p is an identified effector of 
Ypt32p [38], an antibody against this protein was used to control the efficiency of 
the purification. The result of this control is displayed in Figure 27B and confirms 
the nucleotide specificity of the isolation procedure.  
 
Unfortunately, the overwhelming amount of bait present in the purifications lowered 
the quality of the mass spectrometry analysis by covering up the weaker signals. 
However, despite this problem, several interesting candidates where isolated from  
 
 
 
 
Figure 27: Ypt32p effector columns 
A. Example of Ypt32p purification column. GST-Ypt32p (pYG03) and GST (pGEX-6P-1) were 
expressed in bacteria. Purified proteins were immobilized on Glutathione Sepharose beads 
and loaded with the appropriate nucleotide before incubation with wild type (NY10) yeast 
cytosol. After concentration, proteins specifically interacting with the different columns were 
separated on a SDS-PAGE gel, visualized by Coomassie staining and analyzed by 
nanoelectrospray tandem mass spectrometry. The most interesting candidates are displayed 
in table II and the full list is in Appendix D. B. Nucleotide specificity of the column. The same 
samples were analyzed by western blotting using α-Sec2 antibodies. 
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the Ypt32p column and are shown in Table II. The complete list is in Appendix D. 
The identification of Mrs6p, the yeast Rab escort protein, further confirms the 
nucleotide specificity of the purification, since this protein preferentially binds to the 
GDP form of native Ypts and acts as a chaperone in the prenylation reaction [331-
333]. 
 
Table II: Ypt32p effector list 
 Protein Function 
Sec23p COPII vesicle coat 
Cmd1p Calmodulin 
Cna1p Ca2+/calmodulin regulated phosphatase 
Act1p Actin 
Sac6p Fimbrin, actin organization 
Cap2p Actin capping protein 
Smy1p Myo2p interacting protein, exocytosis 
Vps3p Vacuolar protein sorting 
Gvp36p "Golgi vesicle protein", unknown function 
G
T
P
-γ
-S
 
Dnf3p Flippase of the Drs2p family 
G
D
P
 
Msr6p Rab ESCORT protein 
 
 
Among the putative Ypt32p effectors, three proteins are connected to the 
organization of the actin cytoskeleton, actin itself, Sac6p and Cap2p. The role of 
actin in transport from the Golgi is still poorly understood. Besides its recognized 
role in the transport of secretory vesicles to the plasma membrane [334], actin 
polymerization has been suggested to play a role in vesicle formation [335, 336]. 
Myo2p is a class V myosin motor that promotes the delivery of Golgi-derived vesicles 
to sites of polarized growth by moving along actin filaments [337, 338]. Interestingly, 
two of the candidates, Smy1p and calmodulin (Cmd1p), interact with Myo2p and are 
involved in polarized growth [339, 340]. In addition, while this work was going on, 
activated Ypt32p was reported to stimulate the interaction of Myo2p and Mlc1p 
[341], a protein of the calmodulin superfamily, required for vesicle delivery to the 
bud neck during cytokinesis [342]. The calcineurin subunit, Cna1p, is a protein 
phosphatase regulated by Ca2+/calmodulin [343]. The Cna1p homologue in 
S.pombe, is genetically linked to the clathrin adaptor AP-1 and Ypt3, the homologue 
of Ypt31/32p [344, 345], and the human homologue regulates clathrin coated 
vesicle formation in nerve terminals [346]. This connection is interesting since, in 
S.cerevisiae, both AP-1 and clathrin have been involved in the formation of a subset 
of secretory vesicles [142]. In addition, Dnf3p, a Golgi-localized member of the Drs2p 
amino-phospholipid translocase family, is required to create lipid asymmetry in 
post-Golgi secretory vesicles, together with Drs2p [181].  
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3.4/ Follow-up on a screen for post-Golgi sorting mutants 
To identify mutants affecting post-Golgi sorting events, a genome-wide visual screen 
was designed and carried out as a colaboration between Prof. Kai Simons’ laboratory 
and ours. For this, a plasma membrane targeted model cargo protein was designed 
and transformed in the Euroscarf knockout collection. Mutants with altered marker 
localization were isolated by T. Proszynski and R. Klemm. This work resulted in a 
final list of 19 candidates shown in Table III, that I subscreened using classic 
transport assays. This work is published in PNAS [347]. 
 
The mutants isolated in the screen were tested for α-factor, invertase and CPY 
secretion as well as their capacity to localize the plasma membrane ATPase, Pma1p. 
For completeness of this analysis, five additional mutants belonging to the same 
complex as identified candidates where included in the subscreening. Those 
mutants are marked with ‡ in Table III. Four of the mutants, ∆erg4, ∆erg6, ∆ayr1 
and ∆ypc1, were added to the candidate list at a later time point and were therefore 
not included in the α-factor secretion or Pma1p localization experiments. 
 
 
Table III: Candidate list from the visual screen 
Genes Function 
YGL015c Member of the actin filamentous network 
YLR254c Interacts with a member of the dynein/dynactin pathway 
RIM21 Invasive growth  
GIM3 Prefoldin complex 
PAC10 Prefoldin complex 
VRP1 END5, verprolin, actin patch protein 
VPS41 HOPS complex, transport to the vacuole 
MON1 Transport to the vacuole 
FAB1 PI3P 5-kinase, transport to the vacuole  
BUD27 Prefoldin complex 
RVS161 END6, BAR adaptor protein, actin patch protein 
CHS5 Exomer vesicle coat 
SUR4 Suppressor of rvs161, sphingolipid biosynthesis 
SUR2 Suppressor of rvs161, sphingolipid biosynthesis 
KES1 Oxysterol binding protein, post-Golgi transport 
AYR1* Sphingolipid biosynthesis 
ERG4* Ergosterol synthesis 
ERG6* Ergosterol synthesis 
YPC1* Sphingolipid biosynthesis 
RVS167 † Belongs to a complex with Rvs161p 
YKE2 † Prefoldin complex 
GIM4 † Prefoldin complex 
GIM5 † Prefoldin complex 
PFD1 † Prefoldin complex 
 Legend:  * Candidate from the screen added at a later time point 
  † Candidate deduced from database search 
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Secretion of α-factor was assessed on plates using a halo assay. In this method, 
MATα mutant strains are grown on a lawn of MATa cells, hypersensitive to the 
mating pheromone (∆sst1). The MATa strains arrest their growth in response to 
mature α-factor, resulting in the formation of a “halo” of non-growing cells around 
colonies properly processing and secreting the pheromone [348]. Missorting of CPY 
to the surface and secretion of invertase were monitored, by using colony immuno-
blotting and measuring the enzymatic activity, respectively (see § 3.1.2 + 3.1.5). The 
results of these experiments are displayed in Figure 28 A-C. The only mutants with 
reproducible phenotypes in both invertase and α-factor secretion are ∆vrp1 and to a 
lesser extend ∆rvs167. The vrp1 null mutant is temperature sensitive ([349] and 
Figure 28B) and the invertase secretion defect is not due to the reported 
accumulation of cell wall material ([350] + data not shown). As expected, strong CPY 
missorting was observed for mutants affecting vacuolar protein sorting. 
Surprisingly, two subunits of the prefoldin complex, ∆gim4 and ∆gim5, have a strong 
defect in the halo assay (Figure 28A), and ∆pdf1 seems temperature sensitive 
although this phenotype was not reported previously (Figure 28B). All other 
candidates display only weak phenotypes if any, demonstrating that the visual 
screening method employed allows the identification of new mutants affecting 
intracellular transport, which were unlikely to be detected in previous screens. 
 
The major plasma membrane ATPase, Pma1p, is an identified cargo of light density 
secretory vesicles [9]. Studies demonstrating the association of Pma1p with 
detergent resistant membranes (DRMs) suggest that this protein reaches its 
destination through the same pathway as the reporter used for the visual screen 
[347, 351]. To visualize Pma1p, a C-terminal tagged version of the protein expressed 
behind the inducible GALs promoter was used. Induction of this construct resulted 
in a very strong expression and some missorting of Pma1p-GFP to the vacuole 
already in wild type cells, making it difficult to discern weak phenotypes (see Figure  
 
Figure 28: Follow-up work from the genome wide visual screen (see following page) 
Different transport assays were used to identify trafficking phenotypes in the candidates from 
the visual screen listed in Table III. Strains used in this figure were all purchased from the 
Euroscarf collection and either Matα (A-C) or Mata (D) cells were used. A. α-factor secretion. 
The ability of the different candidates to induce a halo of ∆sst1 cells (yGY46) was scored in 3 
independent experiments. The scoring of the phenotype bases on comparison with the wild-
type (BY4742) and a ∆kex2 strain (KR418-1A). B. CPY secretion. Colonies were spotted on 
YPD plates and secretion of CPY was monitored by colony immuno-blotting with α-CPY 
antibodies. C. Invertase secretion. Invertase production was induced in low glucose and the 
percentage of secretion determined by comparing the enzymatic activity of internal versus 
external pool. The exocyst mutant sec6-4ts (NY21) was used as control. The table shows the 
mean values of 3 independent experiments. D. Pma1p-GFP localization. Wild type (BY4741) 
and all mutants were transformed with a PMA1-GFP construct behind GALs promoter 
(TPQ106). Expression from the GALs promoter was induced for ~3h to reproduce the 
conditions used for reporter expression during the screen and cells visualized by live 
microscopy. Strains labeled with † were not identified in the original screen. 
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28D). Hence, a clear alteration of the intracellular distribution of Pma1p-GFP was 
observed only in mutants having severe vacuolar morphology defects (∆sur4, 
∆vps41, ∆mon1) [352-354] and some subunits of the prefoldin complex (∆gim3, 
∆gim5, ∆pac10). 
 
The importance of actin polymerization at the Golgi has long been a matter of 
discussion, although several studies suggest that actin could play a direct role in 
the generation of vesicles [335, 336]. Therefore, the identification of verprolin and 
two BAR proteins is particularly interesting. Verprolin is an actin patch protein, 
promoting actin polymerisation by activating the Arp2/3p complex together with 
class I myosins [355, 356]. Rvs161p and Rvs167p, the yeast amphiphysin 
homologues, form dimers and work together in the scission of endocytic vesicles [31, 
357]. Despite their known role in endocytosis, both kinds of proteins have been 
implicated in exocytosis: Vrp1p by interacting with the cis-Golgi protein Kre6p [350] 
and Rvsp since rvs mutants accumulate secretory vesicles at sites of polarized 
growth [358]. These three proteins have a considerable impact in endocytosis, 
however, their identification in the visual screen implies that accumulation of 
exocytic cargoes can be observed directly. To compare the relative strength of the 
endocytic versus exocytic block, we designed an experiment using the GFP-Snc1p 
reporter construct [22]. Since this construct is cycling between the plasma 
membrane and the Golgi, it is sensitive to either block and the relative contribution 
of each block could then be assessed using additional mutation disrupting the 
cycling. Moreover, this construct although overexpressed, does not saturate the 
secretory pathway and “leak” to the vacuole. However, when expressed in these 
mutants, GFP-Snc1p is completely localized to the plasma membrane, clearly 
revealing the difficulty in elucidating a potential role of these proteins at the Golgi 
without being able to uncouple both processes. 
 
Another highly interesting candidate in the context of the current study is the 
oxysterol binding protein Kes1p. Although the function of Kes1p is tightly linked to 
post-Golgi vesicle formation by its interaction with PI4P and Sec14p [278], the 
mechanism by which this protein influences transport at the TGN is a mystery. In 
an attempt to identify physical interactors of this protein, the tandem affinity 
purification (TAP) method was used [359]. However, preliminary experiments 
demonstrate that this purification cannot be performed using standard protocols 
even with additional ammonium precipitation steps, and would require the 
establishment of a more conservative procedure respecting membrane interactions. 
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4/Disscussion 
 
4.1/ Functional specialization within the yeast Arf-GEF family 
Studies in mammalian cell suggest that Golgi localized Arf-GEFs of the BIG/GBF 
subfamilies act at different sub-compartments and promote the recruitment of 
specific Arf effectors [156, 160-162]. The results presented here confirm this 
hypothesis and indicate that the mechanisms controlling the spatial and temporal 
regulation of Arf are conserved from yeast to mammals.  
 
First, despite the difficulties to visualize endogenously tagged Arf-GEFs in living 
yeast cells, colocalization experiments clearly indicate that Sec7p acts at a different 
level than the Gea’s. The actual overlap between the three GEFs is hard to evaluate 
accurately, due to the low expression levels of the proteins and the mobility of single 
Golgi elements. However, despite those drawbacks, the method we used avoids side 
effects due to overexpression or chemical fixation, and is therefore, best suited to 
reflect the physiological behavior of the GEFs. Second, while sec7 mutants mainly 
accumulate Berkeley bodies, the structures observed in gea mutants are far bigger 
and more intricate, indicating a fundamental difference in the trafficking block. 
Third, the recruitment of clathrin and COPI coat proteins to membranes is not 
affected to the same extend in different gef mutants, since inactivation of Sec7p 
results in an increased cytosolic staining of clathrin while the Gea’s rather affect 
COPI distribution. Although our results do not exclude a participation of Sec7p in 
the formation of COPI coats or of the Gea’s in CCVs, they suggest a preference of 
some Arf effector toward a pool of Arf activated by a specific GEF. Finally, the 
behaviour of trafficking markers that are sensitive to defects in particular Golgi sub-
compartments indicate an earlier transport block in gea than sec7 mutants. 
 
Taken together, these data suggest that Sec7p is mainly involved in the formation of 
post-Golgi transport vesicles and supports forward transport from the late Golgi 
while Gea’s primarily regulate COPI-mediated retrograde traffic. This is consistent 
with most of the previous reports on Gea proteins and Sec7p. A strong connection 
between Gea1/2p function and COPI is well established and the phenotypes 
reported for gea mutants agree with a transport block between the ER and the Golgi 
[93, 151, 152, 178]. Although Sec7p has been implicated in ER-to-Golgi and intra-
Golgi transport as well as post-Golgi trafficking, the evidence supporting its 
participation in early Golgi functions are rather indirect. In vivo experiments 
supporting this view are essentially based on the abnormal glycosylation pattern of 
several reporter proteins in sec7 mutants incubated at non-permissive temperature 
[175, 176]. However, the accumulation of proteins lacking Golgi specific post-
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translational modifications could result from an inability to progress through the 
Golgi and reach the appropriate compartments [117] or a failure to properly localize 
Golgi resident proteins as well as from disruption of ER-to-Golgi transport. A more 
puzzling report in this context is the direct interaction between the Gea2p and 
Drs2p [172], since Drs2p is clearly involved in post-Golgi transport [142, 181-184]. 
However, although there is little doubt about the physiological relevance of this 
interaction, its role remains unclear. Drs2p binds to the catalytic domain of Gea2p 
[172] and is likely to interfere with the GEF activity, either to promote or inhibit 
nucleotide exchange on Arf. In addition, although Drs2p interacts with a highly 
conserved domain shared by all GEFs and interacts also with Gea1p by yeast two 
hybrid [172], a possible binding to the same domain in Sec7p has not been tested. 
 
Despite the apparent correlation between individual GEFs and the different coats, 
the question of specificity remains. By recruiting different effectors, the activation of 
Arf regulates many cellular responses, but even if several Arf orthologues are 
localized to the Golgi in eukaryotic cells, they do not seem to be the sole key 
determinants for specificity. In yeast, the high redundancy of Arf1p and Arf2p in 
Golgi function [128] speaks against one of them being required for a given pathway. 
Similarly, studies in mammalian cells clearly illustrate the difficulty in 
distinguishing the function of individual Arfs, since double knockdowns are required 
to detect any transport phenotype [134]. Even a pair wise silencing of Arfs in this 
study, although indicating some specificity, did not reveal a functional pattern for 
the different Arf proteins [134]. The direct upstream activators of Arf are good 
candidates to confer specificity and the observation that the GEFs activate pools of 
Arf responsible for the formation of different vesicle populations support this view. 
However, although a model where the ArfGEFs directly promote the recruitment of 
different effectors [156] is attractive, this view is difficult to reconsile with the 
current models for vesicle formation. In vitro experiments, reconstituting vesicle 
formation, have demonstrated the requirement for activated Arf, coat and cargo 
protein and ArfGAPs in this process [90, 97-100] but did not point to a direct 
involvement of ArfGEFs. In addition, no direct interaction between the GEFs and 
coat proteins has been reported. An alternative possibility is that the specific 
recruitment of effectors depends on other signals present at the membranes that 
stabilize the interaction between activated Arf, effectors and membranes. Candidates 
for such a dual recognition system include phophoinositide or cargo tails, which are 
known to interact with coat proteins [98, 101]. In this case, the role of the GEFs 
could be to recognize these specific cues and activate Arf only when all the 
conditions required for specific effector recruitment are met. 
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4.2/ A protein interaction network around the ArfGEF Sec7p 
 
4.2.1/ Sec7p and phosphoinositide metabolism 
In this study, we show that the yeast Golgi PI4-kinase Pik1p binds specifically to the 
ArfGEF Sec7p but not Gea1p and Gea2p. The physical interaction between the two 
proteins correlates well with their subcellular distribution and the transport 
phenotypes of the mutants indicating a functional link between them. Hence these 
data indicate that Sec7p and Pik1p collaborate at the late Golgi and suggest that Arf 
activation is directly coupled to phosphoinositide metabolism.  
 
4.2.1.1/ Physical interaction between Sec7p and Pik1p 
Pik1p binds to the N-terminal part of the catalytic domain of Sec7p, which is 
composed of two sub-domains surrounding a groove containing the active site [360] 
and is highly conserved among the ArfGEF protein family. It is therefore not 
surprising that Pik1p interacts with the isolated Sec7 domains of the three yeast 
Golgi ArfGEFs. Whether the specificity of the in vivo interaction is due to the 
presence of additional binding domains inside the Sec7p protein or promoted by 
other factors has not been determined. The two halves of the catalytic domain 
correspond to the N- and C- terminal part of the sequence and are moving toward 
each other during nucleotide exchange on Arf [360]. The initial docking site for Arf is 
thought to be within the C-terminus and the conformational change following Arf 
binding promotes domain closure and exposure of GDP-bound Arf to the catalytic 
glutamate residue located in the N-terminal part [360]. Hence, binding of Pik1p to 
the N-terminal part of the Sec7p domain places this protein in an ideal position to 
control the nucleotide exchange reaction or to sense it. 
 
Interestingly, the Sec7p binding domain of Pik1p contains the PI4-kinase similarity 
region, which is conserved between the PI4-kinase III α and β sub-families. So far, 
no function has been attributed to this domain and expression of the interaction 
domain in yeast did only show that it is not sufficient for Golgi localization. However, 
the conservation of this domain throughout evolution suggests that it might play a 
general role in the function of PI4-kinases.  
 
At the first glance, the interaction between Sec7p and Pik1p might resemble the one 
reported between Gea2p and the flippase Drs2p. Both lipid-regulating enzymes 
interact with the catalytic domain of the GEFs and play an important, although 
different role in vesicle formation at the Golgi. However, while Pik1p binds to the N-
terminal part of the Sec7 domain, Drs2p interacts with the C-terminal part of it 
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[172]. Even if the meaning of this observation is not clear, it might indicate a 
fundamental difference in the impact of the two interactions on the catalytic activity 
of the respective GEF. In addition, the specificity of the Sec7p-Pik1p interaction has 
been demonstrated, while, as mentioned above, the Drs2p-binding specificity toward 
different ArfGEFs has not been reported. 
 
4.2.1.2/ Function of the Sec7p-Pik1p interaction 
The different phosphoinositide derivatives are considered to be organelle landmarks 
and are therefore good candidates for the specific recruitment of effectors to their 
target membranes. However, there are at least two pools of PI4P generated in yeast 
cells: one at the Golgi and the other at the plasma membrane. Although the PI4P 
pool generated by Stt4p is further converted to PI(4,5)P2  [260], a substantial 
amount of this phosphoinositide resides at the plasma membrane and can be 
recognized by PI4P specific PH domains lacking other localization determinants 
[361]. Hence, specific recruitment of proteins to the Golgi apparatus requires 
additional factors besides PI4P.  
 
The colocalization experiments between Sec7p and PI4P combined with the 
distribution of the three Arf GEFs indicate that PI4P is not distributed evenly 
throughout the Golgi, but enriched on later compartments also containing Sec7p. 
Thus, PI4P might provide a signal allowing to distinguish the Arf pool activated by 
Sec7p from the one generated by Gea1p and Gea2p, providing the specificity 
required to recruit different sets of Arf effectors. This hypothesis is supported by our 
observations that in wild-type cells, the compartments containing Sec7p and Pik1p 
are surrounded by clathrin and loss of function of either of these proteins affects the 
recruitment of clathrin to membranes. Although a role for Pik1p and Sec7p in the 
formation of COPI vesicles cannot be excluded, membrane recruitment of the γ-COP 
subunit was comparatively less affected in sec7 mutants than clathrin. In addition, 
previous studies as well as our own results indicate a block in formation of post-
Golgi vesicles in sec7 and pik1 mutants rather than a direct inhibition of retrograde 
transport [151, 153, 173, 258, 259].  
 
Clathrin interacts with membranes through adaptor proteins like the AP complexes 
and Gga’s and the highly specific membrane recruitment of these adaptors is a key 
event in the formation of clathrin-coated vesicles. Although little is known about the 
recruitment of the AP-1 complex in yeast, its mammalian homologue requires both 
PI4P and GTP-bound Arf for proper targeting [99, 285]. Gga proteins also interact 
with activated Arf and, while in mammalian cells this interaction is essential for 
localization, in yeast, additional factors must be involved [100, 136, 147, 148] . The 
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mammalian AP-1 is not the only factor using this dual recognition system for Golgi 
recruitment since a study using a PH-domain construct specifically recognizing PI4P 
demonstrated that its localization is also Arf dependent [277]1 .  
 
A physical interaction between Sec7p and Pik1p might coordinate the activation of 
Arf with the production of PI4P thereby ensuring the proper spatial and temporal 
recruitment of downstream effectors. Many cellular processes are regulated by the 
successive activation of enzymes, resulting in an ordered sequence of events. For 
enzymes cycling between membranes and cytosol, like Pik1p and Sec7p, the 
regulated membrane recruitment is a key factor in the control of their activity. In 
vitro studies have already suggested a role of Arf in the recruitment and activation of 
PI4Kβ, the mammalian homologue of Pik1p [105]. However, this finding has not 
been confirmed in vivo and the results presented here do not support a direct role of 
the yeast Arf GEFs in the recruitment of Pik1p to the Golgi. Neither does Sec7p 
seem to require PI4P to localize to the membrane indicating that these proteins do 
not act as membrane receptor for each other. 
 
The direct impact of the Sec7p-Pik1p interaction on their respective catalytic 
activities is difficult to determine in vivo despite the availability of mutants 
specifically inhibiting PI4P production or Arf activation. Neither recruitment of 
clathrin nor the PH-domain construct are clear read-outs for Sec7p or Pik1p 
function, respectively, since both processes are subject to the dual recognition 
system [99, 277, 285]. In addition, the impact of sec7 and pik1 mutants on Golgi 
integrity affects the entire secretory pathway and disrupts endosomal functions 
resulting in a variety of side effects whose consequences are hard to evaluate. 
However, residual membrane localization of the PH-domain construct in a sec7-4ts 
mutant suggests that PI4P production is not entirely disrupted under these 
conditions. Similarly, the recruitment of the PH-domain in pik1-101 is only partly 
impaired consistent with previous studies demonstrating the role of Arf in this 
process [277]. However, the origin of the activated Arf pool participating in the 
localization of the PH-domain in pik1 mutants has not been addressed and could 
result from the Gea’s as well as from Sec7p. To circumvent these problems, an in 
vitro GEF activity assay to directly measure the impact of Pik1p on the function of 
the Sec7 domain of Sec7p is currently being developed.  
 
 
1 Note: During the preparation of this manuscript, an interaction between mammalian GGA proteins and 
PI4P, participating in the localization of the GGA’s to the Golgi has been reported. Wang, J., et al., PI4P 
Promotes the Recruitment of the GGA Adaptor Proteins to the Trans-Golgi Network and Regulates Their 
Recognition of the Ubiquitin Sorting Signal. Mol Biol Cell, 2007 
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Although the interaction between Sec7p and Pik1p is likely to regulate the 
coordination of Arf activation with PI4P production resulting in a highly specific 
recognition system for effector recruitment to the TGN, analysis of the mutant 
phenotypes indicates that the two proteins also perform independent functions. Two 
lines of evidence support this claim. First, the secretion defect of sec7 mutants is 
stronger than in pik1-101ts. Pulse-chase analysis of newly synthesized proteins 
secreted in the media of wild-type cells, reveal a complete block in the case of sec7-
1ts while pik1-101ts strains are only partially defective (Lars Demmel personal 
communication and data not shown). In addition, secretion of invertase is reduced 
to ~30% in sec7-1ts mutants while pik1-101ts mutants still transport ~70% of this 
cargo to the periplasmic space ([259] + data not shown). These differences do 
probably not reflect a tighter temperature sensitivity of the sec7-1ts mutant 
compared to pik1-101ts, since the catalytic activity of pik1-101ts is already strongly 
compromised at permissive temperature [259], while the consequences of the sec7-
1ts mutation are not visible immediately after transfer to the non-permissive 
temperature [173]. Second, studies at the ultra-structural level show that although 
both mutants accumulate Berkeley bodies, large intricate membrane structures can 
be observed in pik1-101ts but not sec7 mutant strains. These large structures are 
very similar to the multi-lamellar membrane compartments observed in gea double 
mutants indicating that the pik1-101ts mutants accumulate abnormal membrane 
structures characteristic for both classes of Golgi ArfGEF mutants. Berkeley bodies 
have been observed in a variety of mutants believed to affect TGN exit and are likely 
to derive from late Golgi compartments [2, 228]. The origin of the large fenestrated 
compartments accumulating in both gea and pik1-101ts mutants is not clear. Due to 
their proximity to ER membranes and the involvement of Gea’s in retrograde 
transport from the Golgi, it is tempting to speculate that there could be a connection 
between these structures and early Golgi compartments. However, additional work 
is required to identify proteins associated with the large fenestrated compartments 
and immuno-labeling experiments using different organelle markers are planned. 
Taken together these data show that although Sec7p and Pik1p both participate in 
recruiting specific effectors to the late Golgi, they are not restricted to their common 
role at this compartment. This suggests that PI4P production might be important to 
maintain the homeostasis of the different Golgi compartments, possibly 
independently of its collaboration with Arf, while Sec7p might more specifically 
function as a regulator of Golgi exit. 
 
Although the interaction between Sec7p and Pik1p is the first direct connection 
between Arf regulation and PI4P metabolism, studies using the yeast 
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phosphatidylinositol/ phosphatidylcholine transfer protein Sec14p suggested a close 
relationship between these two processes. The viability of sec14-1ts mutants is 
affected by deletion of either ∆gcs1 or ∆age2, the two ArfGAPs involved in post-Golgi 
transport and sec14 bypass mutants require the ArfGAP activity of Gcs1p or Age2p 
in vivo [189, 295]. In addition, deletion of KES1, one of the sec14 bypass mutations, 
phenocopies some of the effects of overexpression of Gcs1p [278]. Since Kes1p 
function seems to antagonize both Sec14p and Pik1p function [278, 283], these data 
indicate that ArfGAP activity is required to maintain Golgi function when PI4P 
regulation is impaired. The molecular mechanisms underlying these observations 
are still unclear. Several studies demonstrate a direct correlation between in vitro 
GAP activity and the lipid composition of membranes, especially acidic 
phospholipids or DAG levels, which are at least partially regulated by Sec14p [292, 
295, 296], but the in vivo relevance of these observations is still unclear. Taken 
together these data clearly underline the importance of the crosstalk between PI4P 
metabolism and Arf regulation in order to maintain the proper balance between the 
amount of activated Arf and PI4P levels which seems crucial for TGN function. 
 
4.2.2/ Regulation of Sec7p function at the Golgi 
In order to ensure the proper material balance of the Golgi apparatus and support 
the sorting of cargo proteins to their correct destination, the spatial and temporal 
activation of Arf needs to be tightly regulated and the exchange factor Sec7p plays 
an essential role in this process. The Arf pool activated by Sec7p seems specialized 
in the recruitment of clathrin adaptor proteins to the TGN in collaboration with 
PI4P, thereby controlling the formation of vesicles exiting the late Golgi. Hence, 
Sec7p is in an ideal position to adjust the flow of outgoing material from the TGN by 
integrating signals from incoming vesicles and sensing the lipid composition of the 
membranes to ensure the timely recruitment of the proper effectors responsible for 
the sorting of specific cargoes. This would place Sec7p at the heart of an intricate 
signaling network and underlines the importance of characterizing the role of the 
non-catalytic domains of this protein to understand how the dynamic equilibrium of 
the Golgi is maintained. 
 
4.2.2.1/sec7-1ts mutation – DCB domain function 
Besides their catalytic domain, ArfGEFs from the BIG/GBF subfamilies share five 
conserved regions, including the DCB (Dimerization/Cyclophilin Binding) domain 
located at the extreme N-terminus [155]. The importance of this domain for ArfGEF 
proteins is illustrated by the dramatic consequences during the development of the 
cerebral cortex of its mutation in the human BIG2 protein [168]. In the present 
study, we show that a single point mutation in the DCB domain of yeast ArfGEF 
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Sec7p results in loss of the essential function of this protein at non-permissive 
temperature. The similarity between the phenotypes of sec7-1ts strains and mutants 
affecting the catalytic activity of Sec7p suggests that the mutation in the DCB 
domain effectively inhibits Arf activation. In addition, the disruption of the DCB 
domain does not seem to affect membrane recruitment of the Sec7-1p mutant 
protein indicating that this region might play an essential role in the activity of the 
protein directly at the Golgi. However, a direct participation of the DCB domain in 
the nucleotide exchange reaction is unlikely since the Sec7 domain alone is 
sufficient to promote this activity suggesting an important regulatory role for the N-
terminus of Sec7p in Arf activation. 
 
The DCB domain was named after a study on the Arabidopsis ArfGEF GNOM, 
showing that the first 246 amino acids of this protein can dimerize and interacts 
with Cyp5 [169]. Cyclophilin 5 belongs to a protein family binding to the 
immunosuppressant cyclosporin A and catalyzing the cis-trans isomerization of 
peptidyl-prolyl bonds (PPIase activity), which is one of the rate limiting steps during 
protein folding [362]. In addition, some GNOM loss-of-function alleles were shown to 
complement each other [363]. A model based on these observations proposes that 
Cyp5 acts as a chaperone to promote the dimerization of GNOM thereby influencing 
the GEF activity [169]. Oligomerization of ArfGEFs has also been proposed for the 
mammalian BIG1 and BIG2 when they were found to coexist in a macromolecular 
complex although in this case no direct interaction was demonstrated [157]. 
Interestingly, the DCB domain of BIG1 also binds to FKBP13, a protein of the FK506 
binding protein family (FKBP) with PPIase activity [171]. Like cycloporin A, FK506 is 
an immunosuppressant effectively inhibiting PPIase activity, however, despite their 
similarity, cyclophilins and FKBPs are two distinct classes of enzymes and no cross 
reactivity has been observed for their inhibitors [362].  
 
Interestingly, while searching for high copy suppressors of the sec7-1ts mutants, we 
realized that expression of a fragment of Sec7p containing the entire portion of the 
protein upstream of the Sec7 domain and the majority of the catalytic site is enough 
to rescue the growth defect of these strains. This observation suggests that this 
portion of the protein is either sufficient to perform the essential function of Sec7p 
or able to restore the activity of the mutant protein. However, although the N-
terminal part of the GEF domain, including the critical catalytic residues for the 
exchange activity is intact, this construct is unlikely to encode a functional ArfGEF 
since most of the C-terminal Arf binding site is missing [360]. Taken together with 
previous work on the DCB domain, this genetic interaction would be consistent with 
a dimerization of Sec7p and suggest that the formation of oligomeric complexes is 
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important for ArfGEF function. The Sec7 N-terminal truncation construct isolated 
from the screen is currently being used to confirm the dimerization of Sec7p in vivo 
and could represent a valuable tool to investigate its role in Arf activation. 
 
Despite the evidence supporting the formation of dimeric ArfGEF complexes, the 
physiological role of these interactions remains unclear. The only in vivo data 
addressing this issue originates from studies in mammalian cells treated with 
FK506 that reported an increase in membrane binding of BIG1/2 and Arf while the 
recruitment of two Arf effectors, clathrin and γ-adaptin is not affected [171]. Hence, 
inactivation of FKBP13 interferes with either Arf activation or its accessibility by 
cytosolic proteins. However, binding of the drug to the PPIase did not interfere with 
complex formation between BIG1, BIG2 and FKBP13 [171]. Therefore the effect of 
FK506 on the Arf cycle might not be a direct result of loss of dimerization. Besides 
the dimerization of ArfGEF the DCB domain supports a number of protein-protein 
interactions, which could be important for its function [169-171].  
 
In addition to its role in dimerization, could the DCB domain of ArfGEFs of the 
BIG/GBF family regulate the membrane targeting of these proteins? Previous 
studies in mammalian cells have shown that the N-terminal half of BIG1 including 
the DCB and the major part of the HUS domains [300] is sufficient for Golgi 
localization, while mutations of the HUS domain of the yeast Gea2p does not affect 
its recruitment to membranes [178]. In addition, the DCB domain of the yeast 
ArfGEF-like protein Mon2p is sufficient for membrane localization of a GFP-reporter 
construct [206]. However, we observe that mutation in the DCB domain of Sec7p 
does not affect the localization of the mutant protein, suggesting that although this 
domain alone can be sufficient for membrane targeting of ArfGEFs, additional 
localization information might be present in other parts of these proteins. 
Alternatively the mutation in the sec7-1ts allele might affect another function of the 
DCB domain beside its role in the membrane association of Sec7p.  
 
In summary, our data suggest that inactivation of the DCB domain effectively 
inhibits Arf activation without affecting the recruitment of Sec7p to membranes and 
could interfere with a possible dimerization of the protein. Further work is required 
to determine whether this domain directly promotes Arf activation by controlling the 
catalytic activity of Sec7p or participates in an alternative event required for efficient 
effector recruitment.  
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4.2.2.2/Cpd1p is a new regulator of Golgi transport 
While investigating the function of the DCB domain of Sec7p, we identified Cpd1p as 
a new Sec7p binding partner and an allele specific dosage suppressor of the 
transport and Golgi morphology defects of sec7-1ts mutants. Although neither Cpd1p 
nor Sec7p are tightly associated with membranes, both proteins colocalize at the 
Golgi but do not require each other for efficient membrane recruitment. The 
missorting of CPY due to overexpression of Cpd1p supports a role of this protein in 
post-Golgi transport. Taken together with the lack of phenotype for ∆cpd1 strain 
beside its sensitivity to brefeldin A, our data suggest that Cpd1p plays a discrete role 
in regulating vesicular traffic at the Golgi through its interaction with Sec7p. The 
dosage suppressor effect of Cpd1p is highly specific for the mutation in the DCB 
domain of the protein since it cannot rescue the growth defect due to mutation in 
the catalytic domain of Sec7p nor compensate for the loss of Arf proteins. In 
addition, in vitro binding experiments using wild type and mutant Sec7p protein 
suggest that Cpd1p might interact with Sec7p through the DCB domain, although 
this observation has to be confirmed with alternative methods.  
 
The rescue of the sec7-1ts mutation requires both the overexpression of Cpd1p and 
the catalytic activity of the protein. Our data show that the increase in Cpd1p 
expression levels results in higher abundance of the protein at the Golgi and 
compensates for the loss of interaction between Cpd1p and the mutant Sec7p 
protein. The mutation in the catalytic activity of the phosphodiesterase affects the 
binding efficiency of this protein with Sec7p but does not abolish it, suggesting that 
the enzymatic activity of Cpd1p plays a direct role in the rescue. In addition, both 
Cpd1p activity and its binding to Sec7p seem to be regulated by additional factors, 
since overexpression of Cpd1p does not increase the diesterase activity of yeast 
extracts [364] nor correlate with increased association with the ArfGEF. 
 
Cpd1p is a cyclic nucleotide phosphodiesterase and the only yeast enzyme able to 
hydrolyze ADP-ribose-1’’,2’’ cyclic phosphate (Appr>p), a very abundant by-product 
of the tRNA splicing pathway to ADP-ribose-1’’-phosphate (Appr-1’’p) [307, 308, 
310]. However increased levels of Appr>p or its hydrolysis product do not affect the 
growth of sec7-1ts strains, suggesting that the role of Cpd1p in the rescue process is 
not limited to the degradation of Appr>p or the production of Appr-1’’p. Although the 
activity of Cpd1p toward Appr>p is well established, the substrate specificity of this 
enzyme toward different nucleoside cyclic phosphates varies between different 
studies [308, 310] suggesting that the catalytic activity of Cpd1p might not be 
restricted to Appr>p in vivo. Considering the role of PKA in the localization of BIG1/2 
and maintenance of Golgi morphology [119, 123, 126], cyclic AMP (cAMP) is an 
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attractive candidate as alternative substrate for Cpd1p. However the capacity of 
Cpd1p to process cAMP has still to be demonstrated.  
 
4.2.2.3/Protein interaction network around Cpd1p and Sec7p 
The crosstalk between the different molecular machineries controlling the entry and 
exit routes from the Golgi is crucial to maintain the integrity of the organelle and 
ensure the proper sorting of cargoes to their cellular destination. ArfGEFs play a 
central role in this process, and both Sec7p and Cpd1p are an integral part of this 
intricate signalling network. We therefore screened the proteome for potential 
interactors of these proteins. Unfortunately, the expression and purification of 
Sec7p or fragments thereof is a technical challenge due to the intrinsic instability of 
this protein. However, the analysis of Cpd1p binding proteins produced several 
interesting candidates. 
 
The most interesting group of potential Cpd1p interactors include the small GTPase 
Ypt6p and the non-classical SCF complex composed of Skp1p and Rcy1p. All three 
proteins have been shown to be involved in the recycling of cargoes from early 
endosomes to the Golgi apparatus [236, 237, 246, 247]. A close connection between 
the recycling pathway and Sec7p function is supported by the genetic interaction 
between sec7-1ts and ∆ypt6. This interaction seems to be specific for the retrieval 
pathway of proteins from the early endosomes to the Golgi since the disruption of 
the retromer complex in the same sec7 mutant background did not affect growth. 
Interestingly, we also observed an allele specific defect in recycling of GFP-Snc1p in 
sec7-1ts mutants supporting a role of the DCB domain of the protein in controlling 
the flow of recycled material through the Golgi. 
 
As all GTPases, the Rab protein Ypt6p is found in different conformations, and the 
determination of the nucleotide specificity of the form interacting with Cpd1p is 
crucial to understand the relationship between the two proteins. The only effectors 
of Ypt6p identified so far are tethering factors that are required for the docking of 
endosome-derived vesicles to the Golgi [250, 251] and the function of Ypt6p itself is 
required for the efficient fusion of these vesicles [245]. Disruption of this transport 
pathway results in the intracellular accumulation and missorting of specific cargo 
proteins like the synaptobrevin homologue Snc1p, a process required for viability at 
higher temperature [245, 248, 253]. However, unlike the deletion of YPT6 or the 
other genes interacting with this GTPase, ∆cpd1p does not have a GFP-Snc1p 
recycling defect and overexpression of Cpd1p is unable to compensate for the loss of 
Ypt6p at non-permissive temperature. Hence, if Cpd1p is an effector of Ypt6p, our 
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data suggest that this interaction plays only a minor role in the recycling pathway 
and could support a previously uncharacterized function of this GTPase.  
 
Previous studies have already suggested a particular connection between Ypt6p and 
the sec7-1ts mutation. First, like Cpd1p, Sro9p is an allele specific high copy 
suppressor of sec7-1ts, however, unlike Cpd1p, overexpression of Sro9p also rescues 
the growth defect of ∆ypt6ts ([248] + data not shown). Although Sro9p has been 
suggested to play a role in several different processes such as translation accuracy 
and actin cytoskeleton organization [302, 303], the actual function of this protein 
has not been elucidated and its connection to trafficking remains unclear. Due to 
their distinct properties, the comparison between the effect of Cpd1p and Sro9p 
represent an interesting tool to unravel the functional relationship between Ypt6p 
and Sec7p. Studies on the early Golgi Rab GTPase Ypt1p further supports a specific 
link between Sec7p and the recycling pathway since overexpression of Ypt1p 
partially rescues the growth defect of sec7-1ts mutants and suppresses the defect of 
∆ypt6 strains but does not improve the phenotype of sec7-4ts mutants [40, 365, 
366]. Besides, although the hydrolysis of Ypt1p is dispensable for secretion and 
morphology of the Golgi apparatus [226], the expression of the GTP-locked form of 
this GTPase disrupts the recycling pathway [257] and it would be interesting to 
know the effect of this mutant on the phenotypes of sec7 deficient strains.  
 
While Ypt6p is thought to mediate the fusion of endosome-derived vesicles with the 
Golgi [251], the role of the Skp1p-Rcy1p complex in the recycling pathway is less 
clear. Rcy1p interacts with Ypt31/32p in a GTP-dependent manner and binds to 
Snc1p, one of the cargoes of the recycling pathway [232]. Skp1p and Rcy1p form a 
“non-classical” SCF complex lacking the cullin moiety of the standard ubiquitin 
ligase SCF complex [237, 238]. Despite its unusual structure, the Skp1p-Rcy1p 
complex has been suggested to modify exocytic proteins destined for recycling either 
by phosphorylation or ubiquitination [232]. However, this hypothesis lacks 
experimental evidence. Interestingly, the Skp1p-Rav1p complex, one of the two other 
non-classic SCF complex identified in yeast [367], plays a role in protein sorting at 
the early endosome [368]. Rav1p is part of the RAVE complex required for the 
assembly of the V-ATPase [367, 369] and Skp1p was shown to contribute to the 
cycling of this complex between membrane and cytosol by promoting its release from 
endosomal membranes [370].  
 
In addition to the three proteins presented above, Vps13p is yet another interesting 
Cpd1p-binding candidate especially since this protein is one of the few interactors 
identified during a pull-down experiment using a Sec7 N-terminal truncation 
 82 
construct as bait (data not shown). VPS13 was first identified as a regulator of 
Kex2p localization [371]. Kex2p is a Golgi-localized membrane protein known to 
cycle through early and late endosomes, and Vps13p regulates this cycling by 
interfering with the function of two TGN-localization signals present in the cytosolic 
part the protein [372]. Although the molecular mechanisms underlying the effect of 
Vps13p have not been solved, this protein seems to both antagonize the TGN-
retention signal of Kex2p at the Golgi and promote its retrieval from the late 
endosome [372]. Besides its role in Kex2p trafficking, Vps13p has been involved in 
the sorting of Ste13p, another cargo cycling between the Golgi and endosomal 
system through early and late endosomes, and affects the stability of Vps10p, a 
cargo of the GGA pathway, which directly connects the Golgi to the late endosome 
[372]. Due to its dual role in the transport out of the Golgi and in retrieval of cargo 
from late endosomes, Vps13p has been proposed to differentially regulate the cycling 
of cargoes between these organelles depending on the nature of the localisation 
signals present in the cytoplasmic tails of the corresponding proteins [372].  
 
In summary, Cpd1p interacts with several proteins specifically involved in transport 
pathways between the Golgi and early endosomes. Although all the interactions 
described above have to be verified in vivo and the relationship between these 
candidates and the DCB domain of Sec7p remain to be tested, this approach allows 
us to formulate some interesting working hypothesis. First, Cpd1p could mediate 
the crosstalk between Sec7p and Ypt6p, thereby connecting the flux of recycled 
material to the activation of Arf and the formation of post-Golgi transport vesicles. 
Taken together with the genetic interactions coupling these processes to the 
function of the early Golgi Rab, Ypt1p, these connections might considerably help 
the unravelling of the overall regulation machinery at the Golgi. Interestingly, a 
recent study in mammalian cells demonstrated a direct interaction between the DCB 
domain of the GBF1 and the GTP-bound form of Rab1b [170]. Both proteins localize 
to the mammalian cis-Golgi and depletion of Rab1b by siRNA decreases the 
membrane association of GBF1, suggesting that the GTPase could participate in the 
membrane recruitment of the GEF and coordinate docking and formation of COPI 
vesicles [170]. Considering these results, a direct interaction between Ypt6p and the 
DCB domain of Sec7p has to be taken into consideration and will be tested both in 
vitro and in vivo. Second, the analogy between Rcy1p and Rav1p could suggest a role 
of the Skp1p-Rcy1p complex in the release of peripheral Golgi proteins to the 
cytosol. The cycling of Sec7p to and from membranes constitutes an important 
aspect of its regulation and a role of DCB domain in the membrane association of 
ArfGEFs has been suggested previously [206, 300]. ArfGEFs from the BIG/GBF 
subfamilies are large proteins susceptible to sterically interfere with the recruitment 
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of cytosolic factor by activated Arf unless they are released from membranes after 
performing their function. In addition, a role of the DCB domain in the release of 
ArfGEFs from the Golgi could explain the effect of FK506 treatment in mammalian 
cells (see §4.2.2.1). Hence it is interesting to speculate a role for the DCB domain of 
Sec7p in the cycling of the protein off the membrane. This hypothesis will be further 
investigated. Finally, the connection between Sec7p and Cpd1p with a factor 
involved in the transport of specific cargoes from the Golgi to the endosomal system 
could represent yet another aspect of the overall spatial and temporal regulatory 
mechanism coordinating cargo sorting with vesicle formation machineries.  
 
In addition to the interactions described above, we also detected a strong binding 
between the mutant Cpd1p protein lacking catalytic activity and Arf1/2p suggesting 
that Cpd1p could influence Arf function directly and not only through the GEF. 
Although it still has to be confirmed in vivo, this physical interaction has several 
intriguing aspects. First, compared to the weak binding of Arf to wild-type Cpd1p, 
the near stoichiometric enrichment of Arf in the Cpd1H39Ap pull-down indicates a 
very high affinity between these proteins. However, despite the strong in vitro 
binding to Arf, overexpression of the Cpd1p mutant protein did not have negative 
effects on the growth of wild type cells, suggesting that this mutant does not 
significantly interfere with Arf function in vivo. We cannot exclude that the 
differences between the wild type and the mutant Cpd1p protein result from 
conformational problems due to the point mutation. However, preliminary 
microscopy experiments indicate that Cpd1H39Ap localizes properly to the Golgi (data 
not shown) and when expressed in bacteria, both alleles of CDP1 precipitate a 
number of common interactors suggesting that the mutant retains some specificity. 
The second intriguing aspect of the Arf-Cpd1H39Ap interaction is the apparent 
molecular weight at which Arf is detected in this sample, since the majority of the 
protein is found at twice the expected size. This shift in molecular weight cannot be 
attributed to our experimental conditions or Arf myristoylation. In addition, since no 
other peptide than Arf itself could be detected in the same area by mass 
spectrometry, the shift is unlikely to result from protein modification. Interestingly, 
recent studies on mammalian ARF1 indicate that the dimerization of an activated 
membrane-bound form is required for the formation of COPI vesicles (Z. Sun and F. 
Wieland, unpublished data). Hence, further characterization of the relationship 
between Sec7p, Arf and Cpd1p is important both to determine the molecular 
mechanism of Cpd1p action and to clarify new aspects of the Arf life cycle. 
Therefore, besides the in vivo confirmation of the pull down experiments and the 
characterization of the high molecular form of Arf, the response of Arf to altered 
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Cpd1p levels and expression of different Cpd1p or Sec7p mutant alleles in living 
cells will be used to clarify the role of Cpd1p in the Arf activation cycle. 
 
4.2.2.4/Arf activity and ADP-ribosylation 
In yeast, one molecule of Appr>p is produced during each tRNA splicing reaction, a 
process estimated up to 0.5x106 events per generation [309] and its conversion to a 
known metabolic intermediate requires at least a two-step reaction ([308] and see 
Figure10). Studies on the tRNA splicing pathway have demonstrated the unique 
ability of Cpd1p to hydrolyze this abundant metabolite in vitro [307, 310] and 
strongly suggest that this enzyme is responsible for its processing in vivo. The 
second step in the conversion of Appr>p to ADP ribose is catalyzed by a phosphatase 
called Poa1p [309]. However, the kinetic parameters of Poa1p combined with its 
abundance would lead to cellular accumulation of the intermediate product [309], 
suggesting that either Appr>p or Appr-1’’p could be involved in an alternative 
process. Although tRNA splicing is an essential process, the generation and turnover 
of Appr>p is not [309, 310, 373, 374] and no cellular function has been connected to 
this process. The production of Appr>p is conserved throughout evolution despite 
the presence of an alternative splicing pathway processing most of the tRNA in 
vertebrates without generating Appr>p [311, 312]. In addition, coronaviruse also 
encodes a protein catalyzing the turnover of Appr-1’’p, although deletion of this 
protein had no effect on viral replication [375]. The identification of Appr>p and the 
enzymes required for its turnover in a wide range of different organisms, has led to 
many speculations concerning the role of this metabolite or its turnover pathway for 
the cell. However the lack of phenotypes associated with the disruption of this 
process suggest a rather discrete regulatory role for its components under standard 
laboratory conditions. 
 
The link between Sec7p and Appr>p processing is intriguing considering the 
connections between Arf and ADP-ribosylation in mammalian cells. Upon infection, 
cholera toxin catalyzes ADP-ribosylation of G proteins, thus interfering with a broad 
range of signaling pathways of the host cell [376]. Arf proteins where initially 
identified as cofactors of this reaction [80] and later shown to directly promote ADP-
ribosylation by forming a complex with the catalytic subunit of the toxin [377]. The 
capacity to promote the ADP-ribosylation activity of cholera toxin is a fundamental 
characteristic of all members of the Arf protein family and one of the requirements 
to classify newly identified proteins in this group [106]. Studies investigating the 
mechanism underlying the physiological effects of brefeldin A (BFA) revealed that the 
association of Arf and cholera toxin is not the only link between these proteins and 
ADP-ribosylation. Brefeldin A is a bacterial toxin promoting ADP-ribosylation of 
 85 
BARS while effectively inhibiting the Arf activation cycle [113, 378]. The combined 
effect of BFA on Arf and BARS in living cells results in the rapid dissociation of the 
Golgi apparatus with early Golgi compartments collapsing with the ER while the 
TGN mixes with endosomal compartments [114, 115]. The impact of Brefeldin A on 
Arf is direct since it was shown to stabilize an inactive ArfGEF-Arf-GDP complex 
[113], however the molecular mechanism by which this toxin promotes the ADP-
ribosylation of BARS has still to be elucidated. 
 
Despite their similarity, these two ADP-ribosylation processes fundamentally differ 
from each other. While cholera toxin intrinsically possesses ADP-ribosyltransferase 
(ADPRT) and NAD-glycohydrolase activity and behaves as a classic mono-ADPRT 
(reviewed in [379] and [376]), BFA has no such activity and depends on components 
of the host cell to promote ribosylation [378]. In addition, the reaction catalyzed by 
BFA does not target the same acceptor residues as other known mono-ADPRTs [378, 
379]. The starting material for ADPRTs including cholera toxin is the ADP-ribose 
moiety of NAD+ [380, 381], but an alternative, non-enzymatic ADP-ribosylation 
reaction creating a covalent bond between free ADP-ribose and the acceptor protein 
has been described [379]. However, the ribosylation of BARS is not supported by 
ADP-ribose [378], suggesting that this reaction is either catalyzed by an endogenous 
ADPRT or relies on a different mechanism than those previously reported. A model 
proposed recently suggests that BFA promotes the auto-ribosylation of BARS [382], 
however, this hypothesis still lacks experimental evidence. Previous studies have 
shown that NAD+ is the starting reagent for the ADP-ribosylation of BARS, however 
Appr>p is directly derived from NAD+ and all reactions were carried out using full 
cell extracts [307, 378, 383]. In addition, despite the intrinsic chemical reactivity 
potential of both Appr>p and Appr-1’’p, their potency to support ADP-ribosylation 
has never been tested. 
 
Both the ADP-ribosylation of G proteins and BARS are stimulated by toxins, and 
under standard growth conditions Arf proteins are not known to promote similar 
reactions, neither in yeast nor in mammalian cells. In addition, although Brefeldin A 
effectively inhibits trafficking in yeast, no homologues of BARS have been identified 
in this organism. Likewise, although the production of Appr>p is conserved 
throughout evolution and Cpd1p belongs to the large 2H phosphodiesterase protein 
superfamily [384], its functional homologue in higher eukaryotes has not been 
identified. Hence, any correlation between the production of Appr>p and the 
ribosylation of BARS is purely speculative. However, the data obtained in the 
mammalian system indicate a surprising affinity of Arf toward ADP-ribose derivates 
and the enzymes processing those metabolites. In this context, the identification of 
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Cpd1p as a binding partner of Sec7p and Arf could represent the first connection 
between Arf and an ADP-ribose related metabolite in wild type cells.  Further 
characterization of the catalytic activity of Cpd1p and the identification of the 
physiological substrates of this enzyme could not only provide valuable information 
on Arf but also lead to the characterization of the cellular role of the Appr>p 
turnover pathway. 
 
 
4.3/ Conclusions 
In this study, I focused on the fundamental role of Arf exchange factors at the yeast 
Golgi apparatus and investigated the function of Sec7p. I demonstrate a specific role 
for this Arf-GEF in regulating the formation of post-Golgi transport vesicles in 
collaboration with the PI 4-kinase Pik1p. I also established the essential role of the 
conserved DCB domain of Sec7p for viability, and identified Cpd1p as a new 
regulator of Golgi trafficking, whose function is tightly linked to this domain. 
Further characterization of Cpd1p will provide valuable insights into the molecular 
mechanisms of Arf function as well as the machinery controlling its activation. 
Hence, by identifying new components of the probably large protein interaction 
network of the late Golgi Arf-GEF Sec7p, my work contributes to the understanding 
of the interplay between key regulators controlling the function and integrity of the 
Trans-Golgi Network. 
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5/Material and methods 
 
5.1/ Yeast strains, plasmid construction and reagents 
Yeast strains used in this study are listed in Table IV. Genomic tagging and 
deletions were performed using PCR based methods described previously [385]. 
Yeast strains were transformed using the lithium acetate procedure and selective 
pressure was maintained at all times. Standard techniques were used for mating, 
sporulation and tetrad dissections.  
 
Table IV: S.cerevisiae strain list 
Strain Genotype Source 
BY4741 MATa ura3∆0 leu2∆0 his3∆1 met15∆0 Euroscarf 
BY4742 MATα ura3∆0 leu2∆0 his3∆1 lys2∆0 Euroscarf 
NY8 MATα ura3-52 sec1-1 Novick lab 
NY10 MATα ura3-52 Novick lab 
NY21 MATα ura3-52 sec6-4 Novick lab 
NY424 MATα ura3-52 sec21-1 Novick lab 
NY737 MATα ura3-52 leu2-3,112 sec23-1 Novick lab 
NY760 MATα ura3-52 sec7-1 Novick lab 
NY1211 MATα ura3-52 leu2-3,112 his3∆200 GAL+ Novick lab 
CSY93 MATa ura3-52 leu2-3,112 his3∆200 pik1-101 Ch.Walch-
Solimena 
CSY394 MATa leu2-3,112 his3∆200 trp1-289::TRP-SEC7-DsRED.T4 L. Demmel 
CSY712 MATα ura3-52 leu2-3,112 pik1-101 Ch.Walch-
Solimena 
CSY901 NY1211 SEC7-DsRED-kanMX6 L. Demmel 
yGY13 BY4741 vps1∆::kanMX6 Euroscarf 
yGY39 NY10 cpd1∆::kanMX6 This study 
yGY43 BY4741 ypt6∆::kanMX6 Euroscarf 
yGY46 BY4741 sst1∆::kanMX6 Euroscarf 
yGY77 CSY394 cpd1∆::kanMX6 This study 
yGY84 NY10 SEC7-GFP-kanMX6 This study 
yGY87 NY760 sec7-1-GFP-kanMX6 This study 
yGY127 NY1211 GEA2-GFP-HIS3MX6 This study 
yGY136 NY1211 GEA1-GFP-HIS3MX6 This study 
yGY148 MATα ura3-52 his3∆200 leu2 ade2 pfy1-111::LEU2 This study 
yGY152 MATα ura3-52 leu2-3,112 his3∆200 GEA1-CFP-kanMX6 GEA2-YFP-HIS3MX6 This study 
yGY162 MATα ura3-52 leu2-3,112 his3∆200 GEA1-CFP-kanMX6 SEC7-YFP-HIS3MX6 This study 
yGY163 MATα ura3-52 leu2-3,112 his3∆200 GEA2-CFP-kanMX6 SEC7-YFP-HIS3MX6 This study 
yGY166 MATα ura3-52 leu2-3,112 his3∆200 gea1-6 ∆gea2::HIS3 This study 
yGY180 Y2922, cpd1∆::natMX This study 
yGY239 MATα ura3-52 leu2-3,112 his3∆200 pik1-101 CHC1-RFP-KanMX6 This study 
yGY240 MATa ura3-52 leu2-3,112 his3∆200 gea1-6 ∆gea2::HIS3 CHC1-RFP-KanMX6 This study 
yGY247 MATα ura3-52 leu2-3,112 trp1 his- sec7-4 SEC21-3xGFP This study 
yGY248 MATα ura3-52 leu2-3,112 trp1 (his?) gea1-6 ∆gea2::HIS3 SEC21-3xGFP This study 
yGY250 MATα ura3-52 leu2-3,112 his3∆200 trp1-∆901 lys2-801 sec7-4 CHC1-RFP-
KanMX6 
This study 
yGY257 NY10 ura3-52::PHO5prom-PHOSBP-GFP-URA3 This study 
yGY259 NY760 ura3-52::PHO5prom-PHOSBP-GFP-URA3 This study 
yGY260 AFM69-1A ura3-52::PHO5prom-PHOSBP-GFP-URA3 This study 
yGY261 yGY166 ura3-52::PHO5prom-PHOSBP-GFP-URA3 This study 
yGY267 CSY901 ura3-52::PHO5prom-PHOSBP-GFP-URA3 This study 
yGY270 NY760 vps35∆::kanMX6 This study 
yGY272 NY760 ypt6∆::kanMX6 This study 
3100-20D MATα ura3-52 leu2-3,112 his3∆200 trp1-∆901 lys2-801 suc2-∆9 GAL+ mel 
CHC1-RFP-KanMX6 
G. Payne 
AFM69-1A MATα ura3-1 leu2 his3-11,15 sec7-4 D. Gallwitz 
BGY211 MATa ura3-52 leu2-3,112 his4 trp1 rme1 HMLa SEC21-3xGFP B. Glick 
CRY2 MATα ura3-1 leu2-3,112 his3-11,15 trp1-1 ade2-101 can1-100 R. Fuller 
KR418-1A CRY2 kex2∆::TRP1 R. Fuller 
Y2922 MATα mfa∆::MFApr-HIS3 can1∆ ura3∆ LEU2 his3∆ lys2∆ Euroscarf 
yWZ361 MATa ura3 leu2-3,112 his3-11,15 ade2-1 trp1-1 can1-100 CDC16-GFP-URA3 W. Zachariae 
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Table V lists the plasmids used in this study. Standard procedures were used for 
recombinant DNA manipulations [386]. PCR reactions were performed according to 
the manufacturer’s instruction (Roche) and oligonucleotides were obtained from 
Proligo. DNA purification kits were provided by Qiagen and Macherey-Nagel. 
Enzymes and reagents used for DNA manipulation were provided by Invitrogen and 
New England Biolabs. For the identification of candidates from the high-copy 
suppressor screen we used the TGS template generation system from Finnzymes. 
 
 
Table V: Plasmid list 
Construct Vector Insert Source 
pYG03 pGEX-6P-1 GST-YPT32 This study 
pYG28 pRS426 CYC1 terminator This study 
pYG30 pYG28 CPD1 prom- CPD1 This study 
pYG32 pRS416ADH-GFPc CPD1 prom- CPD1 This study 
pYG34 pRS416ADH-GFPc CPD1 This study 
pYG45 pYG28 CPD1 prom- CPD1(H39A) This study 
pYG107 pYG28 GEA2 prom-GEA2 This study 
pYG108 pYG28 SEC7 prom-SEC7 This study 
pYG132 pGEX-6P-1 GST-PIK1 aa 301-769 This study 
pYG147 pGEX-6P-1 GST-PIK1 aa 436-529 This study 
pYG148 pGEX-6P-1 GST-STT4 aa 1535-1625 This study 
pYG154 pGEX-6P-1 GST-CPD1 This study 
pYG163 pGEX-6P-1 GST-CPD1(H39A) This study 
CSP8 pRS316 PIK1 prom-PIK1 Ch. Walch-Solimena 
pJMG118 pRS416 TPI prom-GFP-SNC1 H. Pelham 
pJMG122 pRS416 TPI prom-GFP-SNC1pem H. Pelham 
pp1500-GP pRS316 PIK1 prom-GFP-PIK1 J. Thorner 
pSKY5-RER1-0 pSKY5 (CEN, URA3) TDH3 prom-GFP-RER1-CMK1 term A. Nakano 
pTL332 pRS406 PHO5 prom-GFP-PHOSBP T. Levine 
TPQ106 pRS416 GALs prom-GAP1(K9R, K16R)-GFP T. Proszynski 
 
 
All chemicals and reagents were purchased from Sigma unless stated otherwise.  
 
 
5.2/ Media, culture conditions and growth assay 
Standard yeast growth conditions were used [387]. YPD and Synthetic Dextrose (SD) 
media containing 2% glucose were prepared according to standard protocols [387] 
using drop-out amino acid mixes from Q-BIOgene. BFA plates were prepared 
according to [388] and contain 0.17% yeast nitrogen base (Difco), 0.1% proline, 2% 
glucose, 0.003% SDS, 2% agar, 77µg/ml BFA (Molecular Probes, 10mg/ml stock 
solution in DMSO) and required amino acids. Liquid sporulation media contains 1% 
potassium acetate and 9.9mg/l amino acid of the following amino acids uracil, 
adenine, lysine, leucin, tryptophan and hisitidine. 
 
Early log phase cultures represents cells grown for 2 to 3 generations in fresh 
media, while mid-log phase cultures refer to overnight cultures grown below 
0.8uOD/ml. Heat shocks were performed by shifting cultures to the non-permissive 
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temperature for 1 hour before starting the experiment. The optical density of yeast 
cultures were measured at λ=600 nm. 
 
Spotting assays: mid-log phase cultures were harvested and resuspended in fresh 
media at a concentration of 1uOD/ml. Ten-times serial dilutions were spotted on 
agarose plates and incubated for 2 to 3 days at respective temperature. 
 
Halo assays: 5x10-3 uOD of query strains (MATa) grown to mid-log phase were 
spotted on YPD and incubated overnight at 25˚C. Next day, the strains were 
replicated on a fresh lawn of sst1∆ (MATa) cells (0.05 uOD). The development of a 
halo was observed after 2 –3 days incubation at 25˚C [348]. 
 
5.3/ General protocols 
5.3.1/ Fluorescent microscopy  
Live cell microscopy: early log phase cultures were concentrated by low speed 
centrifugation and observed directly under a fluorescent microscope. The 
quantification of the colocalization was performed manually. 
 Wide-field microscopy: Zeiss Axioplan 2 MOT 
 Plan-Neofluar 100x/1.3oil objective, 
 Diagnostics Instruments SPOT camera 
 Confocal microscopy: Zeiss Axioplan 2 imaging with manual stage 
 Plan-Apochromat 100x/1.4oil DIC 
 2-channel META detector  
 
FM4-64 staining: After 1h heat shock, 5 uOD yeast cells grown to early log phase 
were suspended in 150µl fresh YPD. All subsequent steps were performed at 
respective temperature for each sample. After 15min equilibration, the samples were 
pulsed with 3µl 1.6mM FM4-64 (Molecular Probes) in DMSO for another 15 min. The 
labeled cells were harvested and resuspended in fresh YPD for a 10 to 60min chase. 
Before microscopy, the endocytosis of the dye was stopped by replacing the chasing 
media with a 20mM Tris buffer pH7.5 containing 20mM NaN3 + 20mM NaF and 
incubation on ice. Samples were observed with a wide-field fluorescence microscope. 
 
5.3.2/ Immunofluorescence microscopy 
Yeast cells grown to early log phase were fixed at room temperature with 
formaldehyde first for 20min in a 50/50vol solution of 1M KPi pH6.5 and 37% 
formaldehyde (Merck), followed by 1h in a freshly prepared 4% formaldehyde 
solution (4% paraformaldehyde (Merck), 42mM NaOH, 13.6 mg/ml KH2PO4, 1mM 
MgCl2). The cells were then washed with 0.1M KPi pH7.5 and resuspended in 0.1M 
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KPi pH7.5 + 1.2M sorbitol. 8uOD of cells were then harvested and spheroplasted at 
37˚C for 30min in 0.1M KPi pH7.5 + 1.2M sorbitol + 45µl zymolase solution (5mg/ml 
Zymolase 100T (ICN Biomedicals) + 5µl β-mercaptoethanol in 0.1M KPi pH7.5). 
Samples were then washed and resuspended in 0.1M HEPES pH7.5 + 1.2M sorbitol. 
Cells were attached to glass slides coated with polylysine and permeabilized by a 
5min incubation in cold (-20˚C) methanol followed by 30sec in cold (-20˚C) acetone. 
Each sample was washed extensively with PBT2 (PBS containing 5mg/ml BSA, 
5mg/ml bovine collagen, 5µl/ml fish skin gelatin and 0.5% Tween 20). After 30min 
blocking in PBT2, cells were labeled with the primary antibody diluted in PBT2 
overnight at 4˚C in a humid chamber. After washing with PBT2, the secondary 
antibody was applied for 1h at room temperature. The labeled cells were then 
washed with PBT2 and finally with 5mg/ml BSA + 0.5% Tween 20 in PBS. The slides 
were air dried, mounted with 1mg/ml phenylendiamine solution in PBS pH9.0 + 
70% glycerol, sealed with a coverslip and observed with a wide-field fluorescence 
microscope (Zeiss Axioplan 2 MOT). Antibodies: Mouse α-actin (MP Biomedicals, 
1/1000 dilution), Cy3-conjugated goat α-mouse (Molecular Probes, 1/250 dilution). 
 
5.3.3/ Electron microscopy 
Chemical fixation procedure: 10uOD cells grown to early log phase were harvested 
on a 0.45µm Millipore filter apparatus (Nalgene), washed with 0.1M cacodylate 
buffer and resuspended in 10ml 0.1M cacodylate buffer containing 3% 
glutaraldehyde for fixation (1h room temperature then overnight at 4˚C). Next day, 
samples were washed twice with 50mM KPi pH 7.5 and spheroplasted in 50mM KPi 
pH 7.5 + 0,125mg/ml Zymolase 100T (ICN Biomedicals) at 37˚C for 40min. Then, 
the spheroplasted cells were washed and resuspended in 0.1M ice-cold cacodylate. 
100µl of each sample was transferred in a new tube, pelleted and incubated for 1h 
on ice with 0.1M cold cacodylate containing 2% OsO4. The pellets were washed with 
water and further incubated in 0.1M cacodylate + 2% UrAc for 1h at room 
temperature. After washing the UrAc solution with water, samples were dehydrated 
by consecutive washes in increasing concentration of EtOH and a final wash with 
EM grade acetone. The embedding was performed according to manufacturers 
instruction using SPURR low-viscosity embedding media (Polyscience Inc.) and dried 
at 80˚C for 24h. Samples were then cut, mounted on grids and sections stained with 
lead citrate and UrAc. The samples were observed using a Panasonic Morgani 
transmission electron microscope. The reagents for this procedure were purchased 
from Electron Microscopy Sciences. M. Wilsch-Bräuninger provided technical 
assistance throughout the procedure. 
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Cryo-fixation procedure: Yeast cultures grown to early log phase were 
cryoimmobilized using an EMPACT2+RTS high-pressure freezer system (Leica 
Microsystems), freeze-substituted in acetone + 1% OsO4 + 0.1% UrAc and embedded 
in epon [389]. Cut samples were stained with UrAc and lead citrate and observed 
with a TECHNAI 12 (FEI) transmission electron microscope. This procedure was 
done in collaboration with T. Muller-Reichert and J. Maentler. 
 
5.3.4/ Protein preparation and immunodetection 
Total cell extracts were prepared by post-alkaline extraction [390] and standard 
procedures were used for SDS-PAGE and western blotting. HRP-conjugated 
secondary antibodies were detected with the ECL western blotting detection reagents 
from Amersham. Apparent molecular weights were estimated with the broad range 
Prestained Protein Marker from New England Biolabs. Colony immunobloting for 
CPY overlay assays was performed as previously described [225]. 
 
The goat α-GFP antibody used for immuno-precipitation and the rabbit α-GST 
antibody were produced by the protein expression facility of the MPI-CBG, Dresden. 
The rabbit α-Pik1 antibody was affinity purified in the Walch-Solimena Lab, MPI-
CBG, Dresden. Aliquots of rabbit α-CPY antibodies were kindly provided by P. 
Novick (Yale University) and T. Stevens (University of Oregon). The following 
antibodies were purchased from external companies: mouse α-GFP (for detection) 
from Roche, rabbit α-HA (HA.11) from Covence, rabbit α-Adh1 from Chemicon 
International Inc., mouse α-actin from MP Biomedicals, HRP-conjugated goat α-
mouse from Pierce, HRP-conjugated goat α-rabbit from Dianova and Cy3-conjugated 
goat α-mouse from Molecular Probes. See below for the purification of the rabbit α-
Sec7 antibody. 
 
5.3.5/ In vitro pull-down assays  
Recombinant proteins were produced in BL21 as GST fusion proteins. Expression of 
the constructs was induced overnight at 18˚C with 0.5mM IPTG (Fermentas). 
Bacteria cells were lysed with a French press in the presence of protease inhibitors 
(complete protease inhibitors mix from Roche) and the supernatant was incubated 
with 100µl Glutathione Sepharose 4B slurry (Amersham). Unbound proteins were 
washed away with PBS + protein inhibitors and the beads resuspended in yeast lysis 
buffer (50mM Tris pH7.5, 150mM NaCl, 1mM EDTA, 1mM DTT and protease 
inhibitors). In parallel, yeast protein extracts were prepared from mid-log phase 
cultures by glass bead lysis and cleared with a 2500g spin. The amount of protein 
per sample was adjusted using a protein assay kit from Bio-Rad (between 4-6 µg/ml 
protein depending on the experiments). The immobilized recombinant proteins were 
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incubated for 2h at 4˚C with the yeast extracts. The beads were washed with lysis 
buffer, washing buffer (20mM Tris pH7.5, 350mM NaCl, 2mM EDTA and 0.1% NP-
40) and PBS. Bound proteins were recovered by boiling the beads in 50µl 1X SDS 
sample buffer and analyzed either by SDS-PAGE and immuno-blotting or mass 
spectrometry. Quantification of the immunoblots was done with the Image Quant 
Software. Samples for mass spectrometry were separated on a 4-16% gradient SDS-
PAGE gel and stained with Coomassie (Serva). Sample processing and the nano-
electronspray mass spectrometry analysis were performed by A. Shevchenko and H. 
Thomas from the MS facility (MPI-CBG, Dresden). 
 
5.3.6/ Ypt/Rab effector columns 
Recombinant GST-Ypt32p proteins were purified from BL21 strains. Expression of 
the recombinant construct was induced for 5h at 20˚C with 0.5mM IPTG 
(Fermentas). Cells were harvested, resuspended in cold lysis buffer (PBS + 5mM 
MgCl2) and frozen in liquid nitrogen. Bacteria were lysed with a French press in lysis 
buffer in the presence of 200µM GDP, 5µg/ml DNase, 5µg/ml RNase and 1mM DTT. 
The supernatant was cleared by a 30min, 12000g spin and incubated with 1ml 
Glutathione Sepharose 4B slurry (Amersham) for 2h at 4˚C. Unbound proteins were 
washed with cold PBS containing 5mM MgCl2, 1mM DTT and 100µM GDP. Loading 
of the Ypt32p proteins with GTP-γ-S or GDP was performed as previously described 
[391]. Yeast cytosol was prepared by glass beads lysis of mid-log phase cultures and 
cleared by a 20min 100000g spin. The resulting protein extract was dialyzed against 
PBS containing 20mM HEPES pH7.5, 100mM NaCl, 5mM MgCl2 and 1mM DTT. The 
binding reaction to the recombinant GST-Ypt32p protein was done for 2h at 4˚C. 
The subsequent washing and elution steps were performed as described in [391]. 
The recovered proteins were concentrated with the methanol-chloroform 
precipitation procedure [392] and analyzed by mass spectrometry as described 
above (see § 5.3.5). 
 
5.3.7/ Immunoprecipitation  
General IP protocol: 200uOD yeast cells grown to mid-log phase were harvested and 
washed twice with ice-cold water and once with lysis buffer (50mM Tris pH7.5, 
100mM NaCl, 1mM EDTA, protease inhibitors and detergent). Protein extracts were 
prepared by glass bead lysis and cleared by two consecutive centrifugation steps 
(5min at 2000g + 20min at 18000g). The protein amount recovered was measured 
with a protein assay kit from Bio-Rad (typically between 4-6 µg/ml), and the 
concentration of all samples was adjusted using lysis buffer. 500µl yeast lysate was 
incubated for 2h at 4˚C with 20µl goat α-GFP antibody on wheel, before addition of 
50µl Protein G Sepharose (Pierce). After 30min at 4˚C on wheel, the beads were 
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washed 4X with 1ml lysis buffer and resuspended in 50µl 1X SDS sample buffer. 
Samples were analyzed by SDS-PAGE and immunoblotting. 
 
Co-IP between ArfGEFs and Pik1p: we used 0.5% Tween 20 as detergent and the 
beads were washed with lysis buffer containing 200mM NaCl.  
 
Co-IP between ArfGEFs and Cpd1p: we used 1% NP-40 as detergent and the beads 
were washed with lysis buffer containing 300mM NaCl. In addition, we omitted the 
fast centrifugation step to clear the lysate (20min 18000g). 
 
5.3.8/ Subcellular fractionation 
100uOD yeast cells grown to early-log phase were harvested and washed with ice-
cold washing solution (50mM KPi pH7.5, 10mM NaN3, 10mM NaF). The cells were 
resuspended in spheroplasing solution (50mM KPi pH7.5, 1.4M sorbitol, 0.4%vol β-
mercaptoethanol, 0.1mg/ml Zymolase 100T (ICN Biomedical), 10mM NaN3) and 
incubated at 37˚C for 45min. After cooling on ice, the samples were loaded on top of 
a sorbitol cushion (50mM KPi pH7.5, 1.7M sorbitol, 1X complete protease inhibitors 
mix from Roche) and centrifuged for 12min at 1800g. The pellet was resuspended in 
1ml ice-cold lysis buffer (20mM TEA pH7.2, 0.2M sorbitol, 1mM PMSF, complete 
protease inhibitors mix from Roche) and homogenized in a 2ml glass-Teflon 
homogenizer (Braun-Melsungen, ~50 strokes). The lysates were cleared twice with 
5min 1800g spins. 600µl of this supernatant was used as total lysate for the first 
fractionation step done at 13000g for 10min (S13+P13). A small aliquot of the 
supernatant (50µl of S13) was kept for analysis and the rest used for the second 
fractionation step done at 100000g for 45min. Both pellets (P13 +P100) were 
resuspended in 500µl lysis buffer and processed for analysis. 30µl of each fraction 
in 1X SDS sample buffer was analyzed by SDS-PAGE and immunoblotting. 
Quantification of the results was done with the Image Quant Software. 
 
5.3.9/ CPY pulse-chase experiments 
CPY maturation protocol: For each final precipitation, 2.5 uOD yeast cells, grown to 
early-log phase in –methionine media, were concentrated to 2uOD/ml in fresh –
methionine media and incubated for 30min at either 25 or 37˚C. Each sample was 
then kept at respective temperature till the end of the chase. At the start of the 4min 
pulse, 0.15mCi/ml [S35]-methionine (from a 10mCi/ml stock, L-[S35]-methionine, 
Perkin Elmer Life Sciences) was added to each sample. The pulse was stopped by 
adding a 10% v/v of non-radioactive cys-met solution (5mg/ml cystein + 5mg/ml 
methionine) and samples were chased at respective temperature. 1ml labeled 
culture was recovered for each time point (0, 10 and 30min) and immediately 
 94 
transfered to an ice cold tube containing 110µl of a 50% TCA solution. After 5min 
incubation on ice, the precipitated proteins were recovered by centifugation and the 
pellets washed twice with ice-cold acetone. The dried pellets were resuspended in 
75µl boiling buffer (10mM Tris pH8.0, 25mM EDTA pH8.0, 1% SDS). Acid-washed 
glass beads were added to about 2/3 of the top of the fluid and the tubes vortexed 
for 1min, followed by 5min boiling. After addition of 700µl IP buffer (10mM Tris 
pH8.0, 150mM NaCl, 0.1mM EDTA, 0.5% Tween 20), each sample was centrifuged 
at 13000g for 10min at 4˚C. 650µl of supernatant was diluted with an equal volume 
of IP buffer and incubated overnight on wheel at 4˚C with a polyclonal α-CPY 
antibody. Next morning, every sample was incubated for 3h with 50µl washed 
Protein A Sepharose (Amersham). The recovered beads where washed twice with 1ml 
IP buffer and twice with a freshly prepared solution of 2M Urea in IP buffer. The 
beads were resuspended in 50µl 2X SDS sample buffer and boiled for 5min. The 
proteins were separated by SDS-PAGE using an 8% gel. Then, the gel was fixed for 
30min in a 10% isopropanol + 10% acetic acid solution, rinced with water and the 
radioactive signal was enhanced by 1h incubation in 0.5M salycilate solution in 20% 
methanol and 1% glycerol. After vacuum drying for 2h at 60˚C, the signal was 
detected by autoradiography. 
 
CPY missorting (in/out) protocol: 0.5 uOD yeast cells, grown to early-log phase in –
methionine media, were concentrated to 1uOD/ml in fresh –methionine media 
containing 50mM KPi pH5.7 and 2mg/ml BSA and incubated for 30min at either 25 
or 37˚C. Each sample was then kept at respective temperature till the end of the 
chase. At the start of the 10min pulse, 0.1mCi [S35]-methionine (from a 10mCi/ml 
stock, L-[S35]-methionine, Perkin Elmer Life Sciences) was added to each sample. 
The pulse was stopped by adding a 10% v/v of non-radioactive cys-met solution 
(5mg/ml cystein + 5mg/ml methionine). After 30 min chase and addition of 5µl 1M 
NaN3, supernatant and pellet fractions were separated by a fast spin. 100µl 10X IP 
buffer (0.9M Tris pH8.0, 20mM EDTA, 1% SDS, 1% Triton X-100) + 10µl 10X 
complete protease inhibitors mix (Roche) and 150µl water were added to the 
supernatants, which were stored on ice. In parallel, the pellets were washed in 
50mM Tris pH9.5 + 10mM DTT +10mM NaN3 and resuspendend in 150µl 
spheroplast mix (50mM KPi pH7.3, 1.2M sorbitol, 10mM NaN3 and 250µg/ml 
Zymolase 100T (ICN Biomedicals)). After 30min incubation at 30˚C, the cells were 
resuspended in 100µl 10X IP buffer + 10µl 10X complete protease inhibitors mix 
(Roche) and 670µl water. All samples (pellets and supernatants) were then boiled for 
5min, cooled on ice and incubated overnight on wheel at 4˚C with a polyclonal α-
CPY antibody. Next morning, every sample was incubated for 3h with 50µl washed 
Protein A Sepharose (Amersham). The recovered beads where washed twice with 
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with 1ml washing buffer (10mM Tris pH8.0, 2mM EDTA, 0,1% SDS, 0,1% Triton X-
100) and resuspended in 50µl 2X SDS sample buffer. Samples were analyzed by 
SDS-PAGE followed by autoradiography as described above for the CPY maturation 
protocol. Quantification of the results was done with the Image Quant Software. 
 
5.3.10/ General secretion assay 
2.5 uOD yeast cells, grown to early-log phase in –methionine media, were 
concentrated to 2uOD/ml in fresh –methionine media and preincubated for 30min 
at either 25 or 37˚C. Each sample was then kept at respective temperature till the 
end of the chase. At the start of the 5min pulse, 0.15mCi/ml [S35]-methionine (from 
a 10mCi/ml stock, L-[S35]-methionine, Perkin Elmer Life Sciences) was added to 
each sample. The pulse was stopped by adding a 10% v/v of non-radioactive cys-
met solution (5mg/ml cystein + 5mg/ml methionine). After 30min chase, the cells 
were separated from the supernatant by a quick spin and both were processed 
independently. 300µl from the media fraction was immediately transferred to a cold 
tube and treated with 20µl of a 200mM NaN3 + 200mM NaF solution. Remaining 
cells were removed by an additional centrifugation step. Proteins were then 
recovered by TCA precipitation (10% v/v TCA, 30 min on ice). The precipitates were 
washed with cold acetone and resuspended in 50µl 1X sample buffer. In parallel, the 
cells were resuspended in 300µl 1X loading buffer, homogenized with glass beads 
and used as loading control for the experiments. Samples were analyzed by SDS-
PAGE followed by autoradiography as described above (see § 5.3.9). 
 
5.3.11/ Invertase secretion 
The secretion of invertase was measured as described previously [393] with cells 
grown to early log phase in YPD at 25˚C. All following steps were performed in 
duplicates: 3 ODu cells were harvested by centrifugation. Half of each sample was 
washed twice with 10mM NaN3 and stored on ice (uninduced sample) while the rest 
was resuspended in 1ml YP + 0.1% glucose and incubated at respective temperature 
(25 or 37˚C) for 1h before harvesting, NaN3 washing and ice storage (induced 
samples). To measure the amount of internal invertase, 0.5 ml of each sample was 
spheroblasted at 37˚C for 45 min with 0.1mg/ml Zymolase 100T (ICN Biomedicals) 
in a solution containing 2.8M sorbitol, 0.1M Tris pH7.5, 10mM NaN3 and 4µl/ml β-
mercaptoethanol. After spheroblasting cells were recovered by centrifugation and 
lyzed with 0.5ml 0.5% Triton TX-100. Quantification of external and internal 
invertase activity was done by incubating 20µl of cell suspension or lysate 
respectively with 80µl NaOAc pH5,1 + 30µl 0.5M sucrose. After 30 min at 37˚C and 
addition of 150µl 0.2M K2HPO4, the reaction was stopped by cooling the samples in 
ice water. After boiling the samples for 3 min and cooling them down on ice, the 
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amount of liberated glucose was assayed by adding 1ml of assay mix (1400U/ml 
glucose oxidase, 1mg/ml peroxidase, 10mg/ml O-dianisidine, 1.3mg/ml N-
ethylamine in 0.1M KPi pH7.0). After 30min at 37˚C, 1ml 6N HCl was added to stop 
the colorimetric reaction. All samples were analyzed by measuring the absorbance at 
λ=540nm in comparison to the blank (10mM NaN3) and the values were normalized 
to the cell density by measuring the absorbance (λ=600nm) of the starting samples. 
A standard curve for glucose (ranging between 0 and 20µg glucose in NaOAc pH5.1) 
was performed in parallel to every experiment. The percentage of invertase secretion 
was calculated using the following equations: 
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Where A = invertase activity (µMol glucose *min-1 * ml-1 * OD-1). 
 a = OD560 for 1µMol glucose (OD*µMol-1). 
 t = reaction time (min). 
 V = Reaction volume (ml). 
 
5.3.12/ Synthetic lethal screen 
The Synthetic Genetic Array (SGA) analysis was performed against the EUROSCARF 
(European Saccharomyces cerevisiae Archives for Functional analysis) knockout 
collection (http://web.uni-frankfurt.de/fb15/mirko/euroscarf/index.html) as 
described in [319] using ∆cpd1::natMX (yGY180) as bait. I carried out this 
experiment as guest student in the laboratory of C. de Virgilio (University of Geneva, 
Geneva Switzerland). 
 
5.3.13/ α-Sec7 Antibody purification 
Antibodies against the N-terminal part of Sec7p were produced in rabbits and 
affinity purified using recombinant MBP-Sec7 fusion peptide produced by the 
protein expression facility (MPI-CBG, Dresden). Crude serum was filtrated (0.22µm 
filter) and incubated with recombinant Sec7p peptide immobilized on a CNBr-
activated Sepharose (Amersham) for 50min at room temperature. The affinity matrix 
was washed first with 10mM Tris pH7.5 then with 10mM Tris pH7.5 + 0.5M NaCl. 
The bound antibodies were eluted with 0.2M glycine pH2.6 and immediately 
neutralized with 2M Tris Base. Fraction containing antibodies were pooled and 
dialyzed first against PBS and then PBS + 50% glycerol. The purified antibody was 
tested by western blotting and, as illustrated in Figure 29, specifically recognizes 
Sec7p despite the presence of a single contamination band at ~62kDa. 
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Figure 29: α-Sec7 (0641) specifically recognizes Sec7p 
After purification, the α-Sec7 antibody was tested against full yeast lysates of either wild-type 
(NY1211) or Sec7-DsRed (CSY394) overexpressing strains. The antibody specifically 
recognizes a band corresponding to the predicted size of full length Sec7p (230 kDa). The 
purified antibody recognizes only one non-specific band (*), detected around 62kDa. 
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Appendix D: Mass spectrometry analysis of the Ypt32p effector columns
First Ypt32p effector column, GDP-bound form (Maldi)
sample identification gene name MW peptides comments
ypt_a_01 the bait
ypt_a_02 heat shock 70 kDa family sse1 77 26
the bait 9
ypt_a_03 dnaK-type molecular chaperone ssa1 69 29
dnaK-type molecular chaperone ssa2 69 29
dnaK-type molecular chaperone ssc1 70 15
Heat shock protein ssb1/2 70 5
the bait 9
ypt_a_04 dnaK-type molecular chaperone ssb2 66 21
rab geranylgeranyl transferase component A mrs6/YOR370c 67 4
dnaK-type molecular chaperone ssa2 70 3
the bait 9
ypt_a_05 the bait 12
dnaK-type molecular chaperone ssb1/2 66 2
dnaK-type molecular chaperone ssa1/2 70 1
Magnesium-activated aldehyde dehydrogenase ald6 54 1 suggestion only
ypt_a_06 the bait 12
translation elongation factor tef1/YPR080W 50 2
H+-transporting two-sector ATPase atp1/YBL099W 58 1
ypt_a_07 the bait 16
translation elongation factor tef1/YPR080W 50 12
ypt_a_08 the bait 20
enolase eno1/2 47 2
ypt_a_09 the bait 16
dnaJ protein homolog YNL064c 45 1 suggestion only
ypt_a_10 the bait 19
ypt_a_11 the bait 16
translation elongation factor tef1/YPR080W 50 6
ypt_a_12 the bait 7
ypt_a_13 the bait 8
glyceraldehyde-3-phosphate dehydrogenase YGR192c 36 8
ypt_a_14 the bait 9
glyceraldehyde-3-phosphate dehydrogenase YGR192c 36 4
40S ribosomal protein S0-A/B 28 2
translation elongation factor eEF-1 beta chain YAL003w 23 1
ypt_a_15 the bait 10
ypt_a_16 the bait 10
ypt_a_17 the bait 10
Nascent polypeptide-associated complex egd2/YHR193c 19 2
phosphoglycerate mutase gpm1/YKL152C 27 1
ypt_a_18 the bait 13
First Ypt32p effector column, GTP-bound form (Maldi)
sample identification gene name MW peptides comments
ypt_b_01 translation elongation factor eft2/YDR385w 93 21
the bait 13
6-phosphofructokinase pfk1 105 3
GTP-binding protein GUF1 guf1 73 1
ypt_b_02 the bait 13
endopeptidase Clp ATP-binding chain precursor, mitochondrial hsp78/YDR258c 91 2
ypt_b_03 heat shock 70 kDa family sse1 77 26
the bait 12
heat shock 70 kDa family sse2 77 11
dnaK-type molecular chaperone ssc1 71 3
18
sample identification gene name MW peptides comments
glutamate-tRNA ligase gus1/YGL245w 83 1
heat shock protein hsc82 81 1
Glucosamine--fructose-6P aminotransferase gfa1 80 1
ypt_b_04 dnaK-type molecular chaperone kar2 74 17
dnaK-type molecular chaperone ssc1 71 13
the bait 11
heat shock protein hsc82 81 3
heat shock 70 kDa family sse1 77 4
multifunctional amino acid-tRNA ligase ded82/YHR020w 77 4
dnaK-type molecular chaperone ssa1/2 70 2
protein transport protein sec23/YPR181C 85 1
acetate-CoA ligase acs2/YLR153C 75 2
heat shock protein ssb1 66 1
ypt_b_05 heat shock protein ssa1/2 70 31
dnaK-type molecular chaperone ssc1 71 21
the bait 12
heat shock protein ssa3 71 8
Vacuolar membrane ATPase subunit a vma1/YDL185W 64 11
heat shock protein ssb1 66 7
tryptophan synthase trp5/YGL026c 77 2
glycine-tRNA ligase grs1/YBR121C 75 1
ypt_b_06 heat shock protein ssb1/2 66 24
heat shock protein ssa1/2 70 18
the bait 12
rab geranylgeranyl transferase component A mrs6/YOR370c 67 8
acetolactate synthase ilv2/YMR108w 75 4
fimbrin sac6/YDR129c 72 3
succinate dehydrogenase sdh1/YKL148c 70 2
ypt_b_07 the bait 11
heat shock protein ssb2 66 9
heat shock protein ssa2 70 5
Magnesium-activated aldehyde dehydrogenase ald6/ YPL061w 54 6
pyruvate kinase cdc19/YAL038w 109 3
phosphoprotein phosphatase cna1/YLR433c 63 2
ypt_b_08 the bait 13
heat shock protein ssb1/2 66 6
H+-transporting two-sector ATPase atp1/YBL099W 58 7
Translation elongation factor 1-alpha tef1/YPR080W 50 4
alpha,alpha-trehalose-phosphate synthase tps1/YBR126c 56 3
heat shock protein ssa1/2 70 4
ypt_b_09 the bait 15
Translation elongation factor 1-alpha tef1/YPR080W 50 14
heat shock protein ssa2 70 2
heat shock protein ssb1/2 66 1
ypt_b_10 the bait 24
ypt_b_11 the bait 19
actin 41 3
alcohol dehydrogenase adh1 37 2
Translation elongation factor 1-alpha tef1/YPR080W 50 1
hypothetical protein pil1/YGR086c 38 1 suggestion
ypt_b_12 the bait 18
Translation elongation factor 1-alpha tef1/YPR080W 50 7
hypothetical protein YIL041w 37 1 suggestion
ypt_b_13 the bait 18
Glyceraldehyde-3-phosphate dehydrogenase tdh1,2 or 3 36 9
Translation elongation factor 1-alpha tef1/YPR080W 50 3
ypt_b_14 the bait 17
Glyceraldehyde-3-phosphate dehydrogenase tdh1,2 or 3 36 22
40S ribosomal protein S9-A/B 22 1
translation initiation factor eIF-2 alpha chain sui2/YJR007W 35 1
ypt_b_15 the bait 17
Glyceraldehyde-3-phosphate dehydrogenase tdh1,2 or 3 36 19
acidic ribosomal protein P0.e 34 5
19
sample identification gene name MW peptides comments
ribosomal protein L5.e 34 1 suggestion
ypt_b_16 the bait 16
Glyceraldehyde-3-phosphate dehydrogenase tdh1,2 or 3 36 8
acidic ribosomal protein P0.e 34 4
BMH1 protein bmh1/YER177W 30 1
succinate-CoA ligase lsc1/YOR142w 35 1
actin-capping protein beta chain cap2/YIL034c 33 1 suggestion
ypt_b_17 the bait 18
hypothetical protein asc1/YMR116c 34 8
Glyceraldehyde-3-phosphate dehydrogenase tdh1,2 or 3 36 5
26S proteasome regulatory complex rpn12/YFR052W 32 1
F1F0-ATPase gamma subunit atp3/YBR039w 34 1
40S ribosomal protein S0-A 38 1
ypt_b_18 the bait 17
Glyceraldehyde-3-phosphate dehydrogenase tdh2 or 3 36 2
40S ribosomal protein S4 29 1
60S ribosomal protein L2 27 1
ypt_b_19 the bait 16
phosphoglycerate mutase 1, chain A, B, C or D gpm1, 2 or 3 27 7
Translation elongation factor 1-alpha tef1/YPR080W 50 3
Glyceraldehyde-3-phosphate dehydrogenase tdh2 or 3 36 2
40S ribosomal protein S5 25 1
Nascent polypeptide-associated complex egd2/YHR193c 19 1
translation initiation factor eIF-4E cdc33/YOL139c 24 1
ypt_b_20 the bait 17
phosphoglycerate mutase 1, chain A, B, C or D gpm1, 2 or 3 27 5
Glyceraldehyde-3-phosphate dehydrogenase tdh2 or 3 36 4
GTP-binding protein GSP1 or GSP2 gsp1/2 25 3
Mitochondrial thiol peroxidase prx1/YBL064c 25 2
H+-exporting ATPase vma4/YOR332W 26 2
F1F0-ATPase gamma subunit atp3/YBR039w 34 1
succinate dehydrogenase sdh2/YLL041c 30 2
ypt_b_21 the bait 17
heat shock protein ssb1/2 66 2
ribosomal protein L10a.e 24 2
Glyceraldehyde-3-phosphate dehydrogenase tdh2 or 3 36 2
ypt_b_22 the bait 14
heat shock protein mge1/YOR232W 26 6
40S ribosomal protein S7-A 21 4
Glyceraldehyde-3-phosphate dehydrogenase tdh2 or 3 36 2
ribosomal protein L9.e.A 22 2
Thiol-specific antioxidant protein tsa1/YML028W 21 1
ypt_b_23 the bait 17
glutaredoxin grx1/YCL035C 12 4
acidic ribosomal protein P2.e.B 11 3
40S ribosomal protein S14-A 14 3
acidic ribosomal protein P2.e.A 11 2
60S ribosomal protein L33-A 12 2
calmodulin 16 2
Glyceraldehyde-3-phosphate dehydrogenase 3 tdh3 36 3
H+-exporting ATPase vma10/YHR039c-a 13 2
hypothetical protein zeo1/YOL109W 13 2
60S ribosomal protein L33-B 12 2
40S ribosomal protein 14 1 suggestion
60S ribosomal protein L22-A 14 1
ypt_b_24 the bait 15
thioredoxin I trx1/YLR043C 11 4
thioredoxin II trx2/YGR209C 11 2
ubiquitin/polyubiquitin 2
acidic ribosomal protein P2.e.A 11 1
40S ribosomal protein S14-A 14 1
ribosomal protein L23a.e 16 1
20
Second Ypt32p effector column, GDP-bound form (Maldi)
sample identification gene name MW peptides comments
Ypt32_2_1 the bait YPT32 25 13
Glyceraldehyde 3-phosphate dehydrogenase 3 GAP1 36 3
Ypt32_2_2 the bait YPT32 25 14
Glyceraldehyde 3-phosphate dehydrogenase 3 GAP1 36 2
Ypt32_2_3 the bait YPT32 25 13
regulatory protein PDC2 103 7
Glyceraldehyde 3-phosphate dehydrogenase 3 GAP1 36 4
Ypt32_2_4 the bait YPT32 25 14
Glyceraldehyde 3-phosphate dehydrogenase 3 GAP1 36 3
Ypt32_2_5 Heat shocks 70 family proteins SSE1 77 31
Heat shocks 70 family proteins SSE2 77 6+ 1 unique
the bait YPT32 25 10
Glyceraldehyde 3-phosphate dehydrogenase 3 GAP1 36 3
Protein kinase STE20 102 1 Suggestion only!!!
SIR3 SIR3 112 1 Suggestion only!!!
Ypt32_2_6 Heat shocks 70 family proteins SSA2 69 30
Heat shocks 70 family proteins SSA1 69 23+5 unique
Heat shocks 70 family proteins SSC1 70 20
Heat shocks 70 family proteins SSB2 67 16
Heat shocks 70 family proteins SSB1 67 13+1 unique
the bait YPT32 25 11
Microtubule motor activity, linked to spindle SMY1 74 6
Rab GDI MRS6 67 5
Glyceraldehyde 3-phosphate dehydrogenase 3 GAP1 36 4
MAP kinase kinase BCK1 163 1 Suggestion only!!!
Hypothetical protein DNF3 188 2 Suggestion only!!!
Ypt32_2_7 Heat shocks 70 family proteins SSB2/1
the bait YPT32
Heat shocks 70 family proteins SSA1
Rab GDI MRS36
Glyceraldehyde 3-phosphate dehydrogenase 3 GAP1
60S ribosomal protein L2 RPL2 27 2 Suggestion only!!!
Acetolactate syntase ILV2 74 2
Second Ypt32p effector column, GTP-bound form (Maldi)
sample identification gene name MW peptides comments
Ypt32_1_01 the bait YPT32 25 20
Glyceraldehyde 3-phosphate dehydrogenase 3 GAP1 36 1
Heat shock protein SSB2 66 2
Putative reductase YNR074c 41 1 Suggestion only!!!
Dynamin-like protein, mitochondrial MGM1 101 1 Suggestion only!!!
Ribosomal protein YJR123w 25 1 Suggestion only!!!
pyrimidine synthesis protein URA2 245 1 Suggestion only!!!
Ypt32_1_02 the bait YPT32 25 14
Glyceraldehyde 3-phosphate dehydrogenase 3 GAP1 36 3
Translation elongation factor eEF-1 alpha-A chain TEF1 50 1 Suggestion only!!!
Ypt32_1_03 the bait YPT32 25 12
Glyceraldehyde 3-phosphate dehydrogenase 3 GAP1 36 4
Heat shocks 70 family proteins SSB1 66 2
regulatory protein PDC2 103 2
hypothetical protein YDR128w 130 1 Suggestion only!!!
Ypt32_1_04 the bait YPT32 25 13
translation elongation factor eEF-2 EFT2 93 5
Glyceraldehyde 3-phosphate dehydrogenase 3 GAP1 36 2
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sample identification gene name MW peptides comments
Ypt32_1_05 Heat shock protein SSE1 77 24
the bait YPT32 25 10
Heat shock protein SSE2 77 2+4 unique
Glyceraldehyde 3-phosphate dehydrogenase 3 GAP1 36 7
Heat shock protein HSC82 81 1
Ypt32_1_06 Heat shocks 70 family proteins SSA2 69 27
Heat shocks 70 family proteins SSA2 69 20+5 unique
Heat shocks 70 family proteins SSC1 70 16
Heat shocks 70 family proteins SSB2 67 14
the bait YPT32 25 6
Rab GDI MRS6 67 7
Glyceraldehyde 3-phosphate dehydrogenase 3 GAP1 36 4
Heat shocks protein MSI3 70 1
Ypt32_1_07 Heat shocks 70 family proteins SSB2/1 69 27
Heat shocks 70 family proteins SSA1 69 13
the bait YPT32 25 11
Rab GDI MRS6 67 12
Glyceraldehyde 3-phosphate dehydrogenase 3 GAP1 36 3
Acetolactate syntase ILV2 74 2
Succinate dehydrogenase, mitochondrial YJL045W 70 3
Unknown function, mitochondria MPM1 70 1
Vacuolar sorting protein VPS3 118 1 Suggestion only!!!
Hypothetical protein CAF120 118 3 Suggestion only!!!
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